Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,A1BG,Alpha-1B-glycoprotein,19786,88,1.71 [0.49-5.98],0.4034912441478686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AAMDC,Mth938 domain-containing protein,19224,81,0.95 [0.63-1.44],0.8085427542497581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AARSD1,Alanyl-tRNA editing protein Aarsd1,22609,108,0.95 [0.69-1.29],0.7199866716318197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABCA2,ATP-binding cassette sub-family A member 2,19095,82,1.00 [0.54-1.85],0.9954133081005572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABHD14B,Protein ABHD14B,22453,108,1.09 [0.80-1.48],0.581991049746049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABL1,Tyrosine-protein kinase ABL1,22609,108,1.00 [0.77-1.29],0.9726427293411744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABO,Histo-blood group ABO system transferase,19789,88,0.96 [0.84-1.11],0.6036699595438909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABRAXAS2,BRISC complex subunit Abraxas 2,19095,82,0.90 [0.64-1.25],0.5157735319775838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22178,107,1.04 [0.85-1.29],0.6860822765499661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19421,86,1.02 [0.75-1.38],0.9083553511000456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19770,87,0.84 [0.66-1.06],0.1471837319701391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAN,Aggrecan core protein,22495,109,1.05 [0.57-1.94],0.8780014515425076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE,Angiotensin-converting enzyme,19789,88,1.26 [0.60-2.64],0.5371731846980095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,22307,105,1.43 [1.08-1.87],0.0113518394847973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACHE,Acetylcholinesterase,19321,84,1.19 [0.65-2.19],0.5678959974689712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOT13,Acyl-coenzyme A thioesterase 13,19704,87,0.91 [0.76-1.09],0.2915184736447861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22722,109,1.39 [1.04-1.86],0.0271354872027071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19176,84,0.51 [0.30-0.86],0.0119157089125741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP5,Tartrate-resistant acid phosphatase type 5,22819,108,0.96 [0.58-1.60],0.8836143256786412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP6,Lysophosphatidic acid phosphatase type 6,22890,109,0.78 [0.63-0.97],0.024097513707289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRBP,Acrosin-binding protein,19698,87,1.03 [0.61-1.72],0.9246465570462624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRV1,Acrosomal protein SP-10,19176,84,0.94 [0.77-1.15],0.5501327133497123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19095,82,1.15 [0.66-2.01],0.622437565860225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",22307,105,1.53 [1.13-2.07],0.005821117520115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,19095,82,1.34 [1.00-1.80],0.0526767261085058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN4,Alpha-actinin-4,22323,107,0.69 [0.37-1.29],0.2396095610255699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,22480,108,2.10 [1.16-3.83],0.015067338791405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY1,Aminoacylase-1,22722,109,0.98 [0.75-1.30],0.9135916708982618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19095,82,0.88 [0.60-1.30],0.5266895409234232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACYP1,Acylphosphatase-1,19257,84,0.78 [0.56-1.08],0.1329172975899735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA,Adenosine deaminase,22990,109,0.95 [0.59-1.51],0.812883794811241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,22609,107,1.24 [0.86-1.81],0.253820706102527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19176,84,1.82 [1.05-3.15],0.0338074631342938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22307,105,1.90 [1.10-3.28],0.0204717337560086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22521,108,1.18 [0.75-1.88],0.4730700285115673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22990,109,1.10 [0.68-1.80],0.6890954752868848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22893,109,1.17 [0.66-2.07],0.5875299849897826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19704,87,1.69 [0.90-3.19],0.1023751798294275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19176,84,1.28 [0.69-2.40],0.4342916418118572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23006,109,0.56 [0.28-1.09],0.0868589870591664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22609,108,1.21 [0.80-1.85],0.3692837402184605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22307,105,1.38 [0.92-2.08],0.1150204352649596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19176,84,1.09 [0.61-1.97],0.765556854316136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22780,108,0.99 [0.68-1.44],0.9538013917704866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,19775,88,1.78 [1.05-2.99],0.0307434673941899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL4,ADAMTS-like protein 4,19224,81,2.25 [0.99-5.11],0.0531479730090041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL5,ADAMTS-like protein 5,19770,87,1.01 [0.61-1.70],0.957718597339952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22178,107,0.77 [0.41-1.45],0.4199519425729285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADD1,Alpha-adducin,19321,84,0.70 [0.52-0.95],0.0209804640729525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRB3,Adhesion G protein-coupled receptor B3,22480,108,1.09 [0.66-1.81],0.7358475350855191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRD1,Adhesion G-protein coupled receptor D1,19321,84,1.03 [0.61-1.73],0.9197752899506504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE1,Adhesion G protein-coupled receptor E1,19704,87,0.92 [0.63-1.34],0.6555888863551955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE2,Adhesion G protein-coupled receptor E2,22802,107,1.17 [0.65-2.10],0.6108244017283522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE5,Adhesion G protein-coupled receptor E5,22895,109,0.99 [0.58-1.69],0.9623518673073712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRF5,Adhesion G protein-coupled receptor F5,19770,87,0.99 [0.46-2.17],0.987227905006102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,22609,108,1.08 [0.91-1.28],0.3731407263314935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG2,Adhesion G-protein coupled receptor G2,22722,109,0.60 [0.36-1.00],0.0491272374935306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRV1,Adhesion G-protein coupled receptor V1,19125,83,1.04 [0.77-1.40],0.8014533846883587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH1B,All-trans-retinol dehydrogenase,19321,84,1.01 [0.77-1.32],0.9700147816861114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22307,105,1.18 [0.95-1.46],0.136143965967173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,19786,88,1.69 [1.27-2.26],0.0003659111339432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,22917,109,2.45 [1.28-4.69],0.0070634611915639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADRA2A,Alpha-2A adrenergic receptor,19095,82,1.12 [0.85-1.48],0.4058224174229501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFAP1,Actin filament-associated protein 1,19321,84,0.92 [0.71-1.21],0.5665883627801472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFM,Afamin,19786,88,0.38 [0.14-1.01],0.053158425543585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFP,Alpha-fetoprotein,22439,108,1.15 [0.89-1.50],0.2857543539818628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGBL2,Cytosolic carboxypeptidase 2,19125,83,0.90 [0.73-1.11],0.3276731648023315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGER,Advanced glycosylation end product-specific receptor,22657,107,1.21 [0.81-1.82],0.3535526675927097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR2,Anterior gradient protein 2 homolog,22055,108,1.11 [0.93-1.31],0.2522517473301695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR3,Anterior gradient protein 3,22144,107,0.81 [0.60-1.09],0.1615483716722657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,22802,107,1.74 [1.16-2.60],0.0077683754813107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRP,Agouti-related protein,22990,109,1.20 [0.87-1.67],0.2717648528469603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGT,Angiotensinogen,19789,88,1.05 [0.40-2.75],0.9218215608707516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGXT,Serine--pyruvate aminotransferase,22722,109,1.13 [0.91-1.40],0.2840893358492283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHCY,Adenosylhomocysteinase,22722,109,1.01 [0.79-1.31],0.9099807355400812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK,Neuroblast differentiation-associated protein AHNAK,19224,81,0.77 [0.39-1.55],0.4688501341292412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK2,Protein AHNAK2,19224,81,0.95 [0.46-1.93],0.8813359253372856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19698,87,0.98 [0.71-1.35],0.8832456077797763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSG,Alpha-2-HS-glycoprotein,19789,88,0.99 [0.46-2.11],0.9730955717330322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSP,Alpha-hemoglobin-stabilizing protein,22685,107,0.96 [0.78-1.17],0.6698389483916409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",19237,83,0.69 [0.49-0.98],0.0360244109663167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1,Allograft inflammatory factor 1,22178,107,1.11 [0.80-1.53],0.5424056768648484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1L,Allograft inflammatory factor 1-like,19224,81,0.79 [0.50-1.26],0.3252304593736528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22577,108,1.01 [0.86-1.19],0.8634681790736805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK1,Adenylate kinase isoenzyme 1,22722,109,0.93 [0.71-1.22],0.5977976500292308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK2,"Adenylate kinase 2, mitochondrial",19716,86,0.87 [0.72-1.06],0.178633442645431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKAP12,A-kinase anchor protein 12,19321,84,0.73 [0.25-2.13],0.5629619204905116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B1,Aldo-keto reductase family 1 member B1,22178,107,1.00 [0.79-1.26],0.9740836205937382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B10,Aldo-keto reductase family 1 member B10,19237,83,0.96 [0.69-1.34],0.8137866964379272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1C4,Aldo-keto reductase family 1 member C4,22307,105,0.95 [0.66-1.34],0.7554184028822198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19176,84,1.06 [0.79-1.43],0.7037803897100365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT1S1,Proline-rich AKT1 substrate 1,22218,108,0.90 [0.69-1.17],0.4200165628173014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT2,RAC-beta serine/threonine-protein kinase,19729,85,0.95 [0.81-1.11],0.5163980420578556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT3,RAC-gamma serine/threonine-protein kinase,22073,107,0.93 [0.68-1.26],0.6245583094835088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,23006,109,2.29 [1.01-5.19],0.0468711300901401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH1A1,Retinal dehydrogenase 1,22727,108,1.02 [0.75-1.39],0.9087971836224276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19698,87,0.83 [0.52-1.34],0.4544177876655197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22660,107,1.02 [0.80-1.29],0.8828198884209815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19729,85,1.14 [0.74-1.76],0.5597562724265106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALMS1,Alstrom syndrome protein 1,19421,86,1.06 [0.66-1.67],0.820144787759973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPI,Intestinal-type alkaline phosphatase,19176,84,1.00 [0.85-1.18],0.9912948506642968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPP,"Alkaline phosphatase, placental type",22609,108,1.08 [0.92-1.27],0.3418060879260192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBN,Ameloblastin,22323,107,1.39 [0.89-2.15],0.1452050791085761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,22883,109,2.24 [1.00-5.03],0.051081051712119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19775,88,1.25 [0.58-2.70],0.5621204196019844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMFR,E3 ubiquitin-protein ligase AMFR,22218,108,0.91 [0.68-1.22],0.5274595039857448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO1,Amphoterin-induced protein 1,19237,83,0.60 [0.35-1.04],0.0689439808940987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,22609,108,1.24 [0.60-2.54],0.5599022635498685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMN,Protein amnionless,22323,107,1.30 [0.92-1.85],0.1414748658645542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOT,Angiomotin,19321,84,0.54 [0.30-0.96],0.0361497616447062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOTL2,Angiomotin-like protein 2,19610,87,0.86 [0.53-1.38],0.5222935098822368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMPD3,AMP deaminase 3,19716,86,0.81 [0.60-1.08],0.1491485720848538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18572,85,0.89 [0.58-1.36],0.5941841779334625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2A,Pancreatic alpha-amylase,21881,102,1.18 [0.83-1.67],0.3628236060513737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2B,Alpha-amylase 2B,21190,100,1.17 [0.82-1.65],0.3879084074240477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANG,Angiogenin,22686,108,1.36 [0.84-2.20],0.2086333079511323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT1,Angiopoietin-1,22634,106,0.92 [0.75-1.12],0.4045111628791931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,22917,109,2.27 [1.53-3.38],4.605106808144189e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,22362,107,2.41 [1.35-4.31],0.0029202588218887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL2,Angiopoietin-related protein 2,22723,107,0.95 [0.62-1.46],0.806372938397727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL3,Angiopoietin-related protein 3,22762,108,1.09 [0.67-1.76],0.7377909565501728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,22768,107,2.26 [1.56-3.28],1.7018716328866838e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL7,Angiopoietin-related protein 7,22917,109,1.31 [0.83-2.08],0.243173181401309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANK2,Ankyrin-2,19095,82,1.14 [0.87-1.49],0.3315605714846198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19176,84,0.90 [0.69-1.18],0.4436947300069142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRA2,Ankyrin repeat family A protein 2,19082,85,0.68 [0.44-1.03],0.0667650725174291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,22178,107,1.07 [0.80-1.42],0.6585336243372995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19224,81,1.28 [0.81-2.03],0.2854923855333063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,22800,108,1.65 [0.92-2.99],0.0956301834448834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA1,Annexin A1,19226,83,1.09 [0.70-1.71],0.6985093163654601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA10,Annexin A10,22218,108,1.03 [0.85-1.26],0.7459069047590108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA11,Annexin A11,22661,107,1.17 [0.89-1.53],0.2658344454177251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,18949,81,1.27 [0.97-1.66],0.085889288523326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,22893,109,1.15 [0.91-1.46],0.2365785629535219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA4,Annexin A4,22623,108,1.07 [0.84-1.35],0.5867264090996365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA5,Annexin A5,22142,108,1.32 [0.77-2.27],0.319686452818728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22323,107,0.95 [0.69-1.31],0.7643191983472739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC3,Membrane primary amine oxidase,22832,108,1.41 [0.79-2.50],0.240169808702282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP1G2,AP-1 complex subunit gamma-like 2,19698,87,0.87 [0.67-1.14],0.3215263214896446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP2B1,AP-2 complex subunit beta,19237,83,0.59 [0.36-0.98],0.0434996036644571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3B1,AP-3 complex subunit beta-1,19704,87,0.87 [0.66-1.15],0.3236538548017401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3S2,AP-3 complex subunit sigma-2,19716,86,1.04 [0.68-1.59],0.85719194754967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22609,108,1.05 [0.73-1.52],0.7981989352799588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APCS,Serum amyloid P-component,19611,86,0.50 [0.27-0.93],0.0297763996007346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22853,109,1.21 [0.92-1.58],0.1719520854662733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APLP1,Amyloid-like protein 1,22722,109,0.97 [0.70-1.35],0.8591603935279767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA1,Apolipoprotein A-I,19786,88,1.83 [1.00-3.37],0.0516356282375264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA2,Apolipoprotein A-II,19789,88,1.38 [0.92-2.07],0.1198896927831726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA4,Apolipoprotein A-IV,19786,88,1.65 [1.02-2.69],0.043218666396195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOB,Apolipoprotein B-100,19789,88,0.87 [0.36-2.10],0.7529400158311064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOBR,Apolipoprotein B receptor,19224,81,0.85 [0.53-1.39],0.5246804065260458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOC1,Apolipoprotein C-I,19754,88,1.18 [0.71-1.98],0.5236862703578862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOD,Apolipoprotein D,18923,84,1.25 [0.80-1.95],0.3208753268559972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOE,Apolipoprotein E,19786,88,1.18 [0.94-1.49],0.161556015554477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOF,Apolipoprotein F,19789,88,1.29 [0.64-2.60],0.4722151606590485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOH,Beta-2-glycoprotein 1,22727,108,1.45 [0.96-2.19],0.0786842856636982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOL1,Apolipoprotein L1,19789,88,0.87 [0.59-1.29],0.4980819393370391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOM,Apolipoprotein M,22798,108,0.69 [0.39-1.22],0.2046499463993214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APP,Amyloid-beta precursor protein,22692,108,0.88 [0.68-1.14],0.3354439149789462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APPL2,DCC-interacting protein 13-beta,19321,84,0.87 [0.73-1.05],0.1458854093890319
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APRT,Adenine phosphoribosyltransferase,22480,108,1.11 [0.77-1.60],0.5688675133088347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARAF,Serine/threonine-protein kinase A-Raf,19421,86,0.92 [0.67-1.27],0.6111706021348831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,22609,108,2.14 [1.51-3.02],1.617644016816147e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARF6,ADP-ribosylation factor 6,19704,87,0.92 [0.77-1.11],0.395180238886179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARFIP1,Arfaptin-1,19729,85,0.87 [0.64-1.19],0.3968196299377451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG1,Arginase-1,22565,107,0.83 [0.60-1.15],0.2637991777138977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG2,"Arginase-2, mitochondrial",19698,87,0.67 [0.37-1.21],0.1822847563311085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP1,Rho GTPase-activating protein 1,22178,107,0.89 [0.61-1.29],0.5299900865323153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP25,Rho GTPase-activating protein 25,22178,107,1.15 [0.88-1.50],0.2975677103592204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP30,Rho GTPase-activating protein 30,19421,86,0.39 [0.17-0.90],0.0264805779239251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP45,Rho GTPase-activating protein 45,19321,84,0.77 [0.59-1.00],0.05033648225566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP5,Rho GTPase-activating protein 5,19082,85,1.04 [0.79-1.35],0.7910126140515499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF1,Rho guanine nucleotide exchange factor 1,19716,86,0.92 [0.73-1.16],0.4585596610092652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF10,Rho guanine nucleotide exchange factor 10,19729,85,0.89 [0.71-1.11],0.2948156690196798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF12,Rho guanine nucleotide exchange factor 12,22700,107,0.89 [0.75-1.05],0.1553297488830336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF5,Rho guanine nucleotide exchange factor 5,19125,83,1.00 [0.75-1.34],0.988070805971447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID3A,AT-rich interactive domain-containing protein 3A,19125,83,1.04 [0.62-1.75],0.8817689760967284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID4B,AT-rich interactive domain-containing protein 4B,22218,108,1.02 [0.69-1.52],0.9021860323174437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL13B,ADP-ribosylation factor-like protein 13B,19095,82,1.01 [0.74-1.38],0.9342289346729789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19095,82,0.68 [0.39-1.18],0.1717970708798209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARMCX2,Armadillo repeat-containing X-linked protein 2,19125,83,1.21 [0.91-1.62],0.1883241489485032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNT,Aryl hydrocarbon receptor nuclear translocator,22323,107,0.74 [0.44-1.24],0.2526770231052131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19095,82,0.95 [0.62-1.45],0.813885842400511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSA,Arylsulfatase A,22727,108,0.89 [0.61-1.29],0.5431156546020788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSB,Arylsulfatase B,22609,108,0.88 [0.65-1.21],0.4459898785801212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART3,Ecto-ADP-ribosyltransferase 3,22832,108,1.25 [0.79-1.98],0.3380034886942751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART5,Ecto-ADP-ribosyltransferase 5,19125,83,1.13 [0.84-1.52],0.411061669116351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARTN,Artemin,22323,107,1.15 [0.83-1.60],0.3916999298804869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH1,Acid ceramidase,19598,88,0.80 [0.50-1.26],0.3347403119014763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH2,Neutral ceramidase,22521,108,0.91 [0.67-1.23],0.5264616472453914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,22521,108,1.63 [0.96-2.79],0.0712670087922536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR2,Asialoglycoprotein receptor 2,19789,88,1.25 [0.59-2.67],0.5631958920192734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPN,Asporin,19770,87,1.13 [0.56-2.25],0.738117302343126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPSCR1,Tether containing UBX domain for GLUT4,19729,85,0.78 [0.57-1.07],0.124333762772571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19224,81,0.90 [0.73-1.12],0.3630858492012334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASS1,Argininosuccinate synthase,19095,82,0.95 [0.72-1.26],0.736657160796157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF2,Cyclic AMP-dependent transcription factor ATF-2,22218,108,0.94 [0.70-1.24],0.6466719978131709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19082,85,1.12 [0.61-2.05],0.7195094959934185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG16L1,Autophagy-related protein 16-1,19704,87,0.84 [0.66-1.06],0.1472255802644787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG4A,Cysteine protease ATG4A,22178,107,0.98 [0.73-1.31],0.9022876133012028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATOX1,Copper transport protein ATOX1,22780,108,1.16 [0.91-1.49],0.2237376310727528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19095,82,0.96 [0.60-1.53],0.8510583456686358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19095,82,0.75 [0.37-1.53],0.4306512694210379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19095,82,0.67 [0.35-1.27],0.2193464226421875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B4,Protein ATP1B4,19082,85,0.84 [0.49-1.43],0.5270550528607505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19095,82,0.76 [0.48-1.18],0.2141795621261643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19095,82,1.28 [0.93-1.74],0.128030881985773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5IF1,"ATPase inhibitor, mitochondrial",22802,107,0.98 [0.84-1.14],0.7883216831066016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5PO,"ATP synthase subunit O, mitochondrial",22218,108,0.83 [0.54-1.29],0.4086643884837112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6AP2,Renin receptor,22178,107,1.11 [0.73-1.69],0.6116458803513493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1D,V-type proton ATPase subunit D,22609,108,0.95 [0.49-1.87],0.8880518443954634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1F,V-type proton ATPase subunit F,22185,108,0.95 [0.73-1.23],0.680499141063465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G1,V-type proton ATPase subunit G 1,19224,81,0.91 [0.67-1.23],0.5197999434696736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G2,V-type proton ATPase subunit G 2,19095,82,1.00 [0.79-1.26],0.9974589790575386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,19704,87,1.29 [0.73-2.28],0.375949881138897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRN,"Attractin, Isoform 2",19786,88,0.48 [0.14-1.63],0.2414843451873865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN10,Ataxin-10,22218,108,1.12 [0.88-1.42],0.3597245985205054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2,Ataxin-2,19125,83,1.04 [0.86-1.26],0.6953562120556962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2L,Ataxin-2-like protein,19729,85,0.90 [0.56-1.43],0.6451059760749346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN3,Ataxin-3,19716,86,0.70 [0.50-0.98],0.0396017420376936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXIN1,Axin-1,22700,107,0.95 [0.79-1.14],0.5710003139768662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXL,Tyrosine-protein kinase receptor UFO,22832,108,0.91 [0.49-1.68],0.7583908836047857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZI2,5-azacytidine-induced protein 2,19729,85,0.70 [0.46-1.05],0.0857637586559814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZU1,Azurocidin,22082,105,1.13 [0.92-1.38],0.2407801493032138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,19786,88,1.48 [1.01-2.16],0.0416640535810344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19095,82,1.23 [0.44-3.43],0.6863750524236267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19224,81,1.38 [0.77-2.47],0.2718603451653775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",22802,107,2.66 [1.52-4.64],0.0005978967942209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22727,108,0.88 [0.44-1.78],0.7218000760926999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BABAM1,BRISC and BRCA1-A complex member 1,19176,84,0.74 [0.33-1.64],0.4567198211435622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BACH1,Transcription regulator protein BACH1,22700,107,0.88 [0.69-1.13],0.3209816974100427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG3,BAG family molecular chaperone regulator 3,22480,108,1.14 [0.74-1.73],0.5574238722875384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG4,BAG family molecular chaperone regulator 4,19176,84,0.73 [0.46-1.17],0.1953667149051651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG6,Large proline-rich protein BAG6,22307,105,0.80 [0.49-1.30],0.3637457576246158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22178,107,1.21 [0.95-1.55],0.1296629017627839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,22178,107,1.49 [0.87-2.54],0.1456118137126543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BANK1,B-cell scaffold protein with ankyrin repeats,22700,107,0.90 [0.77-1.06],0.2112045225179108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAP18,Chromatin complexes subunit BAP18,19716,86,0.99 [0.74-1.33],0.9548302425638616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BATF,Basic leucine zipper transcriptional factor ATF-like,19237,83,0.81 [0.59-1.12],0.2105762493149647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAX,Apoptosis regulator BAX,22180,108,1.01 [0.83-1.22],0.945308383595906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,22727,108,2.42 [1.27-4.64],0.0074901105612198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,22521,108,0.59 [0.37-0.96],0.033842567630085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19770,87,1.04 [0.53-2.05],0.9055127773500178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19125,83,0.58 [0.34-0.99],0.0463178392751747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,19423,86,0.38 [0.19-0.73],0.0035547952165735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2,Apoptosis regulator Bcl-2,19704,87,1.09 [0.77-1.54],0.6390840911288395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L1,Bcl-2-like protein 1,19716,86,0.95 [0.77-1.17],0.615009611669217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22700,107,1.10 [0.72-1.68],0.6623779412586377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L15,Bcl-2-like protein 15,19176,84,1.26 [0.92-1.72],0.1436209448809489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19082,85,1.18 [0.88-1.58],0.2672607619888874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19698,87,0.52 [0.29-0.92],0.026211538550051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCR,Breakpoint cluster region protein,22700,107,0.93 [0.77-1.12],0.4237968294691859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BDNF,Brain-derived neurotrophic factor,19775,88,0.94 [0.74-1.19],0.6059637514144625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BECN1,Beclin-1,19224,81,0.71 [0.48-1.05],0.088946723396113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BEX3,Protein BEX3,19082,85,0.96 [0.59-1.56],0.8736356478861654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGLAP,Osteocalcin,19775,88,1.11 [0.88-1.40],0.3743012834746305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGN,Biglycan,22144,107,0.91 [0.79-1.06],0.2400943463640296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHLHE40,Class E basic helix-loop-helix protein 40,19125,83,1.02 [0.76-1.36],0.9198737140555008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19095,82,0.94 [0.41-2.14],0.8767415797106562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BID,BH3-interacting domain death agonist,22700,107,1.08 [0.84-1.39],0.5416754577218299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIN2,Bridging integrator 2,22727,108,0.96 [0.79-1.16],0.6773907071086269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIRC2,Baculoviral IAP repeat-containing protein 2,22178,107,1.03 [0.78-1.35],0.8326190978810077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLMH,Bleomycin hydrolase,23006,109,0.81 [0.47-1.40],0.4486480471769277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLNK,B-cell linker protein,19176,84,0.64 [0.35-1.17],0.1471889424065396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19125,83,0.85 [0.62-1.18],0.332155714406721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19716,86,0.72 [0.41-1.25],0.2402422998194993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLVRB,Flavin reductase,22727,108,0.92 [0.71-1.19],0.5168074453242038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP10,Bone morphogenetic protein 10,19321,84,1.69 [0.81-3.53],0.1594133613806783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP4,Bone morphogenetic protein 4,22480,108,1.09 [0.75-1.57],0.6534812228866193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP6,Bone morphogenetic protein 6,22272,105,1.00 [0.64-1.55],0.9981157584546468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMPER,BMP-binding endothelial regulator protein,19321,84,1.82 [0.75-4.42],0.1870463412963022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19770,87,0.98 [0.53-1.82],0.9572040553658008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19176,84,0.63 [0.37-1.08],0.095895686840937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOC,Brother of CDO,22307,105,2.21 [1.05-4.64],0.0362122754311564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA1,BolA-like protein 1,19125,83,1.10 [0.75-1.62],0.6161731876343383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA2_BOLA2B,BolA-like protein 2,19224,81,0.71 [0.48-1.07],0.0994963323243154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFA2,BPI fold-containing family A member 2,18575,79,0.99 [0.81-1.20],0.8961022001455915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB1,BPI fold-containing family B member 1,22683,109,1.11 [0.85-1.44],0.4370726991605295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB2,BPI fold-containing family B member 2,19733,87,0.93 [0.67-1.29],0.6743526875120872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRAP,BRCA1-associated protein,19521,87,0.93 [0.77-1.12],0.4520897806089647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD1,Bromodomain-containing protein 1,19421,86,0.80 [0.38-1.67],0.5446220862907394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD2,Bromodomain-containing protein 2,19125,83,0.70 [0.34-1.41],0.3143626777283199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD3,Bromodomain-containing protein 3,19095,82,1.20 [0.85-1.68],0.3057425970957482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRDT,Bromodomain testis-specific protein,19095,82,0.83 [0.46-1.48],0.5212610983897612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRK1,Protein BRICK1,22218,108,1.22 [0.84-1.76],0.2977750317617406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRME1,Break repair meiotic recombinase recruitment factor 1,19125,83,1.04 [0.62-1.76],0.8751301412975975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRSK2,Serine/threonine-protein kinase BRSK2,19729,85,0.88 [0.49-1.60],0.6741771737789541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,22952,108,1.89 [0.84-4.24],0.1210770776702943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSND,Barttin,19082,85,0.93 [0.49-1.78],0.8238755515350314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22930,109,1.04 [0.72-1.50],0.8399526546565846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,22930,109,1.09 [0.78-1.52],0.6212791087272664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTC,Probetacellulin,22178,107,1.00 [0.79-1.27],0.996387289636396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTD,Biotinidase,19786,88,0.50 [0.19-1.31],0.1577593781032021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTLA,B- and T-lymphocyte attenuator,19082,85,0.94 [0.72-1.23],0.665342672665695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN1A1,Butyrophilin subfamily 1 member A1,19661,87,1.33 [0.87-2.03],0.1832573832360507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,22802,107,1.85 [1.05-3.26],0.0339434931253252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN3A2,Butyrophilin subfamily 3 member A2,22700,107,1.03 [0.66-1.61],0.9052314445333616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,19082,85,0.94 [0.55-1.61],0.8198997358997081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,22218,108,1.21 [0.97-1.52],0.0885632212737654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1GALT1C1,C1GALT1-specific chaperone 1,19095,82,0.97 [0.50-1.91],0.9396580715312316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,22881,108,2.91 [1.46-5.80],0.002338604007115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19729,85,0.91 [0.66-1.27],0.5839175194242432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QL2,Complement C1q-like protein 2,19176,84,0.73 [0.44-1.22],0.2244849474068348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22832,108,0.95 [0.64-1.41],0.8002453683771599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19321,84,1.07 [0.60-1.90],0.8247757485046537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19729,85,0.83 [0.42-1.67],0.6086793202318659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19290,84,0.73 [0.50-1.08],0.1157806519376279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,19786,88,2.24 [1.11-4.49],0.0236751782234524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1RL,Complement C1r subcomponent-like protein,19748,87,0.94 [0.33-2.67],0.9117772264677764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1S,Complement C1s subcomponent,19786,88,1.01 [0.38-2.67],0.9865592031469484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2,Complement C2,22798,108,1.19 [0.54-2.62],0.668927151170774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2CD2L,Phospholipid transfer protein C2CD2L,22185,108,1.01 [0.66-1.55],0.9626748304024436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2orf69,UPF0565 protein C2orf69,19237,83,1.02 [0.71-1.46],0.9289454712590506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,18789,83,1.33 [0.89-1.99],0.1602714867318153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C4BPB,C4b-binding protein beta chain,22780,108,0.83 [0.53-1.30],0.4118895210808803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,19786,88,1.88 [0.50-7.11],0.3532679500324298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,19307,86,3.46 [1.94-6.17],2.6625691176710247e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7orf50,Uncharacterized protein C7orf50,19716,86,0.57 [0.18-1.73],0.317475939262787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C8B,Complement component C8 beta chain,19786,88,1.02 [0.52-2.00],0.9472504263697514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9,Complement component C9,19789,88,1.23 [0.85-1.76],0.2722582689536565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9orf40,Uncharacterized protein C9orf40,19704,87,0.87 [0.67-1.12],0.2761526488846255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA1,Carbonic anhydrase 1,22261,105,0.97 [0.72-1.31],0.8408127873523571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA11,Carbonic anhydrase-related protein 11,22178,107,0.97 [0.54-1.75],0.9311454817379032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,22609,108,1.53 [0.94-2.49],0.0907921252190753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA13,Carbonic anhydrase 13,22458,109,1.01 [0.86-1.19],0.8967613654091948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA14,Carbonic anhydrase 14,22917,109,0.77 [0.49-1.23],0.2786209197446324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA2,Carbonic anhydrase 2,22653,107,0.98 [0.77-1.26],0.8827346986676495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA3,Carbonic anhydrase 3,22972,109,1.22 [0.93-1.60],0.1612374526245493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA4,Carbonic anhydrase 4,23006,109,1.16 [0.59-2.32],0.6633023465940553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA5A,"Carbonic anhydrase 5A, mitochondrial",22307,105,1.15 [0.96-1.39],0.1276590472858805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA6,Carbonic anhydrase 6,22656,108,1.00 [0.76-1.31],0.9916742468683138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA7,Carbonic anhydrase 7,19421,86,0.77 [0.40-1.51],0.4480270884761241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,19176,84,1.74 [1.11-2.73],0.0158175972061595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA9,Carbonic anhydrase 9,22917,109,1.15 [0.82-1.61],0.4146999028261099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CABP2,Calcium-binding protein 2,19237,83,0.71 [0.48-1.05],0.0826229121387662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19125,83,0.61 [0.28-1.31],0.2040808493384154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19095,82,0.66 [0.39-1.11],0.117965505341141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19125,83,0.79 [0.53-1.17],0.2423441197314603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19729,85,1.07 [0.84-1.36],0.6056397131756356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACYBP,Calcyclin-binding protein,19290,84,0.91 [0.74-1.11],0.3397650316875774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CADPS,Calcium-dependent secretion activator 1,19237,83,0.70 [0.37-1.33],0.2766356637711781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,22609,108,1.51 [1.04-2.17],0.0280965527910147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,22218,108,1.41 [1.04-1.91],0.0246638137032905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCA,Calcitonin,22488,108,1.01 [0.79-1.29],0.962501789268948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCB,Calcitonin gene-related peptide 2,19716,86,1.24 [0.78-1.98],0.3563180693170311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22852,109,0.89 [0.75-1.05],0.1754697736949265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19224,81,0.82 [0.61-1.11],0.2031631593585003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALY,Neuron-specific vesicular protein calcyon,19095,82,0.75 [0.39-1.46],0.4017236291050498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22178,107,1.23 [0.85-1.78],0.2745993611375714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19237,83,0.97 [0.65-1.45],0.8746787990291296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19729,85,0.85 [0.70-1.04],0.1214648419256507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CANT1,Soluble calcium-activated nucleotidase 1,22647,109,0.81 [0.35-1.87],0.6157628185365391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,22566,108,1.37 [1.05-1.79],0.0221743471537976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,19698,87,1.50 [1.05-2.15],0.0275364765715976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPS,Calcyphosin,19716,86,0.96 [0.77-1.21],0.7432826613811894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CARHSP1,Calcium-regulated heat-stable protein 1,22218,108,1.00 [0.72-1.39],0.9966558330782532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASC3,Protein CASC3,19237,83,0.75 [0.44-1.28],0.2895842186085092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP1,Caspase-1,22218,108,0.92 [0.72-1.19],0.5400550912644567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP10,Caspase-10,22218,108,1.01 [0.79-1.28],0.9511861971947576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP2,Caspase-2,22700,107,0.96 [0.74-1.24],0.7564779503730865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP3,Caspase-3,23006,109,0.96 [0.80-1.17],0.7169987155805715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP4,Caspase-4,19421,86,0.93 [0.82-1.07],0.3232567035102155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP7,Caspase-7,19716,86,0.90 [0.70-1.16],0.409824881506841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP8,Caspase-8,22856,109,1.03 [0.78-1.35],0.8327944255106954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP9,Caspase-9,19176,84,0.91 [0.64-1.30],0.6217472763104874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASQ2,Calsequestrin-2,19095,82,0.79 [0.46-1.35],0.3835865856766877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAT,Catalase,19510,87,0.72 [0.48-1.08],0.1171247396372349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,22691,109,1.11 [0.89-1.38],0.3560808676137558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN1,Cerebellin-1,19125,83,0.87 [0.66-1.15],0.3173298955396272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN4,Cerebellin-4,22917,109,0.92 [0.55-1.55],0.7591476066608683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBS,Cystathionine beta-synthase,19224,81,0.92 [0.60-1.42],0.7135900597832886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBX2,Chromobox protein homolog 2,19095,82,0.97 [0.55-1.72],0.9277574557825023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22521,108,0.92 [0.72-1.17],0.4801647821093194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCAR2,Cell cycle and apoptosis regulator protein 2,19716,86,0.82 [0.51-1.32],0.4139925599080901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,19698,87,1.20 [0.82-1.76],0.3539816995432587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC28A,Coiled-coil domain-containing protein 28A,19237,83,1.05 [0.52-2.12],0.89897186393986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,19729,85,1.21 [0.96-1.52],0.1007246689964232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,22722,109,2.36 [1.59-3.49],1.871275799773577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19224,81,1.42 [1.04-1.93],0.0275213668068738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,22990,109,1.38 [0.88-2.17],0.1632793809955236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL13,C-C motif chemokine 13,22958,108,0.91 [0.71-1.16],0.438589506045105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,22686,108,1.28 [0.87-1.88],0.2089714544978433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,23006,109,1.49 [1.05-2.12],0.0254132254058474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,23006,109,1.22 [0.88-1.70],0.2343328463497941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL17,C-C motif chemokine 17,22648,107,1.16 [0.97-1.39],0.1092709190954371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL18,C-C motif chemokine 18,22442,106,1.08 [0.85-1.37],0.5252708858951326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL19,C-C motif chemokine 19,22930,109,1.04 [0.91-1.19],0.5416226165649036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL2,C-C motif chemokine 2,22480,108,0.90 [0.65-1.25],0.5255950396101506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,22990,109,1.14 [0.95-1.36],0.1507732894535834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,22802,107,1.68 [1.22-2.31],0.001397374379933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,22459,107,1.27 [0.93-1.74],0.1259276568734603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,22802,107,1.47 [0.99-2.17],0.0563893876861238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL24,C-C motif chemokine 24,22768,107,1.08 [0.88-1.32],0.4768551612391242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,22990,109,1.49 [1.05-2.10],0.0240058525891368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL26,C-C motif chemokine 26,22700,107,0.79 [0.64-0.98],0.0296141262317215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL27,C-C motif chemokine 27,22722,109,0.90 [0.69-1.18],0.4623219332901422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,22622,107,1.09 [0.82-1.45],0.545656548728366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL3,C-C motif chemokine 3,22700,107,1.02 [0.78-1.32],0.9067689439171146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,22727,107,1.22 [0.99-1.50],0.0608790255739842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL5,C-C motif chemokine 5,22832,108,0.96 [0.81-1.14],0.6461896998521119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL7,C-C motif chemokine 7,22700,107,1.15 [0.87-1.51],0.332626236135748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL8,C-C motif chemokine 8,22883,109,1.16 [0.87-1.53],0.3049399412605204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN1,CCN family member 1,22575,108,0.96 [0.76-1.21],0.7364283794144226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN2,CCN family member 2,22693,106,1.00 [0.73-1.36],0.9935353923989834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,22964,109,1.52 [0.95-2.42],0.0790228343323943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN4,CCN family member 4,22917,109,1.15 [0.75-1.75],0.5234921761916227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,22727,108,1.51 [0.98-2.33],0.0635199439069288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCND2,G1/S-specific cyclin-D2,19421,86,1.29 [0.73-2.28],0.3867846482993752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCNE1,G1/S-specific cyclin-E1,19176,84,0.68 [0.44-1.03],0.0680483284460383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCS,Copper chaperone for superoxide dismutase,22521,108,0.90 [0.62-1.30],0.5653689608213941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCT5,T-complex protein 1 subunit epsilon,22178,107,0.93 [0.62-1.40],0.7375217058938668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD101,Immunoglobulin superfamily member 2,19704,87,0.96 [0.59-1.54],0.8519150550869603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD109,CD109 antigen,22727,108,1.05 [0.63-1.74],0.847234239791552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,22307,106,1.41 [0.94-2.10],0.0954329814473666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD160,CD160 antigen,22990,109,1.16 [0.82-1.63],0.3964406371939183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22832,108,0.91 [0.61-1.34],0.627787151432655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164,Sialomucin core protein 24,22727,108,1.20 [0.67-2.17],0.5371550611266862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164L2,CD164 sialomucin-like 2 protein,19237,83,1.07 [0.60-1.91],0.8287379308819213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD177,CD177 antigen,22687,108,1.09 [0.95-1.26],0.2104949505182619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD1C,T-cell surface glycoprotein CD1c,22780,108,0.98 [0.50-1.93],0.954880049071914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2,T-cell surface antigen CD2,19095,82,0.75 [0.39-1.43],0.3856835259355718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200,OX-2 membrane glycoprotein,22700,107,1.61 [0.93-2.81],0.0905257616912079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200R1,Cell surface glycoprotein CD200 receptor 1,22624,106,0.71 [0.43-1.16],0.1726337693248884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD207,C-type lectin domain family 4 member K,22202,105,1.34 [0.86-2.08],0.1948801074065758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD209,CD209 antigen,22788,109,1.22 [0.79-1.87],0.372880115603503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD22,B-cell receptor CD22,22990,109,0.72 [0.48-1.07],0.1049159717052156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD226,CD226 antigen,19176,84,0.71 [0.43-1.18],0.1885664323758433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD244,Natural killer cell receptor 2B4,22990,109,0.83 [0.45-1.55],0.5657867954445338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD248,Endosialin,19775,88,1.06 [0.64-1.76],0.8104469616953609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,22780,108,1.39 [0.95-2.02],0.0885411660887791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,22521,108,1.32 [0.82-2.13],0.2535517039838039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,22689,107,2.34 [1.44-3.80],0.0005915986473187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD28,T-cell-specific surface glycoprotein CD28,22178,107,1.18 [0.76-1.81],0.466085575434497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2AP,CD2-associated protein,22722,109,0.85 [0.64-1.12],0.2439104958954387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300A,CMRF35-like molecule 8,19321,84,1.20 [0.60-2.37],0.6082355039248724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,22930,109,1.34 [0.85-2.12],0.2053466519774975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,22853,109,1.34 [0.91-1.97],0.1413233545221142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LF,CMRF35-like molecule 1,22917,109,1.29 [0.96-1.73],0.0857847963467469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LG,CMRF35-like molecule 9,22727,108,1.63 [1.04-2.54],0.0313214511090509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,22609,108,1.77 [1.09-2.89],0.0219894374243915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD33,Myeloid cell surface antigen CD33,22780,108,0.94 [0.76-1.16],0.5661741701257765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD34,Hematopoietic progenitor cell antigen CD34,22858,109,0.59 [0.29-1.19],0.1383169502089198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD36,Platelet glycoprotein 4,19176,84,0.79 [0.49-1.27],0.3270769500692405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22609,108,0.97 [0.58-1.62],0.9108820656188568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3D,T-cell surface glycoprotein CD3 delta chain,19125,83,0.88 [0.46-1.69],0.7065419975217353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19421,86,0.95 [0.51-1.76],0.8700862320357612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3G,T-cell surface glycoprotein CD3 gamma chain,19176,84,0.81 [0.59-1.12],0.2002887594095751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD4,T-cell surface glycoprotein CD4,22662,107,1.50 [0.91-2.48],0.1145211700350837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40,Tumor necrosis factor receptor superfamily member 5,22693,107,1.00 [0.71-1.41],0.9878037737778594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40LG,CD40 ligand,22990,109,0.99 [0.80-1.22],0.929287879641895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD46,Membrane cofactor protein,22618,108,1.18 [0.66-2.10],0.5846906805945373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,22768,107,1.57 [0.91-2.70],0.1045070528264255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5,T-cell surface glycoprotein CD5,22883,109,1.13 [0.71-1.79],0.5994941457686739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD55,Complement decay-accelerating factor,21952,103,1.41 [0.76-2.63],0.27284445684967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD58,Lymphocyte function-associated antigen 3,22645,107,1.92 [0.72-5.13],0.1924832044900941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,21930,101,1.76 [0.90-3.45],0.0966190831412416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,19690,87,1.54 [1.02-2.34],0.0422449684373437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD6,T-cell differentiation antigen CD6,22952,108,0.89 [0.65-1.23],0.4877513407726641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD63,CD63 antigen,22480,108,0.82 [0.58-1.16],0.2591174263384548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD69,Early activation antigen CD69,22605,109,0.94 [0.77-1.13],0.5027213380990603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,19144,84,1.72 [1.14-2.57],0.0091133667136964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD70,CD70 antigen,22700,107,1.07 [0.72-1.58],0.7386873941019274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD72,B-cell differentiation antigen CD72,19321,84,0.69 [0.41-1.15],0.1539540551116066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,22930,109,1.35 [0.84-2.18],0.2133792107944301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,22990,109,1.45 [1.04-2.02],0.0289062690763356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD80,T-lymphocyte activation antigen CD80,19770,87,1.02 [0.55-1.87],0.9549709632817528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD82,CD82 antigen,19421,86,1.17 [0.75-1.82],0.4949241018183303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD83,CD83 antigen,22700,107,1.21 [0.74-1.98],0.4405596193911927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD84,SLAM family member 5,22700,107,0.85 [0.50-1.45],0.5434742485382392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD86,T-lymphocyte activation antigen CD86,19704,87,0.64 [0.37-1.13],0.1268192016952778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD8A,T-cell surface glycoprotein CD8 alpha chain,22930,109,0.89 [0.64-1.24],0.501908469660459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD93,Complement component C1q receptor,21896,102,1.75 [1.03-2.98],0.0390149748283591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,22727,108,2.68 [1.22-5.91],0.0141715354974808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99L2,CD99 antigen-like protein 2,22727,108,1.89 [0.96-3.74],0.065852387081428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDA,Cytidine deaminase,19737,87,0.63 [0.40-0.99],0.0445620461913381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDAN1,Codanin-1,19716,86,0.89 [0.35-2.24],0.8000921534021624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC123,Cell division cycle protein 123 homolog,19082,85,0.91 [0.63-1.30],0.5999451699786664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC25A,M-phase inducer phosphatase 1,19082,85,1.13 [0.67-1.92],0.6480256336833111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC26,Anaphase-promoting complex subunit CDC26,19660,87,1.00 [0.74-1.35],0.9858261119509256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC27,Cell division cycle protein 27 homolog,22178,107,0.95 [0.71-1.27],0.7055648174636555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC37,Hsp90 co-chaperone Cdc37,22780,108,0.97 [0.79-1.19],0.7616321402292208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19704,87,0.85 [0.69-1.05],0.1279507534441731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDCP1,CUB domain-containing protein 1,22521,108,0.88 [0.64-1.20],0.4166757209908636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH1,Cadherin-1,21990,103,1.34 [0.92-1.96],0.1283495409594969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH15,Cadherin-15,22897,109,1.16 [0.94-1.44],0.1722877329948899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH17,Cadherin-17,22722,109,0.94 [0.74-1.21],0.6362324377513348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH2,Cadherin-2,22722,109,1.40 [0.88-2.22],0.1596318499902336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH22,Cadherin-22,19421,86,0.79 [0.36-1.75],0.5598949179373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH23,Cadherin-23,19716,86,0.59 [0.26-1.35],0.214654849140339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH3,Cadherin-3,22930,109,1.36 [0.87-2.13],0.1796757152128869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH4,Cadherin-4,19125,83,0.89 [0.55-1.42],0.6248379150550485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH5,Cadherin-5,23006,109,0.97 [0.55-1.70],0.9115497472147692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,22722,109,1.57 [1.04-2.38],0.0336804077108536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR1,Cadherin-related family member 1,22218,108,0.92 [0.61-1.40],0.7107822017918932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR2,Cadherin-related family member 2,22609,108,1.06 [0.81-1.38],0.674978633543009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR5,Cadherin-related family member 5,22722,109,1.07 [0.68-1.66],0.7797082795087765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK1,Cyclin-dependent kinase 1,19082,85,1.10 [0.62-1.95],0.7505706370176638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19729,85,0.91 [0.63-1.32],0.628059745458058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKL5,Cyclin-dependent kinase-like 5,19125,83,0.84 [0.53-1.32],0.4398219935453744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN1A,Cyclin-dependent kinase inhibitor 1,22609,108,1.00 [0.86-1.18],0.973455826416536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22609,108,1.05 [0.87-1.26],0.5963335383796573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDNF,Cerebral dopamine neurotrophic factor,22609,108,0.89 [0.52-1.50],0.6532411487309997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22723,107,1.07 [0.55-2.07],0.8445523846721322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDSN,Corneodesmosin,22923,109,1.39 [0.95-2.03],0.0868238592289894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22746,108,1.86 [0.89-3.92],0.0999112114158964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19704,87,0.74 [0.58-0.95],0.0191177335299967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19421,86,0.76 [0.52-1.12],0.159696478837399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19704,87,1.12 [0.68-1.87],0.6489321263437109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19421,86,1.04 [0.65-1.66],0.8651919584578869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22700,107,1.10 [0.91-1.33],0.3348382155746194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22178,107,1.06 [0.75-1.51],0.7264072280043277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21902,107,1.22 [0.94-1.60],0.1387562450160529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19775,88,1.35 [0.94-1.94],0.1088160379704431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22307,105,1.59 [1.18-2.15],0.002548583222525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPA,CCAAT/enhancer-binding protein alpha,19176,84,0.86 [0.45-1.66],0.657670122254938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPB,CCAAT/enhancer-binding protein beta,22307,105,1.42 [0.94-2.14],0.0985199251264008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA2A,Chymotrypsin-like elastase family member 2A,19775,88,1.17 [0.85-1.60],0.3390351503983531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA3A,Chymotrypsin-like elastase family member 3A,22969,108,1.27 [0.97-1.67],0.082296249551891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19321,84,1.06 [0.51-2.19],0.8705583593353423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEMIP2,Cell surface hyaluronidase,19176,84,0.70 [0.33-1.51],0.3666336154555309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEND1,Cell cycle exit and neuronal differentiation protein 1,19125,83,1.12 [0.83-1.51],0.4455377449832395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPF,Centromere protein F,19421,86,0.65 [0.43-0.98],0.0420848078834578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPJ,Centromere protein J,19421,86,0.85 [0.61-1.19],0.3411864472064548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP112,Centrosomal protein of 112 kDa,19095,82,0.93 [0.55-1.55],0.7729914455271629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP152,Centrosomal protein of 152 kDa,19082,85,1.27 [0.82-1.95],0.2873506462306816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP164,Centrosomal protein of 164 kDa,22323,107,1.06 [0.83-1.35],0.650962420750881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP170,Centrosomal protein of 170 kDa,19224,81,0.72 [0.52-0.99],0.0402968373712973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP20,Centrosomal protein 20,22178,107,1.09 [0.87-1.37],0.4369494381720918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,19421,86,1.27 [0.92-1.74],0.1443124160761415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP350,Centrosome-associated protein 350,19082,85,1.06 [0.61-1.85],0.8338370629238054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP43,Centrosomal protein 43,22129,103,0.88 [0.68-1.14],0.3227404786085399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP85,Centrosomal protein of 85 kDa,22178,107,0.95 [0.72-1.26],0.730453959700144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CERT,Ceramide transfer protein,22218,108,1.01 [0.77-1.34],0.91972997562056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES1,Liver carboxylesterase 1,22785,108,0.91 [0.74-1.11],0.3414111627472246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES2,Cocaine esterase,22609,108,0.98 [0.72-1.33],0.8858745868315147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES3,Carboxylesterase 3,22609,108,0.82 [0.62-1.09],0.1668340878201408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN2,Centrin-2,22218,108,0.96 [0.75-1.25],0.786477900110152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN3,Centrin-3,19704,87,0.92 [0.71-1.20],0.5545907168968003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFB,Complement factor B,19442,86,1.38 [0.73-2.63],0.3223248826377793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFC1,Cryptic protein,22178,107,1.10 [0.76-1.57],0.6223258311507536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,19786,88,2.17 [1.09-4.31],0.027070014876399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFH,Complement factor H,18658,84,1.02 [0.41-2.58],0.9614976828286024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR2,Complement factor H-related protein 2,19647,87,0.93 [0.65-1.32],0.6719283527167883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR4,Complement factor H-related protein 4,19745,88,0.95 [0.72-1.26],0.7461891878681912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR5,Complement factor H-related protein 5,19539,87,1.16 [0.71-1.92],0.5510795545410716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFI,Complement factor I,19786,88,1.44 [0.50-4.13],0.4938751767713794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFP,Properdin,19786,88,0.67 [0.25-1.80],0.4272433806458485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGA,Glycoprotein hormones alpha chain,22727,108,1.32 [1.02-1.69],0.0326033118187167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19789,88,0.82 [0.48-1.42],0.4816470905175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGN,Cingulin,19237,83,0.88 [0.49-1.58],0.6626648885170876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGREF1,Cell growth regulator with EF hand domain protein 1,22722,109,1.15 [0.78-1.70],0.4751818487343016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22178,107,0.90 [0.66-1.22],0.4879334542469314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAD,Chondroadherin,19321,84,1.15 [0.74-1.79],0.5421012383135231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19716,86,1.95 [1.30-2.92],0.0012072220770425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,19698,87,1.49 [0.82-2.73],0.1935715733511188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHEK2,Serine/threonine-protein kinase Chk2,22307,105,0.84 [0.49-1.44],0.5232315827160802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,19775,88,1.16 [0.95-1.42],0.145864205036119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGB,Secretogranin-1,22867,109,1.32 [0.89-1.95],0.1708495281583136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,22248,105,1.28 [1.07-1.54],0.0077177212208752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHIT1,Chitotriosidase-1,22820,109,0.96 [0.88-1.06],0.4394365830986585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHL1,Neural cell adhesion molecule L1-like protein,22796,108,1.53 [0.90-2.61],0.1165220498012755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHM,Rab proteins geranylgeranyltransferase component A 1,19237,83,0.76 [0.52-1.09],0.1345644061971148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP1A,Charged multivesicular body protein 1a,22521,108,1.03 [0.83-1.28],0.8017891834888915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP6,Charged multivesicular body protein 6,19770,87,0.82 [0.57-1.18],0.2789785041645949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHP1,Calcineurin B homologous protein 1,19125,83,0.93 [0.69-1.27],0.6664363106575426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,22768,107,1.66 [1.00-2.77],0.0517831787245453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL2,Chordin-like protein 2,22722,109,1.29 [0.90-1.86],0.1648985684568885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRM1,Muscarinic acetylcholine receptor M1,19237,83,0.92 [0.51-1.67],0.7870111415842124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIAPIN1,Anamorsin,22780,108,0.96 [0.72-1.27],0.7529606940745063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,19775,88,1.58 [1.07-2.32],0.0219400940375897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,19421,86,0.47 [0.26-0.87],0.0162681646769133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIRBP,Cold-inducible RNA-binding protein,19704,87,0.89 [0.72-1.11],0.3050441397283497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIT,Citron Rho-interacting kinase,19237,83,0.76 [0.46-1.26],0.2836251163726355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,22877,108,2.21 [1.43-3.43],0.000386018897632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,19775,88,2.06 [1.48-2.86],1.935356035566153e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22615,107,1.01 [0.77-1.31],0.957334819064959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLASP1,CLIP-associating protein 1,19082,85,0.84 [0.61-1.15],0.2665713666979147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLC,Galectin-10,22687,109,1.20 [0.95-1.51],0.1357601910120043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC10A,C-type lectin domain family 10 member A,22521,108,0.62 [0.39-0.99],0.045069291127305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,22694,108,1.31 [0.92-1.85],0.1341201723107092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC12A,C-type lectin domain family 12 member A,19176,84,0.89 [0.29-2.68],0.8315147993311333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,22727,108,1.91 [1.17-3.11],0.0092451559315798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1A,C-type lectin domain family 1 member A,22307,105,1.37 [0.84-2.25],0.2088078162178578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1B,C-type lectin domain family 1 member B,22930,109,0.86 [0.72-1.03],0.1047641135087858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC2L,C-type lectin domain family 2 member L,19237,83,0.65 [0.37-1.14],0.1308899172541659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC3B,Tetranectin,19339,86,0.40 [0.15-1.08],0.069564418965479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4A,C-type lectin domain family 4 member A,22700,107,1.00 [0.62-1.61],0.9929129359914836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4C,C-type lectin domain family 4 member C,22700,107,0.90 [0.63-1.27],0.5422085786103252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,22700,107,1.36 [1.05-1.76],0.0185727624993098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4G,C-type lectin domain family 4 member G,22700,107,1.31 [0.79-2.18],0.2925427230554245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4M,C-type lectin domain family 4 member M,19745,88,0.99 [0.66-1.50],0.9749009841796844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,22646,109,2.27 [1.36-3.79],0.0017183089271199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,22178,107,1.30 [0.92-1.83],0.1349472161682313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC7A,C-type lectin domain family 7 member A,22990,109,1.08 [0.80-1.45],0.6214120010858499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLGN,Calmegin,19237,83,1.18 [0.77-1.81],0.4533988854044111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIC5,Chloride intracellular channel protein 5,19237,83,0.71 [0.34-1.49],0.366984696862311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLINT1,Clathrin interactor 1,19082,85,1.10 [0.73-1.68],0.6483287361329517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIP2,CAP-Gly domain-containing linker protein 2,22700,107,1.00 [0.86-1.17],0.9650376915273788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,22917,109,2.84 [1.46-5.55],0.0021970523416253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLNS1A,Methylosome subunit pICln,19237,83,0.42 [0.21-0.86],0.0172770057895642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22488,108,1.00 [0.84-1.20],0.9985136929011112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPS,Colipase,22685,107,1.07 [0.85-1.34],0.5860082733384369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSPN,Claspin,22185,108,1.16 [0.78-1.73],0.4540621423036108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN1,Calsyntenin-1,22218,108,1.16 [0.87-1.56],0.3154527404763642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,22990,109,2.13 [1.55-2.92],2.784764282465258e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN3,Calsyntenin-3,19716,86,1.14 [0.58-2.24],0.7013769687558826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLTA,Clathrin light chain A,22307,105,1.25 [0.88-1.78],0.2154177148670628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,19786,88,1.77 [1.24-2.55],0.0018978882105069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLUL1,Clusterin-like protein 1,22680,109,1.21 [0.84-1.74],0.3189692661017657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMC1,COX assembly mitochondrial protein homolog,19770,87,0.90 [0.71-1.13],0.3617503256324219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMIP,C-Maf-inducing protein,19698,87,0.89 [0.69-1.14],0.3417512972940152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNDP1,Beta-Ala-His dipeptidase,22832,108,1.08 [0.74-1.55],0.6983440650131357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19125,83,0.74 [0.45-1.23],0.2459523471558199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19192,81,0.84 [0.64-1.11],0.2134851527456024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY2,Protein canopy homolog 2,22307,105,0.91 [0.67-1.25],0.561927853654073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY4,Protein canopy homolog 4,22609,108,1.02 [0.81-1.28],0.8783331915608589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNST,Consortin,22722,109,0.94 [0.80-1.10],0.4236278450500755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTF,Ciliary neurotrophic factor,19125,83,0.72 [0.39-1.34],0.3047265170436593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN1,Contactin-1,23006,109,1.15 [0.61-2.16],0.6756713935457326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN2,Contactin-2,22917,109,1.00 [0.68-1.47],0.9961495396115831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN3,Contactin-3,22727,108,0.73 [0.41-1.31],0.2894230894642005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN4,Contactin-4,22727,108,1.40 [0.68-2.88],0.3571860484333469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN5,Contactin-5,22782,109,0.89 [0.56-1.40],0.6112713098170137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP2,Contactin-associated protein-like 2,22700,107,1.16 [0.79-1.71],0.447624043633552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP4,Contactin-associated protein-like 4,19237,83,1.02 [0.84-1.24],0.8326625253494293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COCH,Cochlin,19770,87,0.94 [0.60-1.46],0.7773383890017218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL15A1,Collagen alpha-1(XV) chain,19775,88,1.28 [0.62-2.64],0.5075944711833362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,22818,109,2.72 [1.38-5.38],0.0039498626546428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL1A1,Collagen alpha-1(I) chain,23006,109,1.91 [0.97-3.77],0.0630247672892547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL24A1,Collagen alpha-1(XXIV) chain,19704,87,0.90 [0.64-1.26],0.5251986863715028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL28A1,Collagen alpha-1(XXVIII) chain,19237,83,0.83 [0.63-1.08],0.1634994894081655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL2A1,Collagen alpha-1(II) chain,19224,81,0.81 [0.61-1.08],0.1503006287657953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL3A1,Collagen alpha-1(III) chain,19775,88,1.90 [0.87-4.15],0.1048518008844256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,22722,109,1.93 [1.31-2.85],0.0009393966733006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A4,Collagen alpha-4(IV) chain,19389,86,1.01 [0.68-1.49],0.9752334539167083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL5A1,Collagen alpha-1(V) chain,19321,84,1.14 [0.68-1.91],0.6108895752654987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,23006,109,2.10 [1.41-3.13],0.0002870935204661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A1,Collagen alpha-1(IX) chain,22700,107,1.14 [0.79-1.65],0.4906365982307582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,19421,86,0.51 [0.29-0.92],0.0248896040850353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,22689,107,2.04 [1.15-3.63],0.0148633901137111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD1,COMM domain-containing protein 1,19224,81,0.87 [0.60-1.25],0.4473876170609473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD9,COMM domain-containing protein 9,19698,87,1.02 [0.62-1.70],0.9270220857580214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMP,Cartilage oligomeric matrix protein,22499,105,1.16 [0.69-1.93],0.5767328109762421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMT,Catechol O-methyltransferase,22062,105,1.03 [0.83-1.28],0.78018390289743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPB2,Coatomer subunit beta',19095,82,0.96 [0.59-1.57],0.8847206515161865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPE,Coatomer subunit epsilon,22218,108,0.73 [0.47-1.12],0.1510082831628075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19224,81,0.94 [0.55-1.59],0.8083130552289166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO1A,Coronin-1A,22294,105,1.01 [0.82-1.23],0.9520423383810716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,19125,83,1.82 [1.24-2.66],0.0021644318960913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22609,108,0.95 [0.74-1.22],0.7105246721595202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX6B1,Cytochrome c oxidase subunit 6B1,19770,87,0.95 [0.51-1.79],0.8823613161237758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA1,Carboxypeptidase A1,23006,109,1.17 [0.90-1.50],0.2404328149484876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA2,Carboxypeptidase A2,22864,109,1.14 [0.89-1.46],0.2993521151568932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA4,Carboxypeptidase A4,18949,82,0.99 [0.60-1.62],0.9539450553293276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB1,Carboxypeptidase B,23006,109,1.16 [0.89-1.51],0.2745486975442285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB2,Carboxypeptidase B2,19754,88,0.72 [0.29-1.79],0.4820606078918626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPE,Carboxypeptidase E,22728,109,1.12 [0.72-1.75],0.60853967454083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPLX2,Complexin-2,19082,85,0.65 [0.31-1.36],0.255810166292949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,22815,108,1.24 [0.77-2.01],0.3701133833955943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19176,84,1.17 [0.54-2.53],0.6879690558833483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPPED1,Serine/threonine-protein phosphatase CPPED1,22930,109,1.00 [0.77-1.30],0.980812295868196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPQ,Carboxypeptidase Q,19743,88,0.84 [0.50-1.43],0.5283344099973133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPTP,Ceramide-1-phosphate transfer protein,19095,82,1.29 [0.80-2.09],0.2902738945008906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPVL,Probable serine carboxypeptidase CPVL,22869,109,1.30 [0.85-1.98],0.2245465088608197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM1,Probable carboxypeptidase X1,22780,108,0.96 [0.75-1.23],0.7633583946123921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,19770,87,2.47 [1.22-5.02],0.0120384170730133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR1,Complement receptor type 1,19721,88,1.29 [0.73-2.28],0.3853591019289113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR2,Complement receptor type 2,22832,108,1.11 [0.78-1.58],0.5661674936263208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22178,107,0.90 [0.72-1.11],0.3233647328076656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRADD,Death domain-containing protein CRADD,22488,108,0.98 [0.78-1.23],0.843888129138205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREB3,Cyclic AMP-responsive element-binding protein 3,19082,85,0.87 [0.58-1.32],0.5121652867539157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREBZF,CREB/ATF bZIP transcription factor,19082,85,1.53 [0.76-3.08],0.2379354661055932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREG1,Protein CREG1,22422,104,0.97 [0.63-1.49],0.8918958947166388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD1,Protein disulfide isomerase CRELD1,19321,84,1.19 [0.68-2.10],0.5428564159725704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD2,Protein disulfide isomerase CRELD2,22768,107,1.15 [0.83-1.59],0.4003045129032112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRH,Corticoliberin,22142,107,0.98 [0.80-1.20],0.8160697182416918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,22689,107,0.93 [0.50-1.72],0.8136507771304595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHR1,Corticotropin-releasing factor receptor 1,22307,105,0.91 [0.67-1.23],0.5435257914775371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,22802,107,2.85 [1.29-6.34],0.009933964784865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,22521,108,1.46 [0.99-2.14],0.0543302987165508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP2,Cysteine-rich secretory protein 2,22917,109,1.03 [0.75-1.41],0.8516509490266111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP3,Cysteine-rich secretory protein 3,19604,88,0.64 [0.31-1.34],0.2365816730592523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRKL,Crk-like protein,22724,107,1.02 [0.87-1.20],0.8166814004696652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRLF1,Cytokine receptor-like factor 1,22802,107,1.87 [0.94-3.72],0.0735927451075696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRNN,Cornulin,22079,104,1.00 [0.77-1.30],0.9876044033958222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAC1,Cartilage acidic protein 1,23006,109,1.15 [0.66-2.00],0.6212905952152455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAM,Cytotoxic and regulatory T-cell molecule,22521,108,0.95 [0.67-1.33],0.7516128797963421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAP,Cartilage-associated protein,19237,83,0.85 [0.52-1.37],0.4962158154014111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRX,Cone-rod homeobox protein,22307,105,1.03 [0.88-1.20],0.6962644700232892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB1,Beta-crystallin B1,19770,87,0.86 [0.62-1.19],0.3566786160910153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB2,Beta-crystallin B2,19716,86,0.95 [0.71-1.26],0.7010588121965533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYGD,Gamma-crystallin D,19716,86,1.01 [0.82-1.24],0.9502179798509284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYM,Ketimine reductase mu-crystallin,19125,83,0.79 [0.57-1.10],0.1703011520168769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYZL1,Quinone oxidoreductase-like protein 1,19224,81,0.90 [0.71-1.14],0.3759203023491034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSDE1,Cold shock domain-containing protein E1,19095,82,0.83 [0.66-1.03],0.0843465472451696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,22802,107,3.04 [1.72-5.37],0.0001253414868702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1R,Macrophage colony-stimulating factor 1 receptor,19789,88,0.95 [0.57-1.57],0.8303419561482617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2,Granulocyte-macrophage colony-stimulating factor,19095,82,0.80 [0.43-1.48],0.4778145214813797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22521,108,1.14 [0.86-1.49],0.36213084098642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RB,Cytokine receptor common subunit beta,19176,84,0.81 [0.49-1.32],0.3946457481877946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3,Granulocyte colony-stimulating factor,22323,107,0.92 [0.64-1.32],0.6401236253085378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3R,Granulocyte colony-stimulating factor receptor,19176,84,0.90 [0.44-1.85],0.7799872015932244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSH1,Chorionic somatomammotropin hormone 1,19789,88,0.72 [0.36-1.47],0.3731626190132356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK1D,Casein kinase I isoform delta,19176,84,0.83 [0.58-1.19],0.3150952790322697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK2A1,Casein kinase II subunit alpha,19729,85,0.95 [0.59-1.51],0.82051077618131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG4,Chondroitin sulfate proteoglycan 4,19775,88,1.48 [0.80-2.72],0.2073240365523722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG5,Chondroitin sulfate proteoglycan 5,19125,83,1.13 [0.75-1.69],0.5655677525734066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,19095,82,1.23 [1.03-1.47],0.0236167387402237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST1,Cystatin-SN,17186,79,0.95 [0.77-1.19],0.6725776595214827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,22792,108,1.91 [1.13-3.21],0.0148997237540872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST5,Cystatin-D,22237,107,1.07 [0.79-1.45],0.6660602328581753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST6,Cystatin-M,22134,104,1.17 [0.83-1.66],0.3712626460759392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,22727,107,1.22 [1.06-1.40],0.0061811631484923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,22422,108,1.36 [0.93-1.99],0.1121588011017075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTAG1A_CTAG1B,Cancer/testis antigen 1,19388,86,0.75 [0.48-1.17],0.1999562823738946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTBS,Di-N-acetylchitobiase,19512,87,1.11 [0.51-2.41],0.7969510818096263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTF1,Cardiotrophin-1,22307,105,0.94 [0.77-1.16],0.5791045429817421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTHRC1,Collagen triple helix repeat-containing protein 1,19775,88,1.40 [0.70-2.81],0.3470248073775323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTLA4,Cytotoxic T-lymphocyte protein 4,19775,88,1.04 [0.54-2.01],0.9134777228137408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTNNA1,Catenin alpha-1,19125,83,0.52 [0.23-1.21],0.1279519719404273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRB1,Chymotrypsinogen B,22727,108,1.18 [0.89-1.56],0.2617842573272557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRC,Chymotrypsin-C,22689,107,1.26 [0.98-1.64],0.0739250135488805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRL,Chymotrypsin-like protease CTRL-1,19716,86,1.12 [0.84-1.49],0.4374583514501242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,22745,109,1.50 [1.10-2.03],0.0094124967902537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSC,Dipeptidyl peptidase 1,22640,105,1.07 [0.73-1.57],0.7230617429436978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSD,Cathepsin D,21285,101,1.09 [0.72-1.64],0.6859678909700982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSE,Cathepsin E,19321,84,1.00 [0.68-1.48],0.9998175361137625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSF,Cathepsin F,22780,108,1.01 [0.66-1.54],0.9747595457404394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSH,Pro-cathepsin H,22224,104,0.99 [0.78-1.24],0.9077793161136596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,22722,109,1.50 [0.77-2.95],0.237567837414062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSO,Cathepsin O,22990,109,1.14 [0.67-1.95],0.6177295801860533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,17890,89,2.56 [1.11-5.92],0.0282095429426426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSV,Cathepsin L2,22828,109,0.89 [0.59-1.34],0.5686622926987489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSZ,Cathepsin Z,22764,108,0.98 [0.58-1.64],0.9270912157988058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19237,83,0.75 [0.41-1.39],0.3684609200674895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CWC15,Spliceosome-associated protein CWC15 homolog,19595,87,0.79 [0.53-1.19],0.2595230842956693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CX3CL1,Fractalkine,22521,108,1.29 [0.79-2.13],0.3116997400629138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,22700,107,1.53 [1.11-2.10],0.00929918837874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL1,Growth-regulated alpha protein,22656,107,0.98 [0.82-1.18],0.8328796934514683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,22802,107,1.03 [0.79-1.34],0.8210311365913574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL11,C-X-C motif chemokine 11,22930,109,0.98 [0.79-1.22],0.8736010736551001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL12,Stromal cell-derived factor 1,22323,107,0.95 [0.61-1.47],0.815806999193668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,22930,109,0.98 [0.74-1.29],0.8636274836189797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL14,C-X-C motif chemokine 14,22323,107,0.94 [0.68-1.29],0.6971592686704335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,22970,109,3.40 [1.72-6.71],0.0004232009523007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,22990,109,1.48 [1.04-2.11],0.0310849413978169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL3,C-X-C motif chemokine 3,22693,107,0.98 [0.82-1.18],0.8569821939249149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL5,C-X-C motif chemokine 5,22646,109,0.94 [0.81-1.09],0.4385987338965736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL6,C-X-C motif chemokine 6,22990,109,0.98 [0.78-1.22],0.834670716734916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,22562,107,1.07 [0.84-1.35],0.595023501179364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,22802,107,1.23 [0.96-1.57],0.1037335729269822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5A,Cytochrome b5,19082,85,0.75 [0.53-1.07],0.1156028840933502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5R2,NADH-cytochrome b5 reductase 2,19501,87,1.19 [0.84-1.68],0.3272111978031888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19095,82,0.92 [0.70-1.21],0.5537752290253463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTH3,Cytohesin-3,19082,85,1.07 [0.81-1.40],0.6419474056242069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTL1,Cytokine-like protein 1,19775,88,1.77 [0.81-3.84],0.1504767678364475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAAM1,Disheveled-associated activator of morphogenesis 1,19321,84,0.74 [0.56-0.96],0.0248581290954603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAB2,Disabled homolog 2,22917,109,0.99 [0.85-1.15],0.8642447528452182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAG1,Dystroglycan,22802,107,1.01 [0.70-1.46],0.9575702807899654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,19176,84,1.04 [0.74-1.46],0.8310552347137269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPK2,Death-associated protein kinase 2,19176,84,1.07 [0.74-1.53],0.7253829066004123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22700,107,1.04 [0.90-1.20],0.5907893503716384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22488,108,0.96 [0.76-1.22],0.7323234973947266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBH,Dopamine beta-hydroxylase,19756,88,1.06 [0.88-1.28],0.5450565399876552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBI,Acyl-CoA-binding protein,22619,108,1.15 [0.92-1.43],0.217202489424402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBN1,Drebrin,19176,84,0.71 [0.45-1.12],0.1451098044779291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBNL,Drebrin-like protein,22802,107,0.99 [0.83-1.20],0.9504165285972253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22780,108,1.52 [0.96-2.41],0.0747260214859518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCC,Netrin receptor DCC,19237,83,0.39 [0.12-1.22],0.1061179705823699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCDC2C,Doublecortin domain-containing protein 2C,19082,85,0.85 [0.58-1.23],0.391889342150498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCLRE1C,Protein artemis,19082,85,0.63 [0.31-1.29],0.2046122204073115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCN,Decorin,22307,105,1.61 [0.79-3.27],0.187442986440339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTD,Deoxycytidylate deaminase,19321,84,0.91 [0.73-1.13],0.3965961902441441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN1,Dynactin subunit 1,22917,109,0.92 [0.70-1.21],0.5517817463356524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN2,Dynactin subunit 2,22609,108,0.92 [0.76-1.11],0.3975175285404736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN6,Dynactin subunit 6,22218,108,0.90 [0.70-1.17],0.42850336408294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTPP1,dCTP pyrophosphatase 1,22722,109,1.30 [0.76-2.21],0.3412302516273254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D1,DCN1-like protein 1,19125,83,0.69 [0.47-1.01],0.0549179611744173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D2,DCN1-like protein 2,19082,85,1.11 [0.87-1.41],0.4204697794489599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCXR,L-xylulose reductase,22780,108,1.09 [0.80-1.50],0.5805576620833641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDA1,DET1- and DDB1-associated protein 1,19095,82,0.50 [0.25-0.98],0.0441029781281212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22609,108,1.28 [0.88-1.85],0.1970292369899653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDC,Aromatic-L-amino-acid decarboxylase,22691,109,1.00 [0.70-1.43],0.9838902617035165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDHD2,Phospholipase DDHD2,19729,85,0.83 [0.60-1.14],0.2422111770286918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,19321,84,0.74 [0.56-0.98],0.0383851170241633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,22930,109,2.07 [1.05-4.07],0.0361391131388396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDT,D-dopachrome decarboxylase,19775,88,0.89 [0.54-1.45],0.633146249080926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX1,ATP-dependent RNA helicase DDX1,19704,87,0.93 [0.59-1.45],0.7450937617982125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX25,ATP-dependent RNA helicase DDX25,19237,83,0.79 [0.40-1.53],0.4775328763289268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX39A,ATP-dependent RNA helicase DDX39A,19176,84,1.21 [0.54-2.71],0.636681490843394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX4,Probable ATP-dependent RNA helicase DDX4,19176,84,0.88 [0.58-1.36],0.5728827357437134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX53,Probable ATP-dependent RNA helicase DDX53,19237,83,0.84 [0.46-1.54],0.5695552338416322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX58,Antiviral innate immune response receptor RIG-I,22178,107,0.94 [0.69-1.29],0.7201303942286698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22700,107,0.94 [0.79-1.13],0.5326685870572927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,22284,104,1.22 [0.92-1.63],0.1729389373191965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB103A_DEFB103B,Beta-defensin 103,19041,84,1.35 [0.93-1.97],0.1167182763869073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB104A_DEFB104B,Beta-defensin 104,19125,83,1.10 [0.76-1.59],0.598540572333528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB116,Beta-defensin 116,19125,83,1.10 [0.84-1.43],0.4995406673525446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,19125,83,1.42 [1.14-1.77],0.001703318348362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB4A_DEFB4B,Beta-defensin 4A,22381,108,1.07 [0.95-1.20],0.2562818516329271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENND2B,DENN domain-containing protein 2B,19095,82,1.02 [0.66-1.57],0.9264247305178898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENR,Density-regulated protein,19176,84,0.91 [0.62-1.34],0.633812968600291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DFFA,DNA fragmentation factor subunit alpha,22990,109,0.99 [0.77-1.28],0.9559480682977708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGCR6,Protein DGCR6,19125,83,0.86 [0.49-1.50],0.5904147259409807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKA,Diacylglycerol kinase alpha,19176,84,0.87 [0.59-1.30],0.4992868665843438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKZ,Diacylglycerol kinase zeta,22323,107,1.18 [0.74-1.87],0.4852132424972131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHODH,Dihydroorotate dehydrogenase,19095,82,1.20 [0.79-1.84],0.3892119741526526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHPS,Deoxyhypusine synthase,19698,87,0.88 [0.52-1.50],0.6403197359702297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19716,86,0.98 [0.63-1.53],0.9305236414108689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIABLO,"Diablo homolog, mitochondrial",22646,109,0.99 [0.85-1.16],0.9294740766807096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK1C,Divergent protein kinase domain 1C,19237,83,0.93 [0.55-1.60],0.7998876863911367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK2B,Divergent protein kinase domain 2B,19321,84,0.72 [0.34-1.50],0.3745746352076112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK1,Dickkopf-related protein 1,22930,109,0.83 [0.62-1.10],0.1907519583472418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK3,Dickkopf-related protein 3,23006,109,1.51 [0.86-2.64],0.1480183087588577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,22480,108,1.43 [1.02-1.99],0.0364718503890248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKKL1,Dickkopf-like protein 1,22609,108,1.10 [0.90-1.36],0.3545500884426658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLG4,Disks large homolog 4,19716,86,0.69 [0.50-0.94],0.0202759893982954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLGAP5,Disks large-associated protein 5,19729,85,1.23 [0.91-1.65],0.17709213276201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLK1,Protein delta homolog 1,23006,109,0.85 [0.63-1.14],0.2732299020375616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,22780,108,1.76 [1.05-2.95],0.0332808605704497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL4,Delta-like protein 4,19224,81,1.01 [0.81-1.27],0.9238932899925728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMD,Dystrophin,19224,81,1.14 [0.75-1.75],0.5374095307390707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMP1,Dentin matrix acidic phosphoprotein 1,19224,81,0.99 [0.68-1.45],0.96362356647422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA1,DnaJ homolog subfamily A member 1,19082,85,0.96 [0.59-1.56],0.8736588503601473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA2,DnaJ homolog subfamily A member 2,22915,109,0.97 [0.79-1.19],0.7597966355946939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA4,DnaJ homolog subfamily A member 4,19716,86,0.86 [0.65-1.16],0.3279479096473389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB1,DnaJ homolog subfamily B member 1,22609,108,0.92 [0.76-1.13],0.4323160826753729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB14,DnaJ homolog subfamily B member 14,19704,87,0.88 [0.63-1.22],0.4514588359253259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB2,DnaJ homolog subfamily B member 2,19321,84,0.68 [0.45-1.02],0.0639724802070722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB6,DnaJ homolog subfamily B member 6,19150,83,0.85 [0.66-1.10],0.2294123912753243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB8,DnaJ homolog subfamily B member 8,22307,105,1.06 [0.78-1.44],0.7079572383988877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC21,DnaJ homolog subfamily C member 21,19716,86,0.67 [0.37-1.19],0.1724336998466448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19224,81,0.89 [0.69-1.15],0.3722995548720457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC9,DnaJ homolog subfamily C member 9,19704,87,0.95 [0.73-1.25],0.734808673815154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNER,Delta and Notch-like epidermal growth factor-related receptor,22653,107,1.00 [0.52-1.91],0.998888043032178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNLZ,DNL-type zinc finger protein,19125,83,0.91 [0.69-1.20],0.5149261231813774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM1,Dynamin-1,19704,87,1.06 [0.88-1.27],0.5324722735300249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM3,Dynamin-3,19729,85,0.98 [0.66-1.44],0.9055237341535316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNMBP,Dynamin-binding protein,22521,108,0.95 [0.71-1.28],0.7407723099967509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPEP,Aspartyl aminopeptidase,19716,86,0.93 [0.65-1.34],0.7049550380786918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22758,107,1.02 [0.73-1.42],0.9072678530236006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOC2B,Double C2-like domain-containing protein beta,19237,83,1.10 [0.64-1.89],0.7327145567502515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOCK9,Dedicator of cytokinesis protein 9,19125,83,1.00 [0.83-1.20],0.9688268844951528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK1,Docking protein 1,19716,86,0.94 [0.81-1.09],0.3979801044818134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK2,Docking protein 2,22722,109,0.99 [0.86-1.14],0.9282666367567848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP1,Dipeptidase 1,22488,108,0.92 [0.65-1.32],0.670025138594196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP2,Dipeptidase 2,22609,108,1.09 [0.62-1.89],0.7704775348178948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP10,Inactive dipeptidyl peptidase 10,22700,107,1.08 [0.69-1.70],0.7326190575818454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP4,Dipeptidyl peptidase 4,22323,105,0.73 [0.39-1.36],0.3234058691563988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP6,Dipeptidyl aminopeptidase-like protein 6,22609,108,0.83 [0.51-1.37],0.471183227096143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP7,Dipeptidyl peptidase 2,22549,108,0.88 [0.67-1.15],0.3465838542252256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,23006,109,2.59 [1.27-5.26],0.0086834306323235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,22853,109,1.20 [0.93-1.56],0.1600987780121558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRAXIN,Draxin,22521,108,1.26 [0.85-1.87],0.2415642448880526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRG2,Developmentally-regulated GTP-binding protein 2,22609,108,0.94 [0.69-1.27],0.6748728834298829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,22446,107,2.01 [1.28-3.17],0.0026171648911132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSCAM,Down syndrome cell adhesion molecule,19729,85,0.72 [0.41-1.30],0.27767559501907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,22727,108,2.20 [1.22-3.96],0.0085065805551368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,22842,109,1.60 [1.00-2.55],0.0476731325781987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG4,Desmoglein-4,22537,108,0.87 [0.61-1.23],0.4351005852753807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTD1,D-aminoacyl-tRNA deacylase 1,19321,84,0.95 [0.74-1.21],0.6583517108496648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,19654,87,1.60 [1.05-2.43],0.0289732455776434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19237,83,0.98 [0.68-1.41],0.9106205277684796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22609,108,2.43 [1.40-4.21],0.0016046232629464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTYMK,Thymidylate kinase,19770,87,0.76 [0.56-1.04],0.0826308172394301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUOX2,Dual oxidase 2,22307,105,0.79 [0.58-1.06],0.1191119668571076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP13,Dual specificity protein phosphatase 13 isoform A,19698,87,0.88 [0.54-1.43],0.607033463141951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP29,Dual specificity phosphatase 29,19237,83,1.17 [0.89-1.53],0.2569698725711297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP3,Dual specificity protein phosphatase 3,22218,108,1.04 [0.86-1.25],0.7176340519499577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19704,87,0.90 [0.74-1.09],0.2871370548578023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DXO,Decapping and exoribonuclease protein,19716,86,0.65 [0.41-1.05],0.081450294898293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19698,87,0.66 [0.38-1.15],0.1401910167157183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT1,Dynein light chain Tctex-type 1,19237,83,0.75 [0.55-1.03],0.0753987940229734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT3,Dynein light chain Tctex-type 3,19698,87,0.93 [0.58-1.50],0.7740832138120726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22521,108,1.03 [0.86-1.24],0.7112486460056043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,22890,109,1.87 [1.10-3.18],0.0211553927390806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECE1,Endothelin-converting enzyme 1,22218,108,1.06 [0.65-1.72],0.8192043535580757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19770,87,1.03 [0.79-1.36],0.8092243594186979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19224,81,0.90 [0.72-1.14],0.3851910391410614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECI2,Enoyl-CoA delta isomerase 2,19095,82,1.06 [0.76-1.48],0.728746891128722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECM1,Extracellular matrix protein 1,19277,85,1.29 [0.71-2.33],0.3998071934513124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,19125,83,0.42 [0.22-0.82],0.01095874571914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,22917,109,2.37 [1.65-3.41],3.01796622048717e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22700,107,0.97 [0.80-1.17],0.7473519338447483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDDM3B,Epididymal secretory protein E3-beta,19698,87,0.88 [0.62-1.25],0.4849199032764453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19095,82,0.83 [0.43-1.58],0.5623108523002205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDF1,Endothelial differentiation-related factor 1,19729,85,0.92 [0.67-1.28],0.6258330143383295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22307,105,1.43 [0.89-2.29],0.1383094813045697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,19224,81,2.55 [1.33-4.88],0.0048511701499869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDNRB,Endothelin receptor type B,19176,84,0.84 [0.48-1.47],0.5463134966236933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EEF1D,Elongation factor 1-delta,19770,87,0.75 [0.59-0.95],0.0166571894773487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19704,87,1.56 [0.94-2.60],0.0840081265696766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB2,Dynein regulatory complex protein 8,19421,86,0.63 [0.33-1.19],0.1522154984871701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22797,108,1.99 [1.21-3.28],0.0064811796741999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFHD1,EF-hand domain-containing protein D1,19729,85,1.53 [0.95-2.49],0.0828763642124182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,22687,108,2.07 [1.24-3.44],0.0051576929436771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,22480,108,1.68 [1.05-2.69],0.0312923618645036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNB2,Ephrin-B2,19237,83,0.77 [0.50-1.18],0.2230300481099312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGF,Pro-epidermal growth factor,22653,107,0.95 [0.81-1.12],0.5240808032589064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFL7,Epidermal growth factor-like protein 7,22178,107,1.30 [0.85-1.97],0.2290800971590663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFLAM,Pikachurin,19704,87,1.37 [0.73-2.58],0.3219435635607518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFR,Epidermal growth factor receptor,23006,109,0.40 [0.14-1.13],0.0834083855724376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGLN1,Egl nine homolog 1,22700,107,1.09 [0.82-1.43],0.5584888779368862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHBP1,EH domain-binding protein 1,19770,87,0.82 [0.62-1.09],0.173299284706243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHD3,EH domain-containing protein 3,19224,81,0.90 [0.75-1.07],0.232103272406227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19716,86,0.75 [0.48-1.16],0.1959220573815715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19629,87,0.92 [0.76-1.12],0.3969601134808711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19095,82,0.74 [0.51-1.07],0.1096947566420649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19224,81,0.65 [0.36-1.16],0.1428649972729253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4B,Eukaryotic translation initiation factor 4B,22521,108,0.96 [0.71-1.31],0.8187878279232105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4E,Eukaryotic translation initiation factor 4E,19176,84,0.91 [0.71-1.15],0.4205822643483951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22722,109,1.12 [0.87-1.44],0.3913304678417934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22990,109,0.95 [0.80-1.12],0.5219740405732172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19729,85,0.75 [0.53-1.06],0.1009173380506925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5,Eukaryotic translation initiation factor 5,19095,82,0.65 [0.37-1.15],0.1410730771303791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5A,Eukaryotic translation initiation factor 5A-1,22323,107,1.35 [0.84-2.16],0.2179304408582387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAC1,Zinc phosphodiesterase ELAC protein 1,19729,85,0.94 [0.73-1.20],0.6209541826169602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAVL4,ELAV-like protein 4,19125,83,1.02 [0.79-1.32],0.8994469940868879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,19770,87,2.31 [1.32-4.05],0.0033003358822958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOA,Elongin-A,22609,108,1.19 [0.92-1.53],0.1780896625705565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOB,Elongin-B,19095,82,0.72 [0.39-1.35],0.3033387432719134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,22323,107,1.53 [1.12-2.09],0.0073871029156191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENDOU,Poly(U)-specific endoribonuclease,18249,79,1.44 [1.00-2.07],0.048065590988975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENG,Endoglin,23006,109,1.53 [0.58-4.02],0.3865562502909891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO1,Alpha-enolase,22719,109,1.02 [0.82-1.27],0.8295699364505247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO2,Gamma-enolase,22930,109,0.90 [0.69-1.17],0.4331969738148625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO3,Beta-enolase,19224,81,0.98 [0.69-1.39],0.9079847525840464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOPH1,Enolase-phosphatase E1,19698,87,0.79 [0.50-1.24],0.3070934002987151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19095,82,0.63 [0.28-1.42],0.2627202105018608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPEP,Glutamyl aminopeptidase,19095,82,0.72 [0.39-1.34],0.300256046901988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23006,109,1.66 [0.87-3.17],0.1232142886385393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22802,107,0.99 [0.67-1.46],0.9588188725720156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19224,81,1.10 [0.60-2.01],0.7533503137581461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22038,105,1.07 [0.87-1.32],0.5270208005347099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENSA,Alpha-endosulfine,19698,87,1.08 [0.74-1.56],0.6908331040785518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22178,107,0.96 [0.64-1.44],0.835768760828204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22307,105,1.30 [0.59-2.89],0.5170324384905975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22307,105,2.16 [1.06-4.40],0.0334151904738559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,19224,81,0.51 [0.33-0.79],0.0025704477441134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EP300,Histone acetyltransferase p300,19176,84,1.00 [0.51-1.95],0.993234762159364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPB41L5,Band 4.1-like protein 5,19237,83,1.16 [0.87-1.54],0.3144747927755096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPCAM,Epithelial cell adhesion molecule,22683,106,0.98 [0.82-1.18],0.8360113304534613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPGN,Epigen,19698,87,1.08 [0.71-1.63],0.7145085359259277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA1,Ephrin type-A receptor 1,22758,107,1.63 [0.95-2.80],0.0740020250302045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA10,Ephrin type-A receptor 10,22218,108,0.96 [0.73-1.26],0.7730617926878974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,21876,102,2.28 [1.44-3.62],0.0004762869492131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA4,Ephrin type-A receptor 4,19321,84,1.39 [0.68-2.83],0.3704873615111108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,23006,109,2.03 [1.11-3.71],0.0211881983311357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,22488,108,2.01 [1.24-3.26],0.0049170160727878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHX2,Bifunctional epoxide hydrolase 2,22307,105,1.07 [0.82-1.40],0.6337853563603726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,19421,86,0.50 [0.26-0.96],0.0358441700884789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPO,Erythropoietin,22700,107,1.21 [0.98-1.48],0.0716469145347839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPPK1,Epiplakin,19224,81,1.08 [0.81-1.43],0.6010617897490461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22880,109,1.61 [0.96-2.71],0.0701077323558049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB2,Receptor tyrosine-protein kinase erbB-2,22780,108,0.75 [0.37-1.51],0.41604593767345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB3,Receptor tyrosine-protein kinase erbB-3,22604,107,1.28 [0.54-3.01],0.579220035311247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB4,Receptor tyrosine-protein kinase erbB-4,22780,108,0.92 [0.45-1.89],0.8236639344124786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBIN,Erbin,22609,108,0.92 [0.78-1.09],0.3567599023820679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERC2,ERC protein 2,19237,83,1.01 [0.76-1.34],0.9423863366617252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERCC1,DNA excision repair protein ERCC-1,19082,85,1.36 [0.87-2.12],0.1789203849598833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EREG,Proepiregulin,22488,108,0.93 [0.75-1.16],0.5428930879583723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERI1,3'-5' exoribonuclease 1,19421,86,0.68 [0.36-1.30],0.2467091966276975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERMAP,Erythroid membrane-associated protein,19176,84,0.81 [0.50-1.31],0.3944817013518396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19698,87,0.78 [0.44-1.39],0.4076215122052788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP29,Endoplasmic reticulum resident protein 29,19321,84,0.93 [0.78-1.11],0.428453817353373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP44,Endoplasmic reticulum resident protein 44,22575,108,0.92 [0.47-1.79],0.794941855799002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19095,82,1.12 [0.70-1.78],0.6435091915275526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESAM,Endothelial cell-selective adhesion molecule,23006,109,1.28 [0.78-2.12],0.3321500376769075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESM1,Endothelial cell-specific molecule 1,22689,107,1.45 [0.89-2.36],0.1371822639826134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESPL1,Separin,19082,85,1.18 [0.87-1.60],0.2974762532474246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESR1,Estrogen receptor,19176,84,0.84 [0.54-1.30],0.4397419039521369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESYT2,Extended synaptotagmin-2,19716,86,0.82 [0.63-1.06],0.1296022664730958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,19082,85,1.51 [1.08-2.11],0.0155008880926817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI5,Ecotropic viral integration site 5 protein homolog,19176,84,0.86 [0.67-1.09],0.2056791360606717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVPL,Envoplakin,19421,86,0.74 [0.37-1.49],0.3990377805554017
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXOSC10,Exosome component 10,19095,82,0.92 [0.62-1.38],0.6976879170321364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXTL1,Exostosin-like 1,19095,82,0.72 [0.42-1.22],0.2246659842427781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EZR,Ezrin,22930,109,0.66 [0.33-1.35],0.2569172109766373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F10,Coagulation factor X,19789,88,0.72 [0.36-1.46],0.3604924783876063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,19507,86,1.54 [1.02-2.31],0.0382563949989062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11R,Junctional adhesion molecule A,22727,108,0.85 [0.62-1.16],0.2972444120656278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F12,Coagulation factor XII,19786,88,1.41 [0.84-2.36],0.1964840068011245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F13B,Coagulation factor XIII B chain,19690,87,0.84 [0.38-1.87],0.6731462134183507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2,Prothrombin,19786,88,0.52 [0.14-2.02],0.3467875530880432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2R,Proteinase-activated receptor 1,22768,107,1.03 [0.76-1.40],0.8397645964987683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F3,Tissue factor,22770,108,1.17 [0.62-2.21],0.6273322672508064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F7,Coagulation factor VII,22791,108,0.65 [0.39-1.08],0.0938910825686519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F9,Coagulation factor IX,22798,108,1.35 [0.53-3.43],0.526888227919084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",22689,107,1.20 [1.01-1.42],0.0384449754941471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP2,"Fatty acid-binding protein, intestinal",22722,109,0.98 [0.79-1.21],0.8460842771132207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",19770,87,1.53 [1.11-2.11],0.0093785362602278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",23006,109,1.71 [1.27-2.30],0.0003813001851573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,22852,108,1.04 [0.80-1.34],0.7814196133434324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP6,Gastrotropin,22273,105,1.07 [0.80-1.43],0.6436155787006124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,22700,107,0.81 [0.60-1.11],0.1878482002267618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FADD,FAS-associated death domain protein,22722,109,1.01 [0.80-1.26],0.9433663014226048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM13A,Protein FAM13A,19704,87,0.83 [0.60-1.14],0.2465884484114293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171A2,Protein FAM171A2,19729,85,1.07 [0.95-1.21],0.2730236007673372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171B,Protein FAM171B,19698,87,0.99 [0.46-2.15],0.9792302349391556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM172A,Cotranscriptional regulator FAM172A,19224,81,0.87 [0.61-1.25],0.4512017452944705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM20A,Pseudokinase FAM20A,19770,87,1.45 [0.73-2.89],0.2861274006468693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3B,Protein FAM3B,22609,108,1.33 [0.82-2.17],0.2466585134485314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,22691,109,1.97 [1.17-3.32],0.0105718208192877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3D,Protein FAM3D,19704,87,1.01 [0.79-1.28],0.96200719071679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAP,Prolyl endopeptidase FAP,23006,109,0.70 [0.38-1.30],0.2614924123412377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,19237,83,0.63 [0.43-0.91],0.0144017623635342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAS,Tumor necrosis factor receptor superfamily member 6,22929,109,1.19 [0.77-1.84],0.4407659402919281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FASLG,Tumor necrosis factor ligand superfamily member 6,22990,109,0.85 [0.54-1.34],0.4784266912581456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBLN2,Fibulin-2,19775,88,1.47 [0.80-2.71],0.2114411299582256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBN2,Fibrillin-2,19237,83,1.16 [0.81-1.66],0.4189258323924861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBP1,"Fructose-1,6-bisphosphatase 1",22722,109,1.03 [0.82-1.30],0.8012078671388772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19770,87,0.94 [0.71-1.25],0.6784521414122386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAR,Immunoglobulin alpha Fc receptor,22700,107,1.01 [0.71-1.44],0.947501417643054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19729,85,1.09 [0.46-2.60],0.8385841577409118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22727,108,0.98 [0.71-1.35],0.9099261164138388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22646,107,1.04 [0.77-1.40],0.7979505931029199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22178,107,0.91 [0.67-1.23],0.5383126078011028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22759,108,1.04 [0.73-1.47],0.8396191444276104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN1,Ficolin-1,19756,88,1.28 [0.86-1.90],0.2184177365229605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN2,Ficolin-2,22643,107,0.90 [0.60-1.35],0.5988784262976083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL1,Fc receptor-like protein 1,22722,109,0.75 [0.51-1.10],0.1363685172457983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL2,Fc receptor-like protein 2,22883,109,1.34 [1.00-1.79],0.0468226114441174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL3,Fc receptor-like protein 3,22323,107,1.03 [0.75-1.41],0.8591006356106607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL5,Fc receptor-like protein 5,22727,108,1.23 [0.93-1.63],0.1492563085398312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL6,Fc receptor-like protein 6,22700,107,0.92 [0.72-1.18],0.531084548602042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,22178,107,1.30 [1.05-1.60],0.0153369752604547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",19095,82,1.01 [0.71-1.44],0.9438451943527688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX2,"Ferredoxin-2, mitochondrial",19095,82,1.17 [0.82-1.66],0.381260834759249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FEN1,Flap endonuclease 1,22178,107,1.15 [0.93-1.42],0.1846960506729099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FES,Tyrosine-protein kinase Fes/Fps,22178,107,1.19 [0.87-1.64],0.2804584748854277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FETUB,Fetuin-B,22798,108,1.13 [0.66-1.96],0.6539887799108353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGA,Fibrinogen alpha chain,19332,85,1.79 [0.94-3.41],0.0743241597799452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19729,85,0.91 [0.70-1.18],0.4820067968202634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF12,Fibroblast growth factor 12,19176,84,1.13 [0.78-1.65],0.5190949179519628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,19176,84,0.54 [0.31-0.92],0.0235857136688989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF19,Fibroblast growth factor 19,22802,107,1.02 [0.82-1.27],0.845672042594033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF2,Fibroblast growth factor 2,22700,107,1.07 [0.84-1.37],0.5828107446571813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF20,Fibroblast growth factor 20,19176,84,0.93 [0.55-1.57],0.7869250612679217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,22890,109,1.11 [0.97-1.28],0.1185758064196594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,22879,109,1.37 [1.07-1.76],0.0126386468633181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF3,Fibroblast growth factor 3,19176,84,0.63 [0.27-1.46],0.2808717049758798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,22323,107,1.58 [0.98-2.54],0.058501390607313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF6,Fibroblast growth factor 6,19176,84,0.82 [0.45-1.51],0.5289808890190181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF7,Fibroblast growth factor 7,19082,85,1.07 [0.84-1.37],0.5652840117961178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF9,Fibroblast growth factor 9,19050,85,0.94 [0.56-1.58],0.8137553367834097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP1,Fibroblast growth factor-binding protein 1,22780,108,0.88 [0.53-1.46],0.6278235736064968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP2,Fibroblast growth factor-binding protein 2,19775,88,0.93 [0.62-1.39],0.7285469556382338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP3,Fibroblast growth factor-binding protein 3,19716,86,0.65 [0.37-1.13],0.1283060473832481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,22780,108,2.12 [1.06-4.26],0.0341443947118492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR4,Fibroblast growth factor receptor 4,19321,84,1.25 [0.84-1.85],0.2630303160660436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,19789,88,1.46 [1.09-1.96],0.0118856365864051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,22218,108,1.24 [1.00-1.54],0.0482495004254099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FH,"Fumarate hydratase, mitochondrial",19125,83,0.93 [0.70-1.24],0.6180570168105843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19095,82,0.53 [0.31-0.90],0.0194440914435126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIT,Bis(5'-adenosyl)-triphosphatase,22218,108,0.96 [0.76-1.22],0.7327484926257117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FIS1,Mitochondrial fission 1 protein,22683,107,1.00 [0.79-1.25],0.9752974060149946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19729,85,0.96 [0.78-1.18],0.6997869747544354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22808,107,0.98 [0.84-1.14],0.7534526093121982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22521,108,1.19 [0.79-1.78],0.4042205167694995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22521,108,1.04 [0.86-1.25],0.6981283428090791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22185,108,1.09 [0.77-1.54],0.6272351983967379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBPL,FK506-binding protein-like,19704,87,0.74 [0.52-1.06],0.1031649570851872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLI1,Friend leukemia integration 1 transcription factor,22178,107,0.99 [0.84-1.15],0.8720558429250981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22521,108,2.07 [1.21-3.55],0.007944000263867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,22570,108,2.03 [1.16-3.56],0.0133416336043853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3,Receptor-type tyrosine-protein kinase FLT3,22178,107,0.89 [0.50-1.58],0.6921243677977283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3LG,Fms-related tyrosine kinase 3 ligand,22990,109,1.31 [0.81-2.12],0.2749209697125935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT4,Vascular endothelial growth factor receptor 3,22780,108,0.95 [0.58-1.58],0.8524410899116845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMNL1,Formin-like protein 1,22218,108,1.02 [0.79-1.30],0.9052207226853016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMR1,Synaptic functional regulator FMR1,22178,107,0.67 [0.41-1.10],0.1120908743570874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FN1,Fibronectin,19786,88,0.69 [0.32-1.48],0.3359166408161128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNDC1,Fibronectin type III domain-containing protein 1,19716,86,0.90 [0.58-1.40],0.6467285680676815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19698,87,0.82 [0.44-1.53],0.5376375702819427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLH1,Glutamate carboxypeptidase 2,19176,84,0.87 [0.67-1.13],0.3049694385026037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR1,Folate receptor alpha,22689,108,1.52 [0.87-2.63],0.1383633492167137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,22930,109,1.89 [1.07-3.32],0.027039548661574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR3,Folate receptor gamma,22709,108,0.98 [0.90-1.07],0.6853043557640714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOS,Proto-oncogene c-Fos,19050,85,0.86 [0.48-1.54],0.6161176988418473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOSB,Protein fosB,22218,108,0.75 [0.45-1.26],0.2766885587322255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXJ3,Forkhead box protein J3,19176,84,0.68 [0.39-1.16],0.1578097516629085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO1,Forkhead box protein O1,22700,107,0.93 [0.76-1.14],0.4820469370117499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO3,Forkhead box protein O3,22178,107,0.89 [0.73-1.07],0.2176004291682289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD4B,FERM domain-containing protein 4B,19095,82,0.76 [0.54-1.07],0.1102483618580886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD7,FERM domain-containing protein 7,19237,83,1.27 [0.74-2.20],0.3846639360506034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRZB,Secreted frizzled-related protein 3,22452,108,0.61 [0.32-1.17],0.1360255395335877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSHB,Follitropin subunit beta,19224,81,1.33 [0.87-2.04],0.1915555484777558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FST,Follistatin,22768,107,1.11 [0.79-1.58],0.5439176810874246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL1,Follistatin-related protein 1,19224,81,1.95 [0.78-4.92],0.1548778420320731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,22658,107,2.40 [1.53-3.76],0.000128257215058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FTCD,Formimidoyltransferase-cyclodeaminase,19672,86,1.09 [0.86-1.38],0.4621652581562887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUCA1,Tissue alpha-L-fucosidase,22853,108,0.87 [0.72-1.04],0.1326982000664405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUOM,Fucose mutarotase,19321,84,0.85 [0.61-1.19],0.3532224866509972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FURIN,Furin,22780,108,0.62 [0.37-1.05],0.0754318455677193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUS,RNA-binding protein FUS,22140,107,1.16 [0.76-1.76],0.488692480214736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19389,86,0.95 [0.67-1.34],0.7544959304500722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22930,109,1.24 [0.87-1.76],0.2310267369850587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT8,"Alpha-(1,6)-fucosyltransferase",22521,108,0.84 [0.62-1.13],0.2529936392618656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXN,"Frataxin, mitochondrial",22917,109,1.00 [0.79-1.26],0.9841942732639258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXYD5,FXYD domain-containing ion transport regulator 5,22323,107,1.11 [0.86-1.44],0.427696739017133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FYB1,FYN-binding protein 1,22685,107,0.93 [0.78-1.12],0.472065304799642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD10,Frizzled-10,19237,83,0.87 [0.57-1.32],0.5172465544566649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD8,Frizzled-8,19125,83,0.72 [0.41-1.28],0.2674462972856948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19698,87,1.19 [0.80-1.76],0.3843462539719486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19421,86,0.76 [0.51-1.13],0.1744717368259889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19125,83,1.05 [0.76-1.44],0.7870865417923787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD1,Glutamate decarboxylase 1,19082,85,1.41 [0.64-3.09],0.3956436761983409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD2,Glutamate decarboxylase 2,19176,84,1.15 [0.78-1.69],0.4779600888385842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19421,86,0.88 [0.53-1.45],0.6192492167192992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19224,81,0.97 [0.65-1.47],0.8997681369918139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAGE2A,G antigen 2A,19082,85,0.92 [0.65-1.31],0.6519335839289061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAL,Galanin peptides,22802,107,1.10 [0.85-1.42],0.4513923819429872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22609,108,1.32 [0.72-2.41],0.3728510647744061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22917,109,0.54 [0.29-1.00],0.0482161986213465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22323,107,0.94 [0.63-1.40],0.7444036683238537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19770,87,1.35 [0.68-2.69],0.3905229257897623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT7,N-acetylgalactosaminyltransferase 7,22609,108,1.29 [0.57-2.92],0.5423329529361354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAMT,Guanidinoacetate N-methyltransferase,19095,82,0.54 [0.24-1.19],0.1252904106448936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18901,81,0.80 [0.41-1.55],0.501375729541782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GART,Trifunctional purine biosynthetic protein adenosine-3,19729,85,0.87 [0.37-2.01],0.73702507145668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS2,Growth arrest-specific protein 2,19421,86,0.65 [0.39-1.08],0.0947141357009184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,22863,109,1.41 [0.71-2.79],0.3223418977482026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GASK1A,Golgi-associated kinase 1A,19095,82,0.59 [0.36-0.97],0.0363207327207397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAST,Gastrin,19716,86,1.04 [0.90-1.20],0.6049547426289529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19082,85,0.80 [0.36-1.77],0.5805277953191355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19224,81,0.91 [0.68-1.21],0.5171656734061998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBA,Lysosomal acid glucosylceramidase,19237,83,1.06 [0.73-1.55],0.7566540590334815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP1,Guanylate-binding protein 1,19680,85,0.86 [0.63-1.17],0.3315316839203723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP2,Guanylate-binding protein 2,22323,107,0.96 [0.72-1.29],0.7850905275296192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP4,Guanylate-binding protein 4,22218,108,1.02 [0.71-1.47],0.8971602589035071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP6,Guanylate-binding protein 6,19095,82,0.96 [0.57-1.59],0.859885063081784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GC,Vitamin D-binding protein,19786,88,1.50 [0.69-3.27],0.3058182018667998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCC1,GRIP and coiled-coil domain-containing protein 1,19716,86,0.91 [0.75-1.10],0.3123461150694273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,22178,107,1.15 [1.01-1.32],0.0399805829964123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18839,82,1.02 [0.67-1.57],0.9250384549764348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCLM,Glutamate--cysteine ligase regulatory subunit,19095,82,0.99 [0.61-1.60],0.9618456319038684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22609,108,0.99 [0.60-1.62],0.9573456964921032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,23006,109,2.17 [1.69-2.80],1.86509994336816e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF2,Growth/differentiation factor 2,22722,109,0.90 [0.56-1.45],0.6775338500437642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDNF,Glial cell line-derived neurotrophic factor,22218,108,1.32 [0.86-2.03],0.2073389028732928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GET3,ATPase GET3,19770,87,1.35 [0.98-1.85],0.0660845004946188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,22140,106,1.83 [1.31-2.56],0.0004238537319659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFER,FAD-linked sulfhydryl oxidase ALR,22178,107,1.12 [0.85-1.47],0.4170868001168235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22178,107,0.87 [0.73-1.03],0.1119868974351903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,22890,109,2.67 [1.59-4.48],0.0001998794995759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA2,GDNF family receptor alpha-2,22609,108,1.66 [0.75-3.69],0.2121625643358808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA3,GDNF family receptor alpha-3,22451,108,1.36 [0.74-2.49],0.320448854285592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRAL,GDNF family receptor alpha-like,19153,85,1.28 [0.96-1.72],0.0982926382140649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGA1,ADP-ribosylation factor-binding protein GGA1,22218,108,0.94 [0.71-1.24],0.6464638544474401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGACT,Gamma-glutamylaminecyclotransferase,19770,87,0.83 [0.62-1.12],0.2329393934556881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGCT,Gamma-glutamylcyclotransferase,19738,87,0.79 [0.50-1.23],0.293855824268639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGH,Gamma-glutamyl hydrolase,22361,105,1.04 [0.62-1.72],0.8932784925146224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,22687,108,1.30 [0.95-1.78],0.1009321142236421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT5,Glutathione hydrolase 5 proenzyme,22521,108,1.93 [0.99-3.77],0.0551266905375227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH1,Somatotropin,22691,109,1.00 [0.90-1.10],0.94626289432518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH2,Growth hormone variant,22178,107,1.02 [0.92-1.13],0.7344248776026214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHR,Growth hormone receptor,19321,84,0.50 [0.24-1.04],0.0649599463361206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRHR,Growth hormone-releasing hormone receptor,22218,108,1.23 [0.95-1.58],0.110471250754404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRL,Appetite-regulating hormone,22722,109,1.05 [0.86-1.28],0.657311208680097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GID8,Glucose-induced degradation protein 8 homolog,19729,85,0.86 [0.43-1.73],0.6727923182387234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIGYF2,GRB10-interacting GYF protein 2,19729,85,0.84 [0.63-1.13],0.2511869425470746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP7,GTPase IMAP family member 7,19321,84,0.74 [0.36-1.52],0.4153827114592595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP8,GTPase IMAP family member 8,19082,85,1.10 [0.74-1.65],0.6349953540153952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,19224,81,1.59 [1.12-2.26],0.0091709409693629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,19716,86,1.94 [1.06-3.54],0.03157875283496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC3,PDZ domain-containing protein GIPC3,19704,87,0.92 [0.75-1.13],0.4526439358100818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPR,Gastric inhibitory polypeptide receptor,19176,84,0.81 [0.47-1.37],0.4255881212286863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIT1,ARF GTPase-activating protein GIT1,19176,84,0.87 [0.70-1.09],0.2323319200606482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GJA8,Gap junction alpha-8 protein,19082,85,0.99 [0.70-1.40],0.9430135989966344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GKN1,Gastrokine-1,21811,107,1.07 [0.57-2.02],0.8323493295993232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLA,Alpha-galactosidase A,19290,84,0.59 [0.35-0.99],0.0468467716434047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLB1,Beta-galactosidase,22521,108,0.73 [0.48-1.11],0.1445244584578935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLI2,Zinc finger protein GLI2,19176,84,0.55 [0.25-1.19],0.1282365530073731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,22307,105,1.04 [0.77-1.40],0.8040254731482915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLOD4,Glyoxalase domain-containing protein 4,22649,107,1.19 [0.72-1.97],0.4883449092410981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLP1R,Glucagon-like peptide 1 receptor,19125,83,0.65 [0.33-1.27],0.2061926510382249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX,Glutaredoxin-1,22576,108,0.99 [0.73-1.33],0.929180028328954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19321,84,0.89 [0.70-1.14],0.3530967921744181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22218,108,0.96 [0.65-1.42],0.8499057650067128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLYR1,Putative oxidoreductase GLYR1,19698,87,0.94 [0.64-1.37],0.7452960773287586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,19297,86,1.54 [1.10-2.16],0.0121193389945679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMFG,Glia maturation factor gamma,19770,87,0.91 [0.68-1.22],0.5291644200056023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR,GMP reductase 1,22990,109,0.97 [0.69-1.37],0.8716507244554629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR2,GMP reductase 2,19321,84,0.76 [0.55-1.05],0.0954617746079209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNAS,Neuroendocrine secretory protein 55,19729,85,1.08 [0.86-1.37],0.5054725082895958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22178,107,1.04 [0.80-1.35],0.7702759506735246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19237,83,0.76 [0.46-1.26],0.2920780019716231
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNLY,Granulysin,22727,108,0.81 [0.60-1.10],0.1736782712924669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA1,Glucosamine-6-phosphate isomerase 1,19224,81,0.54 [0.24-1.21],0.1354094756175845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA2,Glucosamine-6-phosphate isomerase 2,19321,84,0.72 [0.40-1.28],0.2641475113060411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLGA3,Golgin subfamily A member 3,19729,85,0.87 [0.65-1.16],0.3369851470500166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLM2,Protein GOLM2,22930,109,1.38 [0.69-2.73],0.3628951134173311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22700,107,0.95 [0.80-1.12],0.5136202772102965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GORASP2,Golgi reassembly-stacking protein 2,19704,87,0.72 [0.46-1.13],0.1525508681878101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOT1,"Aspartate aminotransferase, cytoplasmic",19775,88,0.98 [0.61-1.58],0.9318142563282498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BA,Platelet glycoprotein Ib alpha chain,22646,106,0.86 [0.51-1.45],0.5724774907421705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BB,Platelet glycoprotein Ib beta chain,19095,82,0.83 [0.60-1.13],0.2358337153240887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22018,105,1.32 [1.11-1.58],0.0018187332367093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP5,Platelet glycoprotein V,19321,84,0.64 [0.38-1.10],0.1041928738294054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP6,Platelet glycoprotein VI,22685,107,0.97 [0.80-1.18],0.7609342356712212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPA33,Cell surface A33 antigen,22609,108,0.97 [0.85-1.10],0.6037791186800446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC1,Glypican-1,22917,109,1.57 [0.90-2.77],0.1149181635359848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC5,Glypican-5,22521,108,0.78 [0.57-1.05],0.1054803747991764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,19698,87,1.35 [0.94-1.93],0.1023950140738725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPHA2,Glycoprotein hormone alpha-2,19704,87,0.84 [0.49-1.43],0.5198092544406221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPI,Glucose-6-phosphate isomerase,19789,88,0.81 [0.52-1.27],0.3618930780510417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19704,87,1.10 [0.82-1.48],0.534320697658362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPKOW,G-patch domain and KOW motifs-containing protein,22218,108,1.12 [0.68-1.86],0.6486989474332037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPNMB,Transmembrane glycoprotein NMB,22105,106,1.03 [0.57-1.87],0.9141382414873086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR101,Probable G-protein coupled receptor 101,19125,83,0.82 [0.52-1.29],0.3922666709992067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR158,Probable G-protein coupled receptor 158,19729,85,1.20 [0.67-2.15],0.5451787869532648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR15L,Protein GPR15L,19704,87,0.80 [0.58-1.11],0.1869026379518346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,22307,105,1.33 [1.02-1.74],0.0327097897004314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,19698,87,1.33 [0.99-1.79],0.0564572226992554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRAP2,GRB2-related adapter protein 2,22722,109,1.00 [0.87-1.14],0.964146879797124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19770,87,0.88 [0.63-1.23],0.4624830498952773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIK2,"Glutamate receptor ionotropic, kainate 2",19729,85,0.91 [0.55-1.50],0.7154004545765369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19125,83,0.77 [0.48-1.26],0.3027819505096473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRK5,G protein-coupled receptor kinase 5,22307,105,1.06 [0.76-1.48],0.7413169883229277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,22605,107,1.60 [0.82-3.13],0.1671917411466066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRP,Gastrin-releasing peptide,19224,81,1.05 [0.70-1.57],0.8082695477159914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",22609,108,1.29 [0.99-1.68],0.0574218962401653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRSF1,G-rich sequence factor 1,18981,85,0.91 [0.70-1.18],0.4812598530092473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSAP,Gamma-secretase-activating protein,22178,107,0.88 [0.69-1.12],0.2955819276387903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSN,Gelsolin,19705,88,1.14 [0.38-3.42],0.8097190610828385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSR,"Glutathione reductase, mitochondrial",19687,88,0.58 [0.23-1.43],0.2379533229766693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA1,Glutathione S-transferase A1,22687,109,1.02 [0.83-1.25],0.843400160277702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA3,Glutathione S-transferase A3,22178,107,1.06 [0.85-1.33],0.5982840744269933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTM4,Glutathione S-transferase Mu 4,19095,82,1.13 [0.88-1.45],0.355098267706226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTP1,Glutathione S-transferase P,22079,107,0.85 [0.65-1.11],0.2271157946580609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTT2B,Glutathione S-transferase theta-2B,19716,86,0.99 [0.91-1.08],0.8654117309956539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19421,86,0.95 [0.69-1.32],0.7741781561492401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTPBP2,GTP-binding protein 2,19237,83,0.88 [0.68-1.15],0.3634307660937038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCA2A,Guanylin,22609,107,1.40 [0.87-2.23],0.1629939733204634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCY2C,Heat-stable enterotoxin receptor,19421,86,1.12 [0.89-1.42],0.3291847253821571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUK1,Guanylate kinase,19095,82,1.06 [0.62-1.82],0.8294928806789825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUSB,Beta-glucuronidase,22819,108,0.97 [0.74-1.27],0.8163120649984914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GYS1,"Glycogen [starch] synthase, muscle",22307,105,1.07 [0.88-1.29],0.49488177300112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMA,Granzyme A,22990,109,0.67 [0.40-1.12],0.1286582518235496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMB,Granzyme B,22700,107,0.69 [0.51-0.92],0.0125871890568578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMH,Granzyme H,22307,105,0.88 [0.70-1.12],0.3132716430029248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,H2AP,Huntingtin-interacting protein M,19082,85,1.00 [0.65-1.53],0.9978940777985352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19095,82,0.61 [0.37-1.01],0.0537220779981569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22856,109,0.91 [0.71-1.15],0.4273851384707166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAO1,Hydroxyacid oxidase 1,22917,109,1.00 [0.87-1.15],0.9954451541011384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HARS1,"Histidine--tRNA ligase, cytoplasmic",22727,108,1.05 [0.84-1.31],0.6680449961323791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,22883,109,1.31 [1.03-1.67],0.0299660277573161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,22727,108,1.61 [1.03-2.52],0.0373605199051882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBEGF,Proheparin-binding EGF-like growth factor,22856,109,0.82 [0.65-1.03],0.0935676259164497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBQ1,Hemoglobin subunit theta-1,22917,109,1.01 [0.77-1.32],0.9362765031501205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBZ,Hemoglobin subunit zeta,19770,87,0.96 [0.79-1.16],0.6574640235342133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCG22,Protein PBMUCL2,19095,82,1.05 [0.75-1.47],0.7829074821326992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCLS1,Hematopoietic lineage cell-specific protein,22990,109,1.06 [0.78-1.44],0.7250450368095049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC8,Histone deacetylase 8,19176,84,0.54 [0.31-0.94],0.029325940775479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC9,Histone deacetylase 9,19125,83,1.03 [0.76-1.39],0.845551781388404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDDC2,5'-deoxynucleotidase HDDC2,19704,87,0.89 [0.55-1.43],0.6219463252957588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,22879,108,1.14 [0.94-1.37],0.1751895698292165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGFL2,Hepatoma-derived growth factor-related protein 2,19716,86,0.98 [0.71-1.36],0.9253484944172398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEBP1,Heme-binding protein 1,22307,105,0.89 [0.63-1.26],0.5142868234640224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEG1,Protein HEG homolog 1,19321,84,1.01 [0.47-2.17],0.9782543837382084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPACAM2,HEPACAM family member 2,19716,86,1.30 [0.82-2.07],0.2661369198439313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPH,Hephaestin,19770,87,1.57 [0.70-3.52],0.2700692746038073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEXIM1,Protein HEXIM1,22700,107,0.88 [0.70-1.09],0.2421435410517385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,22990,109,2.16 [1.43-3.29],0.000286591589869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGFAC,Hepatocyte growth factor activator,19613,88,1.00 [0.47-2.13],0.995715264725994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22178,107,1.00 [0.80-1.25],0.9890331411354636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HHEX,Hematopoietically-expressed homeobox protein HHEX,19716,86,0.95 [0.72-1.25],0.7223451507344567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIF1A,Hypoxia-inducible factor 1-alpha,19176,84,0.98 [0.69-1.39],0.9200084390346684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1,Huntingtin-interacting protein 1,19095,82,0.81 [0.40-1.63],0.5581127342501953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1R,Huntingtin-interacting protein 1-related protein,19676,86,0.87 [0.54-1.42],0.586255756938405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HJV,Hemojuvelin,19729,85,1.12 [0.70-1.78],0.6346342688411724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HK2,Hexokinase-2,22307,105,0.84 [0.44-1.61],0.6035453864745826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19729,85,0.91 [0.49-1.70],0.774548835889197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22627,107,0.99 [0.62-1.57],0.9503966017573744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22700,107,1.46 [0.85-2.53],0.1700947198024462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMBS,Porphobilinogen deaminase,22917,109,0.96 [0.64-1.43],0.8300849888553606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMCN2,Hemicentin-2,19286,84,1.06 [0.74-1.53],0.7459719322899345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19224,81,0.91 [0.58-1.44],0.6909791163188097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19095,82,1.15 [0.74-1.80],0.5389873420445763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMMR,Hyaluronan mediated motility receptor,19038,85,0.87 [0.54-1.39],0.5623877412762578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX1,Heme oxygenase 1,22467,107,0.79 [0.55-1.12],0.188971694289352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,22218,108,1.21 [0.87-1.68],0.2642131772365951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNF1A,Hepatocyte nuclear factor 1-alpha,19237,83,0.72 [0.48-1.09],0.1234733279365024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNMT,Histamine N-methyltransferase,22420,108,1.15 [0.81-1.64],0.4289250792698175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22228,105,0.97 [0.77-1.22],0.7883964534129329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19729,85,0.81 [0.52-1.28],0.3703734476545535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPCAL1,Hippocalcin-like protein 1,22990,109,1.02 [0.81-1.28],0.884833314019943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,22178,107,0.67 [0.42-1.07],0.0965080712033873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPSE,Heparanase,19538,88,0.94 [0.76-1.17],0.6032071324645195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRAS,GTPase Hras,19388,86,1.00 [0.80-1.25],0.9855959134920088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19224,81,1.17 [0.63-2.19],0.6135385526990481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRG,Histidine-rich glycoprotein,19690,87,1.47 [0.80-2.71],0.2123716994980324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS1BP3,HCLS1-binding protein 3,19224,81,0.97 [0.76-1.24],0.8095035920482627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22609,108,0.79 [0.51-1.25],0.3146427819047874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22917,109,1.00 [0.61-1.61],0.9841449404155688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19176,84,0.68 [0.38-1.22],0.1946127407994699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSBP1,Heat shock factor-binding protein 1,19224,81,1.10 [0.88-1.38],0.4029304586303807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22700,107,1.24 [0.81-1.89],0.3249492822882386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19716,86,1.07 [0.76-1.50],0.696922515136811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19095,82,0.59 [0.35-0.99],0.0467760139251755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19224,81,0.79 [0.50-1.24],0.302196710420166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSP90B1,Endoplasmin,22114,108,1.06 [0.82-1.36],0.6504746089901225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA1A,Heat shock 70 kDa protein 1A,22758,107,1.04 [0.82-1.33],0.7480972727305972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA2,Heat shock-related 70 kDa protein 2,19698,87,1.01 [0.56-1.82],0.9811355759915162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB1,Heat shock protein beta-1,22363,108,1.04 [0.81-1.33],0.7492771556792373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,22917,109,2.00 [1.39-2.88],0.000203488848486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22577,106,1.62 [0.91-2.88],0.1011250565941467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1A,5-hydroxytryptamine receptor 1A,19125,83,1.09 [0.84-1.42],0.5249779310541489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,19125,83,0.47 [0.25-0.87],0.0171979483442062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTRA2,"Serine protease HTRA2, mitochondrial",22780,108,0.98 [0.74-1.30],0.9097188180880802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYAL1,Hyaluronidase-1,22625,107,1.06 [0.52-2.19],0.8678855573060903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYOU1,Hypoxia up-regulated protein 1,23006,109,1.70 [0.84-3.45],0.1391275038240326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICA1,Islet cell autoantigen 1,22323,107,0.93 [0.74-1.16],0.5276334276695539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,22641,107,1.57 [0.89-2.76],0.1160754898620715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM2,Intercellular adhesion molecule 2,23006,109,1.26 [0.75-2.13],0.3829861384057851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM3,Intercellular adhesion molecule 3,23006,109,1.08 [0.58-2.02],0.801231731936618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM4,Intercellular adhesion molecule 4,22700,107,0.98 [0.70-1.35],0.8847265283931764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM5,Intercellular adhesion molecule 5,22722,109,1.14 [0.79-1.64],0.4784745869898904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICOSLG,ICOS ligand,22609,108,0.86 [0.36-2.11],0.7487710036148538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ID4,DNA-binding protein inhibitor ID-4,19421,86,0.76 [0.42-1.35],0.3505007354374576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22218,108,1.43 [1.06-1.93],0.0179142913344488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDO1,"Indoleamine 2,3-dioxygenase 1",19224,81,0.80 [0.56-1.14],0.2197182892771457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDS,Iduronate 2-sulfatase,22990,109,2.03 [0.29-14.30],0.4764288857212032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDUA,Alpha-L-iduronidase,22917,109,0.80 [0.56-1.13],0.1998783431558587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19237,85,1.10 [0.65-1.86],0.718099654748396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19421,86,0.86 [0.56-1.33],0.4956493535119862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19421,86,0.73 [0.40-1.30],0.2822100543416716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNAR1,Interferon alpha/beta receptor 1,19704,87,0.75 [0.33-1.72],0.4942519202569879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNG,Interferon gamma,22323,107,1.06 [0.90-1.23],0.4949101780315325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,22802,107,2.19 [1.13-4.22],0.0198398857251511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR2,Interferon gamma receptor 2,22521,108,0.97 [0.70-1.34],0.8363294323300869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL1,Interferon lambda-1,22218,108,1.01 [0.69-1.47],0.9597028453472528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL2,Interferon lambda-2,19125,83,0.72 [0.45-1.14],0.1612312568125969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNLR1,Interferon lambda receptor 1,22700,107,0.83 [0.49-1.41],0.4945176977622899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,19095,82,1.56 [1.09-2.22],0.0141440690792442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFT20,Intraflagellar transport protein 20 homolog,19237,83,0.62 [0.36-1.08],0.0899923209218026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGBP1,Immunoglobulin-binding protein 1,19729,85,0.82 [0.58-1.17],0.2725228043339087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19125,83,0.75 [0.44-1.29],0.2986339513148634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19775,88,0.84 [0.40-1.76],0.643499713877236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF1R,Insulin-like growth factor 1 receptor,22609,108,1.01 [0.46-2.22],0.987301203518056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19095,82,0.55 [0.30-1.02],0.0580280624756585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,22727,108,2.19 [1.08-4.43],0.0302096502634744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,22972,109,1.16 [1.01-1.33],0.0358382724492342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,22972,109,1.99 [1.51-2.63],1.2498054712104978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP3,Insulin-like growth factor-binding protein 3,22832,108,0.79 [0.49-1.26],0.3160784921186447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,22452,108,1.85 [1.37-2.49],5.975090977048155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP6,Insulin-like growth factor-binding protein 6,22646,107,1.24 [0.74-2.06],0.4149671862090982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,23006,109,1.76 [1.16-2.65],0.0075284367484524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22722,109,1.74 [1.11-2.73],0.0150989608720237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFL4,Insulin growth factor-like family member 4,19176,84,0.79 [0.54-1.16],0.2259434880787597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGHMBP2,DNA-binding protein SMUBP-2,19095,82,0.78 [0.51-1.20],0.2551672483484316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,19760,88,1.83 [1.16-2.90],0.0095994895311492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLON5,IgLON family member 5,19082,85,1.00 [0.80-1.25],0.9810382770045648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF21,Immunoglobulin superfamily member 21,19224,81,0.84 [0.47-1.49],0.5439925195474542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,22609,108,1.19 [0.76-1.85],0.4525342652337635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF8,Immunoglobulin superfamily member 8,22722,109,1.00 [0.58-1.74],0.9990948853556934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF9,Protein turtle homolog A,19770,87,0.97 [0.76-1.22],0.7755619674288952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKBKG,NF-kappa-B essential modulator,22700,107,0.89 [0.73-1.08],0.2319194167390637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKZF2,Zinc finger protein Helios,22178,107,0.84 [0.66-1.08],0.1713568186440316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10,Interleukin-10,22323,107,0.98 [0.78-1.23],0.8883021463430641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RA,Interleukin-10 receptor subunit alpha,22323,107,0.99 [0.73-1.34],0.9267764323637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RB,Interleukin-10 receptor subunit beta,22802,107,1.65 [0.97-2.80],0.064071763453382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL11,Interleukin-11,22323,107,0.94 [0.70-1.25],0.6568779495651369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12A_IL12B,Interleukin-12,22609,108,0.97 [0.78-1.21],0.7680930123907074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12B,Interleukin-12 subunit beta,22990,109,0.95 [0.70-1.29],0.7367312641619872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB1,Interleukin-12 receptor subunit beta-1,22323,107,1.29 [0.81-2.03],0.2811434091187157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB2,Interleukin-12 receptor subunit beta-2,19176,84,0.78 [0.45-1.35],0.3763508132154314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13,Interleukin-13,22323,107,1.14 [0.85-1.53],0.3811423757067161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA1,Interleukin-13 receptor subunit alpha-1,22438,106,0.68 [0.33-1.37],0.2780728918036973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA2,Interleukin-13 receptor subunit alpha-2,19125,83,1.09 [0.52-2.26],0.8264533469139888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,22700,107,2.42 [1.54-3.81],0.0001241425888617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15RA,Interleukin-15 receptor subunit alpha,22323,107,1.53 [0.94-2.48],0.0855156394752718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL16,Pro-interleukin-16,22990,109,0.87 [0.58-1.30],0.4977632228678087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17A,Interleukin-17A,22276,107,1.32 [0.95-1.83],0.0937410499002457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,22323,107,1.26 [1.03-1.55],0.026628672913405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17D,Interleukin-17D,22323,107,1.29 [0.88-1.88],0.185596297872206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17F,Interleukin-17F,22323,107,1.07 [0.87-1.33],0.5142821398433852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RA,Interleukin-17 receptor A,22727,108,1.15 [0.79-1.68],0.4641869482337535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RB,Interleukin-17 receptor B,22415,107,0.96 [0.70-1.32],0.8112658447470383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,22611,107,1.42 [0.99-2.03],0.0588812099589376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,22832,108,1.59 [0.96-2.62],0.071518126133103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18R1,Interleukin-18 receptor 1,22990,109,0.92 [0.55-1.54],0.7530520597514444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18RAP,Interleukin-18 receptor accessory protein,22375,108,1.03 [0.93-1.14],0.5866105634721841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,22160,106,1.26 [1.02-1.56],0.0301515346767576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1A,Interleukin-1 alpha,22323,107,1.02 [0.78-1.33],0.8748250980850625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,22214,105,1.51 [1.19-1.91],0.0007391940819731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,22687,108,3.01 [1.57-5.76],0.0008578451840351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R2,Interleukin-1 receptor type 2,22648,107,1.83 [0.78-4.29],0.1650167018058931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RAP,Interleukin-1 receptor accessory protein,22727,108,1.30 [0.91-1.86],0.1504824724254109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL1,Interleukin-1 receptor-like 1,22929,109,1.12 [0.77-1.62],0.5559842706413992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL2,Interleukin-1 receptor-like 2,22323,107,0.61 [0.39-0.95],0.0279251346625137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,22647,107,1.41 [1.08-1.85],0.0124515047120043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2,Interleukin-2,22323,107,0.90 [0.53-1.55],0.714483150989204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20,Interleukin-20,22323,107,0.96 [0.65-1.40],0.8224316516468346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RA,Interleukin-20 receptor subunit alpha,22323,107,0.91 [0.60-1.38],0.6521818882839894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RB,Interleukin-20 receptor subunit beta,19176,84,0.76 [0.45-1.27],0.2909738220918457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL21R,Interleukin-21 receptor,19176,84,0.98 [0.66-1.43],0.8990004698588598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22,Interleukin-22,19698,87,1.26 [0.96-1.66],0.0938031529167977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22RA1,Interleukin-22 receptor subunit alpha-1,22323,107,1.07 [0.75-1.54],0.7027472732407469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL24,Interleukin-24,22323,107,0.97 [0.68-1.39],0.883833568903004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL25,Interleukin-25,19014,85,0.66 [0.37-1.20],0.1760709697240927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,22577,108,1.53 [1.06-2.21],0.0235197491088737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RB,Interleukin-2 receptor subunit beta,22323,107,0.95 [0.59-1.53],0.8402863536594954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,19698,87,1.65 [1.09-2.50],0.0171088610872638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3,Interleukin-3,19082,85,0.83 [0.62-1.10],0.1840384688994091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31,Interleukin-31,19176,84,1.22 [0.89-1.67],0.2139152012697667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31RA,Interleukin-31 receptor subunit alpha,19107,83,0.78 [0.44-1.38],0.3888109526523022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,22700,107,1.25 [0.87-1.80],0.2261998871057807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL33,Interleukin-33,22323,107,1.09 [0.70-1.67],0.7109680727645735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL34,Interleukin-34,22180,108,1.29 [0.79-2.09],0.304963346063849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36A,Interleukin-36 alpha,19176,84,0.98 [0.67-1.44],0.9184458772080392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,19113,84,1.22 [0.96-1.55],0.1066159822761786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3RA,Interleukin-3 receptor subunit alpha,22323,107,1.23 [0.72-2.10],0.4414692242366244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4,Interleukin-4,22323,107,1.24 [0.99-1.55],0.0640959295586448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,22700,107,1.80 [1.19-2.72],0.0055508434384636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,22323,107,1.09 [0.98-1.21],0.1310657231802754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,22700,107,1.35 [1.01-1.79],0.0392822321557197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,22609,108,1.29 [1.09-1.53],0.0028657040020974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6R,Interleukin-6 receptor subunit alpha,22610,107,0.96 [0.59-1.58],0.8853000226056311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,22722,109,2.59 [1.05-6.43],0.0395889130540591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7,Interleukin-7,22700,107,0.81 [0.62-1.07],0.1362266866052782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,22727,108,0.85 [0.62-1.17],0.310376371941528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL9,Interleukin-9,19421,86,0.70 [0.43-1.14],0.1525889858001528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22179,108,1.24 [0.95-1.62],0.1112838758037057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,19698,87,1.39 [0.94-2.07],0.0999741587106645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPA1,Inositol monophosphatase 1,22521,108,0.98 [0.74-1.31],0.90471741359731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPACT,Protein IMPACT,19716,86,0.75 [0.51-1.09],0.1343425872039101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPG1,Interphotoreceptor matrix proteoglycan 1,19125,83,0.80 [0.38-1.70],0.5572003302203787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ING1,Inhibitor of growth protein 1,22185,108,1.05 [0.74-1.47],0.798995884654864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBB,Inhibin beta B chain,19321,84,1.42 [0.97-2.06],0.0695380007666015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBC,Inhibin beta C chain,22727,108,1.08 [0.70-1.68],0.7286192029370226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP1,Inositol polyphosphate 1-phosphatase,22609,108,0.99 [0.72-1.38],0.973318127597554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19224,81,0.80 [0.54-1.19],0.2712409052666177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19729,85,0.60 [0.33-1.09],0.0947127716813418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22609,108,0.94 [0.79-1.13],0.5094419534149763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL3,Insulin-like 3,19716,86,0.85 [0.69-1.06],0.1536127873501264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL4,Early placenta insulin-like peptide,19698,87,1.22 [0.84-1.77],0.3040193574793096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL5,Insulin-like peptide INSL5,19704,87,1.08 [0.88-1.32],0.4825892160197002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSR,Insulin receptor,19176,84,0.79 [0.23-2.77],0.7142300599623551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IPCEF1,Interactor protein for cytohesin exchange factors 1,22480,108,1.06 [0.87-1.28],0.5622427072023906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22609,108,0.89 [0.64-1.23],0.4688958476327075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22307,105,0.92 [0.74-1.14],0.4342210863904951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK1,Interleukin-1 receptor-associated kinase 1,22323,107,0.87 [0.67-1.13],0.2910071137835339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK4,Interleukin-1 receptor-associated kinase 4,22700,107,1.00 [0.85-1.18],0.9675843789996488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21896,108,0.87 [0.55-1.38],0.5593144180341352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM1,Isthmin-1,22700,107,0.95 [0.61-1.46],0.8032790809504153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM2,Isthmin-2,19775,88,1.28 [0.86-1.92],0.2299466910986232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IST1,IST1 homolog,19558,87,0.91 [0.74-1.12],0.3871971318979571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,22700,107,0.54 [0.33-0.89],0.0157924470769597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,19321,84,0.46 [0.25-0.83],0.0102915047064655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA5,Integrin alpha-5,22727,108,0.71 [0.36-1.40],0.3230824885502473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA6,Integrin alpha-6,22700,107,0.87 [0.61-1.25],0.4581460381980875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAL,Integrin alpha-L,19176,84,0.95 [0.59-1.54],0.8402971881844529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAM,Integrin alpha-M,22727,108,0.69 [0.40-1.20],0.1879184086877752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,22917,109,0.39 [0.15-1.05],0.0612957935032395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAX,Integrin alpha-X,19421,86,1.12 [0.78-1.62],0.5405722807695936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1,Integrin beta-1,22720,108,0.97 [0.43-2.19],0.9469469864189076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,22178,107,1.27 [0.83-1.94],0.2717678525168973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP2,Integrin beta-1-binding protein 2,22307,105,1.01 [0.86-1.18],0.9381152283776204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB2,Integrin beta-2,22605,108,0.60 [0.32-1.11],0.104142544649341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB5,Integrin beta-5,22780,108,0.77 [0.49-1.22],0.2708098758139063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB6,Integrin beta-6,22323,107,1.10 [0.63-1.92],0.7420485193209274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB7,Integrin beta-7,22917,109,1.00 [0.69-1.45],0.9888530013676652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,19775,88,1.33 [0.83-2.14],0.2312733707034884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19786,88,1.88 [0.67-5.33],0.2323678187307271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22832,108,1.91 [1.22-2.99],0.0045960387863118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19786,88,1.75 [0.89-3.48],0.1073280860102245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19698,87,0.84 [0.51-1.37],0.4865557328662075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITM2A,Integral membrane protein 2A,22700,107,1.04 [0.78-1.37],0.8009518161717424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPA,Inosine triphosphate pyrophosphatase,19095,82,0.90 [0.65-1.24],0.5202187221502368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19224,81,0.85 [0.60-1.20],0.3455786209912843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19125,83,0.94 [0.57-1.55],0.8117400847197125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22218,108,0.95 [0.67-1.36],0.7910598854080858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IZUMO1,Izumo sperm-egg fusion protein 1,19082,85,1.05 [0.69-1.60],0.8112496404268252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,22930,109,1.39 [0.76-2.52],0.2857158583296499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM3,Junctional adhesion molecule C,19321,84,0.66 [0.42-1.05],0.0819724127361736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JCHAIN,Immunoglobulin J chain,22323,107,1.25 [0.95-1.64],0.1142605030698215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19082,85,1.13 [0.82-1.56],0.4533509581375532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JPT2,Jupiter microtubule associated homolog 2,19704,87,0.93 [0.74-1.18],0.5708912866812723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JUN,Transcription factor AP-1,22323,107,1.31 [1.00-1.72],0.0523052099982167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22609,108,1.12 [0.76-1.63],0.571345281920047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZN,Kazrin,19704,87,0.90 [0.74-1.10],0.3126967490437357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNC4,Potassium voltage-gated channel subfamily C member 4,19125,83,1.29 [0.96-1.74],0.0962379512806036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNH2,Potassium voltage-gated channel subfamily H member 2,19237,83,0.93 [0.68-1.26],0.6406506502386318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNIP4,Kv channel-interacting protein 4,22218,108,1.19 [0.89-1.59],0.2362260850729845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,19343,85,0.59 [0.35-0.99],0.0463231126394742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDM3A,Lysine-specific demethylase 3A,19176,84,0.84 [0.62-1.14],0.2562588454364831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDR,Vascular endothelial growth factor receptor 2,22780,108,0.63 [0.33-1.21],0.1679424348316983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KEL,Kell blood group glycoprotein,22218,108,1.32 [0.83-2.10],0.2403143189541045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHDC3L,KH domain-containing protein 3,19082,85,0.86 [0.60-1.24],0.4195704484109982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHK,Ketohexokinase,19224,81,0.84 [0.60-1.18],0.3171888213395428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA0319,Dyslexia-associated protein KIAA0319,19716,86,0.78 [0.39-1.58],0.4923980048322732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549,UPF0606 protein KIAA1549,19421,86,0.72 [0.54-0.96],0.0233103839166716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549L,UPF0606 protein KIAA1549L,19421,86,0.70 [0.32-1.52],0.362777809046613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA2013,Uncharacterized protein KIAA2013,19698,87,1.14 [0.81-1.61],0.4500321194097985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF1C,Kinesin-like protein KIF1C,19095,82,0.78 [0.38-1.61],0.5039758896508666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF20B,Kinesin-like protein KIF20B,19125,83,0.86 [0.63-1.17],0.3301062855074538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF22,Kinesin-like protein KIF22,19095,82,0.93 [0.79-1.10],0.3987687246369469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIFBP,KIF-binding protein,22609,108,0.98 [0.79-1.20],0.8096373806331976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19698,87,0.96 [0.77-1.21],0.7509275287415187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22178,107,0.93 [0.75-1.16],0.530206394501951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19704,87,1.06 [0.94-1.19],0.3683944173842669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22178,107,1.00 [0.88-1.15],0.9486695214991878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19082,85,0.86 [0.63-1.18],0.3489122622292393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL1,Kin of IRRE-like protein 1,19125,83,1.09 [0.77-1.53],0.637805158371678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL2,Kin of IRRE-like protein 2,22218,108,1.10 [0.73-1.67],0.6460264416048981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIT,Mast/stem cell growth factor receptor Kit,22798,108,0.87 [0.49-1.54],0.6282138808076068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KITLG,Kit ligand,22722,109,1.17 [0.75-1.83],0.4922384953245824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLB,Beta-klotho,22218,108,0.97 [0.77-1.22],0.8057445698221173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLF4,Krueppel-like factor 4,19125,83,1.10 [0.68-1.80],0.6930072546193371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLHL41,Kelch-like protein 41,19729,85,1.34 [0.96-1.88],0.0872525801862515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK1,Kallikrein-1,22511,105,1.08 [0.95-1.22],0.2579312101777157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK10,Kallikrein-10,22718,107,1.20 [0.80-1.78],0.3762562271129156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,22560,107,1.60 [1.07-2.39],0.0217909331265834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,22178,107,0.83 [0.74-0.94],0.0042039259612913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK13,Kallikrein-13,22187,107,1.08 [0.75-1.56],0.6649866671137195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK14,Kallikrein-14,22917,109,1.22 [0.86-1.74],0.2654269796074119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK15,Kallikrein-15,19658,87,1.10 [0.74-1.64],0.6250921119479533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK3,Prostate-specific antigen,19775,88,0.93 [0.79-1.10],0.4131774563865875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,22917,109,1.54 [1.24-1.91],9.483918506416582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK6,Kallikrein-6,22736,108,1.08 [0.63-1.86],0.78530285956432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK7,Kallikrein-7,18854,82,1.08 [0.63-1.85],0.7778128685137287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK8,Kallikrein-8,21952,100,1.31 [0.82-2.09],0.2535576919531099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLKB1,Plasma kallikrein,19384,86,1.24 [0.53-2.89],0.6172189430345296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22990,109,1.13 [0.74-1.71],0.5791923349976877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19125,83,0.95 [0.65-1.39],0.7909485321517254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRD1,Natural killer cells antigen CD94,22990,109,0.79 [0.56-1.13],0.2033980219133042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19176,84,0.90 [0.55-1.46],0.656819674514139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRK1,NKG2-D type II integral membrane protein,19716,86,0.99 [0.63-1.53],0.9489341238530312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT14,"Keratin, type I cytoskeletal 14",21543,102,1.00 [0.55-1.80],0.9887382809843572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT17,"Keratin, type I cytoskeletal 17",19095,82,1.24 [0.78-1.98],0.3654925691088276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT18,"Keratin, type I cytoskeletal 18",22609,108,1.07 [0.88-1.31],0.493004392496623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",22660,107,1.10 [0.86-1.40],0.4599738053918427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT5,"Keratin, type II cytoskeletal 5",22218,108,1.00 [0.72-1.39],0.9986081664848574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT6C,"Keratin, type II cytoskeletal 6C",19095,82,0.79 [0.41-1.51],0.4726181213273744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT8,"Keratin, type II cytoskeletal 8",19125,83,0.94 [0.72-1.22],0.6167460018804098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYAT1,Kynurenine--oxoglutarate transaminase 1,22686,109,1.01 [0.74-1.36],0.9654480473596976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYNU,Kynureninase,22990,109,0.96 [0.66-1.39],0.8206054816145503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L1CAM,Neural cell adhesion molecule L1,22780,108,0.94 [0.53-1.65],0.8189106889427258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19770,87,0.88 [0.70-1.12],0.2972618479529368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACRT,Extracellular glycoprotein lacritin,19660,87,0.99 [0.64-1.52],0.9547210975218204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACTB2,Endoribonuclease LACTB2,22722,109,1.00 [0.77-1.30],0.9771126622766924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAG3,Lymphocyte activation gene 3 protein,22609,108,0.83 [0.54-1.28],0.3880420575088859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22689,107,1.37 [0.96-1.95],0.0810113504255916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22521,108,1.16 [0.98-1.37],0.0916748844436794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA1,Laminin subunit alpha-1,19095,82,0.88 [0.55-1.40],0.5791126627088337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA4,Laminin subunit alpha-4,22802,107,1.19 [0.73-1.95],0.4907378369157147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMB1,Laminin subunit beta-1,19224,81,1.97 [0.98-3.98],0.0570719280461985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP1,Lysosome-associated membrane glycoprotein 1,19232,87,0.73 [0.31-1.75],0.4876804476745409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP2,Lysosome-associated membrane glycoprotein 2,22031,105,1.02 [0.44-2.37],0.9545444636489472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,22952,108,1.57 [1.15-2.15],0.0045231972514722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMTOR5,Ragulator complex protein LAMTOR5,19698,87,0.85 [0.50-1.47],0.5697789252775869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAP3,Cytosol aminopeptidase,22323,107,1.06 [0.74-1.51],0.7526092184335517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LARP1,La-related protein 1,19698,87,0.69 [0.47-1.01],0.0584806774646203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT,Linker for activation of T-cells family member 1,22990,109,1.00 [0.80-1.25],0.9951214529263004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT2,Linker for activation of T-cells family member 2,22609,108,0.99 [0.86-1.13],0.8775210454523706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LATS1,Serine/threonine-protein kinase LATS1,19176,84,0.94 [0.74-1.21],0.6530505554339987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,22488,108,1.55 [1.00-2.41],0.0517118683158212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBP,Lipopolysaccharide-binding protein,22832,108,1.29 [0.97-1.72],0.0756841898793892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBR,Delta(14)-sterol reductase LBR,22930,109,0.96 [0.75-1.23],0.7252217273993083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCAT,Phosphatidylcholine-sterol acyltransferase,19789,88,0.41 [0.17-1.02],0.0562352665477239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN15,Lipocalin-15,19729,85,1.27 [0.97-1.66],0.0848652724861115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN2,Neutrophil gelatinase-associated lipocalin,22060,104,1.26 [0.83-1.90],0.277139865007392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCP1,Plastin-2,19775,88,1.23 [0.84-1.81],0.2885062647048583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,22787,109,0.64 [0.45-0.90],0.0097670800947959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19729,85,0.97 [0.79-1.19],0.7593800497922858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,19770,87,1.32 [0.97-1.78],0.0733960930949403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEFTY2,Left-right determination factor 2,22890,109,0.97 [0.70-1.34],0.8418512758619825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEG1,Protein LEG1 homolog,18692,83,1.06 [0.79-1.42],0.7097379408357438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LELP1,Late cornified envelope-like proline-rich protein 1,19125,83,0.81 [0.57-1.14],0.2231520854660291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEO1,RNA polymerase-associated protein LEO1,19729,85,1.16 [0.64-2.10],0.634436890232069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEP,Leptin,22722,109,1.10 [0.85-1.41],0.4708895931104853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEPR,Leptin receptor,22722,109,1.06 [0.62-1.81],0.8200655750627837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LETM1,Mitochondrial proton/calcium exchanger protein,19729,85,1.06 [0.73-1.55],0.7538687896565286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,22722,109,1.37 [0.86-2.17],0.1871096653385087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3,Galectin-3,22788,109,1.28 [0.73-2.26],0.3832253014846565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3BP,Galectin-3-binding protein,19786,88,1.11 [0.59-2.08],0.7494375461438557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,22689,107,1.24 [0.93-1.65],0.1372027646727335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,22656,108,1.50 [1.11-2.01],0.0080287632843303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS8,Galectin-8,22930,109,0.84 [0.62-1.12],0.229294378839995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,22693,107,1.45 [0.86-2.46],0.1672164786974062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGMN,Legumain,22802,107,0.75 [0.46-1.22],0.2464622933328379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,22178,107,1.10 [0.93-1.31],0.2772212755476186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22722,107,1.05 [0.79-1.40],0.7308085608681738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIF,Leukemia inhibitory factor,22218,108,0.79 [0.54-1.16],0.2265874537726245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,22700,107,2.74 [1.45-5.17],0.001899003004363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22727,108,0.96 [0.61-1.51],0.8508877395008243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19775,88,0.99 [0.86-1.14],0.9016866844394128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19095,82,0.87 [0.54-1.38],0.5436382243981064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22691,109,1.24 [0.74-2.07],0.4182138302594652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19770,87,1.06 [0.81-1.39],0.6649727427920581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23006,109,1.16 [0.63-2.14],0.6388396456425424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22895,109,1.51 [0.91-2.50],0.1076921982703007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22323,107,1.45 [1.00-2.09],0.0494351933930645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23006,109,1.06 [0.83-1.36],0.6452813931117092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIPF,Gastric triacylglycerol lipase,19224,81,0.95 [0.68-1.34],0.7789159984730817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB1,Lamin-B1,19671,87,0.85 [0.60-1.20],0.3578273422030199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB2,Lamin-B2,19716,86,1.19 [0.57-2.46],0.6463511998368359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,19729,85,2.41 [1.71-3.40],5.019104977397363e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD2,Leiomodin-2,19125,83,0.86 [0.58-1.26],0.4259867386625635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LONP1,"Lon protease homolog, mitochondrial",19224,81,0.89 [0.69-1.15],0.3737472911470516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPA,Apolipoprotein(a),19344,86,0.99 [0.88-1.11],0.821098163117662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22609,108,0.98 [0.67-1.45],0.9342353421251705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPL,Lipoprotein lipase,22722,109,0.96 [0.68-1.37],0.8364812565226424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPO,Lactoperoxidase,21916,104,0.88 [0.66-1.17],0.3882941359832313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPP,Lipoma-preferred partner,19095,82,0.95 [0.69-1.32],0.7720184414752156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19095,82,0.96 [0.70-1.32],0.7987694499970539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19237,83,0.87 [0.51-1.47],0.6045730788334553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,19786,88,2.38 [1.15-4.95],0.0200188383418589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22856,109,1.35 [0.84-2.15],0.2109561205931411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19117,84,1.66 [0.93-2.96],0.0870126759430785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP1,Prolow-density lipoprotein receptor-related protein 1,22609,108,1.27 [0.68-2.37],0.4491048637668587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,22722,109,1.70 [1.10-2.63],0.015949955699283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2,Low-density lipoprotein receptor-related protein 2,19237,83,0.83 [0.45-1.53],0.5469151084959635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2BP,LRP2-binding protein,19237,83,0.81 [0.58-1.12],0.2042893668470535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22930,109,1.07 [0.80-1.42],0.6618453171030247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC25,Leucine-rich repeat-containing protein 25,22609,108,1.31 [0.88-1.95],0.1870105046656153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19704,87,1.18 [0.74-1.89],0.4959870112086404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC38,Leucine-rich repeat-containing protein 38,19237,83,1.21 [0.79-1.83],0.3807989347639484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC59,Leucine-rich repeat-containing protein 59,19770,87,0.78 [0.49-1.24],0.2892093349342179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19698,87,0.68 [0.42-1.09],0.1058346896533652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,22323,107,0.54 [0.35-0.82],0.0037682216957236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19237,83,1.52 [1.07-2.16],0.0181128362670534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19729,85,0.45 [0.19-1.06],0.0663970454361867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM1,U6 snRNA-associated Sm-like protein LSm1,22178,107,0.96 [0.70-1.32],0.7965909530803553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM8,U6 snRNA-associated Sm-like protein LSm8,19421,86,0.86 [0.63-1.16],0.3209044440822562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSP1,Lymphocyte-specific protein 1,22700,107,1.02 [0.67-1.56],0.9216805173672968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA,Lymphotoxin-alpha,22700,107,0.80 [0.51-1.24],0.3159036112756903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA4H,Leukotriene A-4 hydrolase,22917,109,1.06 [0.80-1.39],0.7035786018155196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTB,Lymphotoxin-beta,19698,87,1.07 [0.60-1.91],0.8115865845425259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,23006,109,2.41 [1.49-3.89],0.0003091172711071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP3,Latent-transforming growth factor beta-binding protein 3,22178,107,1.05 [0.77-1.43],0.7542682561350149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,22570,107,2.29 [1.39-3.76],0.0010838691248103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTO1,Protein LTO1 homolog,22323,107,0.99 [0.65-1.51],0.9546136195454828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LUZP2,Leucine zipper protein 2,19698,87,0.93 [0.58-1.49],0.7527187020452426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LXN,Latexin,22411,107,1.02 [0.80-1.30],0.8819922888064844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,22575,107,1.51 [1.04-2.21],0.0313155496987923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY75,Lymphocyte antigen 75,22700,107,1.15 [0.74-1.79],0.5451556490369934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY9,T-lymphocyte surface antigen Ly-9,22444,109,1.41 [0.81-2.45],0.2183996799656321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY96,Lymphocyte antigen 96,22521,108,0.99 [0.62-1.58],0.9537356449126082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYAR,Cell growth-regulating nucleolar protein,22178,107,0.84 [0.58-1.21],0.3393455334100528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYN,Tyrosine-protein kinase Lyn,22609,108,1.08 [0.88-1.32],0.4717496250349025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD1,Ly6/PLAUR domain-containing protein 1,22218,108,0.90 [0.66-1.23],0.5251809423558811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD3,Ly6/PLAUR domain-containing protein 3,22606,107,0.82 [0.49-1.36],0.4430332853991541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD8,Ly6/PLAUR domain-containing protein 8,22178,107,1.05 [0.77-1.45],0.7428405785449661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPLA2,Acyl-protein thioesterase 2,19125,83,1.01 [0.84-1.23],0.8799892453527542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19237,83,0.84 [0.66-1.07],0.1567082169411659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19786,88,1.07 [0.37-3.08],0.8934885104963737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYZL2,Lysozyme-like protein 2,19082,85,0.55 [0.29-1.05],0.0716900947725945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LZTFL1,Leucine zipper transcription factor-like protein 1,19321,84,0.86 [0.64-1.17],0.3351305160935785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,M6PR,Cation-dependent mannose-6-phosphate receptor,19224,81,0.98 [0.57-1.71],0.9522191972790266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22449,108,1.14 [0.85-1.52],0.3894587153184791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAEA,E3 ubiquitin-protein transferase MAEA,22178,107,0.94 [0.59-1.50],0.8092474697028834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAG,Myelin-associated glycoprotein,19237,83,0.77 [0.51-1.17],0.222538283322343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,19421,86,0.81 [0.68-0.98],0.027658944598416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGED1,Melanoma-associated antigen D1,22178,107,0.91 [0.63-1.31],0.6004988482651071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC2,MAM domain-containing protein 2,19770,87,1.93 [1.12-3.33],0.0170673903593734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC4,Apical endosomal glycoprotein,19698,87,1.10 [0.77-1.56],0.6006493551761818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19224,81,1.66 [0.72-3.83],0.2326060509104245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN2B2,Epididymis-specific alpha-mannosidase,19770,87,1.06 [0.75-1.49],0.7460209781573541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19082,85,0.76 [0.50-1.16],0.202512383706634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANF,Mesencephalic astrocyte-derived neurotrophic factor,22802,107,1.02 [0.88-1.17],0.8067707584616578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,22780,108,1.89 [1.06-3.39],0.0312912135341513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC4,MANSC domain-containing protein 4,19095,82,0.94 [0.68-1.28],0.6793119867939288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19125,83,0.83 [0.43-1.62],0.586189670573964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19095,82,1.31 [1.06-1.62],0.0108693285359659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2,Microtubule-associated protein 2,19716,86,1.04 [0.67-1.62],0.8657888560677522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19704,87,0.81 [0.59-1.12],0.2038823020024007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22700,107,1.00 [0.84-1.19],0.9757807671180312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22178,107,0.83 [0.69-1.01],0.0666377342080793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22488,108,0.96 [0.83-1.12],0.6360442605860405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK13,Mitogen-activated protein kinase 13,19082,85,1.08 [0.68-1.73],0.7329410308952575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK9,Mitogen-activated protein kinase 9,22700,107,0.75 [0.50-1.11],0.1519972892557409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPKAPK2,MAP kinase-activated protein kinase 2,19421,86,0.87 [0.65-1.16],0.3403763773399942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPRE3,Microtubule-associated protein RP/EB family member 3,19082,85,0.89 [0.74-1.06],0.1842655569780088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPT,Microtubule-associated protein tau,22218,108,1.43 [1.01-2.03],0.0457835513488265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARCO,Macrophage receptor MARCO,22722,109,1.17 [0.61-2.25],0.6332311188116369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARS1,"Methionine--tRNA ligase, cytoplasmic",19290,84,0.82 [0.63-1.06],0.1215444475026282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MASP1,Mannan-binding lectin serine protease 1,22488,108,1.05 [0.50-2.18],0.9013065699351048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,22723,107,2.05 [1.15-3.63],0.0143124269388683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN3,Matrilin-3,22480,108,1.37 [0.84-2.24],0.202154101829401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAVS,Mitochondrial antiviral-signaling protein,22178,107,0.91 [0.74-1.11],0.346818046664318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAX,Protein max,22218,108,0.94 [0.80-1.10],0.4427576812783784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,23006,109,1.22 [0.92-1.62],0.1611020135408363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MBL2,Mannose-binding protein C,19515,86,1.14 [0.94-1.38],0.1843825298135208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCAM,Cell surface glycoprotein MUC18,22832,108,1.59 [0.98-2.58],0.0598008058437418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19729,85,1.30 [0.86-1.96],0.2083049059971173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEMP1,Mast cell-expressed membrane protein 1,19176,84,1.02 [0.81-1.30],0.8480705872624026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCFD2,Multiple coagulation factor deficiency protein 2,22605,109,1.14 [0.78-1.67],0.4886637736090686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCTS1,Malignant T-cell-amplified sequence 1,19704,87,0.74 [0.32-1.72],0.4797856054897844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22521,108,1.15 [0.90-1.47],0.2768486407353956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDH1,"Malate dehydrogenase, cytoplasmic",19691,88,0.72 [0.42-1.23],0.2290205438975715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,22709,108,1.26 [0.93-1.70],0.139684021492489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDM1,Nuclear protein MDM1,19237,83,0.85 [0.42-1.72],0.6594203272666438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19224,81,0.95 [0.75-1.21],0.6928156040559874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED18,Mediator of RNA polymerase II transcription subunit 18,22178,107,1.03 [0.82-1.29],0.8146907605708746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED21,Mediator of RNA polymerase II transcription subunit 21,19095,82,0.81 [0.48-1.36],0.4277695784581329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF10,Multiple epidermal growth factor-like domains protein 10,22689,107,1.30 [0.84-2.00],0.2323711109692275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF11,Multiple epidermal growth factor-like domains protein 11,19095,82,1.20 [0.64-2.24],0.5789638247914644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF9,Multiple epidermal growth factor-like domains protein 9,22929,109,1.09 [0.45-2.61],0.8474627087280342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MELTF,Melanotransferrin,19770,87,1.36 [0.70-2.65],0.3583961910872542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MENT,Protein MENT,19321,84,0.92 [0.38-2.22],0.8526761432437908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1A,Meprin A subunit alpha,19704,87,0.92 [0.70-1.20],0.5272319314579773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1B,Meprin A subunit beta,22722,109,1.04 [0.90-1.20],0.6107208195139273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEPE,Matrix extracellular phosphoglycoprotein,22689,107,1.18 [0.57-2.41],0.6558617706715291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,22990,109,1.88 [0.97-3.66],0.0620570144266302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MESD,LRP chaperone MESD,22727,108,1.01 [0.88-1.16],0.8901862788454352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MET,Hepatocyte growth factor receptor,22784,109,1.15 [0.48-2.73],0.7574364746081791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1,Methionine aminopeptidase 1,22218,108,0.91 [0.50-1.65],0.7515837847435091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22700,107,1.00 [0.81-1.23],0.992692024857438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP2,Methionine aminopeptidase 2,22890,109,0.99 [0.73-1.34],0.9589626632497326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3,Microfibril-associated glycoprotein 3,22307,105,0.91 [0.62-1.33],0.6348017074425716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3L,Microfibrillar-associated protein 3-like,19237,83,0.58 [0.36-0.96],0.0341259023408709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP4,Microfibril-associated glycoprotein 4,19321,84,1.54 [0.81-2.92],0.1888200628213302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP5,Microfibrillar-associated protein 5,23006,109,1.04 [0.68-1.58],0.8571262213492004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFGE8,Lactadherin,22727,108,1.14 [0.79-1.66],0.4728161284334436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGLL,Monoglyceride lipase,22768,107,1.00 [0.82-1.21],0.9965491605642116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22700,107,1.06 [0.91-1.22],0.4568689368994331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIA,Melanoma-derived growth regulatory protein,22780,108,1.04 [0.66-1.64],0.8589680361823346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICALL2,MICAL-like protein 2,19237,83,0.81 [0.57-1.15],0.2400252976886855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22700,107,0.99 [0.89-1.11],0.8780867475113923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIF,Macrophage migration inhibitory factor,22683,108,1.00 [0.77-1.29],0.9945693936389728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MILR1,Allergin-1,22323,107,1.09 [0.79-1.52],0.5962465991846493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19698,87,0.93 [0.77-1.13],0.4704604762958553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINK1,Misshapen-like kinase 1,19716,86,0.89 [0.71-1.11],0.3112801308051454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MITD1,MIT domain-containing protein 1,22521,108,1.02 [0.86-1.22],0.8100973045064583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MKI67,Proliferation marker protein Ki-67,19176,84,0.98 [0.57-1.68],0.9485644313764044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLLT1,Protein ENL,19082,85,0.73 [0.50-1.07],0.1110648154245264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLN,Promotilin,22700,107,1.21 [1.00-1.47],0.0531110123715447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MME,Neprilysin,22609,108,1.10 [0.89-1.36],0.3790999315504614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP1,Interstitial collagenase,21973,103,1.08 [0.89-1.32],0.4363028883589309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP10,Stromelysin-2,22648,106,1.24 [0.93-1.64],0.1398068393044212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP12,Macrophage metalloelastase,22752,109,1.24 [0.92-1.68],0.1510091937982114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP13,Collagenase 3,22218,108,1.16 [0.68-1.98],0.5787022610835109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP15,Matrix metalloproteinase-15,19770,87,0.86 [0.53-1.41],0.5578694422750408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP3,Stromelysin-1,22727,108,1.28 [0.92-1.78],0.143819522952621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,22276,105,1.48 [1.04-2.13],0.0308632777310263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,22893,109,1.47 [1.21-1.80],0.0001458140525694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,22695,108,1.58 [1.19-2.09],0.001316522373057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19095,82,1.28 [0.88-1.87],0.19361906056984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MN1,Transcriptional activator MN1,19237,83,0.68 [0.43-1.06],0.0870273171105164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNAT1,CDK-activating kinase assembly factor MAT1,19421,86,1.01 [0.63-1.62],0.9643137427572818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,22687,109,1.12 [0.97-1.30],0.1151280970750659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOCS2,Molybdopterin synthase catalytic subunit,19321,84,0.86 [0.62-1.19],0.3533598434428354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOG,Myelin-oligodendrocyte glycoprotein,22917,109,1.14 [0.70-1.87],0.5948114659215358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORC3,MORC family CW-type zinc finger protein 3,19716,86,0.81 [0.36-1.81],0.6075779735039424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L1,Mortality factor 4-like protein 1,19421,86,1.26 [0.82-1.95],0.2962864876931985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L2,Mortality factor 4-like protein 2,19082,85,0.93 [0.52-1.67],0.8156745757905429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORN4,MORN repeat-containing protein 4,19082,85,1.10 [0.88-1.39],0.3960538092087726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPHOSPH8,M-phase phosphoprotein 8,22307,105,0.98 [0.78-1.24],0.8950807570374499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPI,Mannose-6-phosphate isomerase,22609,108,1.05 [0.86-1.29],0.6135538002260845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22768,107,0.92 [0.74-1.14],0.4548200099898685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,22727,108,1.53 [1.13-2.08],0.0060545520321239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPRIP,Myosin phosphatase Rho-interacting protein,19666,87,0.81 [0.50-1.31],0.3820755929582086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,19789,88,2.01 [1.01-4.02],0.0472641096744067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRI1,Methylthioribose-1-phosphate isomerase,19237,83,0.82 [0.60-1.11],0.2035887141826785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL24,"39S ribosomal protein L24, mitochondrial",19095,82,0.72 [0.37-1.38],0.3161304654763104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL28,"39S ribosomal protein L28, mitochondrial",19729,85,0.77 [0.38-1.57],0.471477033322741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL46,"39S ribosomal protein L46, mitochondrial",22218,108,1.53 [0.92-2.54],0.1005996804870604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL52,"39S ribosomal protein L52, mitochondrial",19038,85,0.86 [0.38-1.97],0.7290909874022644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19729,85,1.06 [0.80-1.40],0.6906891686649421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPS16,"28S ribosomal protein S16, mitochondrial",19176,84,0.97 [0.44-2.13],0.9322035099141208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLN,Mesothelin,22569,108,1.17 [0.89-1.54],0.2531367957840194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLNL,Mesothelin-like protein,19237,83,1.04 [0.60-1.81],0.894204229458521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSMB,Beta-microseminoprotein,22699,109,1.13 [0.89-1.43],0.3167973196217326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSR1,Macrophage scavenger receptor types I and II,22930,109,1.06 [0.74-1.52],0.739499505001531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSRA,Mitochondrial peptide methionine sulfoxide reductase,22780,108,1.01 [0.80-1.28],0.9344650759626072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MST1,Hepatocyte growth factor-like protein,19499,88,1.10 [0.78-1.55],0.5786027173665378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSTN,Growth/differentiation factor 8,22307,105,1.12 [0.82-1.54],0.4676920237337734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTDH,Protein LYRIC,19176,84,1.02 [0.82-1.28],0.8542296099064237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19716,86,0.98 [0.42-2.27],0.9640054825658024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19421,86,0.90 [0.75-1.09],0.2768314172936187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTIF3,"Translation initiation factor IF-3, mitochondrial",19704,87,0.93 [0.74-1.18],0.5697864156251408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTPN,Myotrophin,22307,105,1.11 [0.67-1.85],0.6743494031131967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTR,Methionine synthase,19095,82,0.87 [0.60-1.26],0.4687195635513524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS1,Protein MTSS 1,19704,87,0.83 [0.69-1.00],0.0556843043255745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS2,Protein MTSS 2,19698,87,1.07 [0.87-1.31],0.511232992805593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTUS1,Microtubule-associated tumor suppressor 1,19421,86,1.33 [0.97-1.83],0.0787605811583774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC13,Mucin-13,22218,108,1.35 [0.99-1.85],0.0551912854948767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC16,Mucin-16,22609,108,1.02 [0.93-1.11],0.7301854065429354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC2,Mucin-2,19775,88,1.01 [0.82-1.25],0.9132951208845248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUCL3,Mucin-like protein 3,19082,85,1.15 [0.75-1.77],0.5112862261816624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MVK,Mevalonate kinase,22323,107,1.08 [0.88-1.33],0.4588420496312149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MXRA8,Matrix remodeling-associated protein 8,19321,84,0.86 [0.43-1.72],0.6671789507360382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",19770,87,1.34 [1.06-1.71],0.0148520657283243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC2,"Myosin-binding protein C, fast-type",19224,81,1.02 [0.80-1.30],0.8838315962542097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19729,85,1.11 [0.82-1.51],0.4857794500132312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYDGF,Myeloid-derived growth factor,19770,87,0.94 [0.77-1.17],0.597823093650427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH4,Myosin-4,19095,82,0.96 [0.60-1.56],0.8820186108898671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH7B,Myosin-7B,19082,85,1.08 [0.69-1.71],0.7324360644358472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH9,Myosin-9,19775,88,0.90 [0.75-1.08],0.2466671107188169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19095,82,0.66 [0.35-1.24],0.1930919517886461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL3,Myosin light chain 3,19224,81,1.31 [1.00-1.71],0.0505142852317444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL4,Myosin light chain 4,19224,81,0.97 [0.65-1.45],0.8791619207479243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL6B,Myosin light chain 6B,19237,83,0.75 [0.56-1.01],0.0578361329270016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19237,83,1.11 [0.77-1.62],0.5748474731256867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO6,Unconventional myosin-VI,19729,85,1.10 [0.65-1.86],0.7128243991841582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO9B,Unconventional myosin-IXb,22323,107,0.80 [0.60-1.08],0.143422598367947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOC,Myocilin,22727,108,1.16 [0.79-1.70],0.444905411230837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM1,Myomesin-1,19125,83,0.93 [0.57-1.51],0.7668799835112649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM2,Myomesin-2,19095,82,1.27 [0.91-1.77],0.1554267469185324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM3,Myomesin-3,19321,84,1.28 [1.03-1.58],0.0250075943087358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,22757,107,1.26 [0.91-1.74],0.1560857858842833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZT1,Mitotic-spindle organizing protein 1,22178,107,0.90 [0.62-1.29],0.5549995307246757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA10,N-alpha-acetyltransferase 10,19095,82,1.07 [0.70-1.64],0.738389751221314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA80,N-alpha-acetyltransferase 80,19237,83,0.97 [0.81-1.15],0.7246478440431049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22417,107,0.75 [0.56-1.01],0.057336802167175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NACC1,Nucleus accumbens-associated protein 1,19698,87,1.05 [0.73-1.51],0.7822326754131166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NADK,NAD kinase,22722,109,1.17 [0.89-1.54],0.2540947696404501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,19144,84,0.55 [0.33-0.93],0.0266182782766046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,19192,81,0.56 [0.37-0.83],0.0045457338782946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19321,84,0.54 [0.21-1.38],0.2010895725713368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAMPT,Nicotinamide phosphoribosyltransferase,22178,107,0.91 [0.65-1.28],0.5989386608485707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAP1L4,Nucleosome assembly protein 1-like 4,19660,87,0.71 [0.46-1.08],0.1118286065737392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAPRT,Nicotinate phosphoribosyltransferase,19716,86,0.88 [0.46-1.66],0.6899384471933057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19729,85,0.83 [0.54-1.29],0.4077576681098206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22780,108,2.36 [1.32-4.20],0.0036435881275473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBN,Nibrin,22323,107,0.84 [0.58-1.20],0.3332449483937778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM1,Neural cell adhesion molecule 1,22832,108,1.16 [0.70-1.94],0.5584864498592912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,22727,108,1.96 [1.05-3.66],0.0357201317244275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAN,Neurocan core protein,22930,109,0.66 [0.43-1.02],0.0628359328910647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,22655,107,1.17 [0.98-1.39],0.0836587627687693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCK2,Cytoplasmic protein NCK2,22802,107,1.02 [0.87-1.20],0.7654028715459269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCLN,Nicalin,22323,107,0.68 [0.42-1.08],0.1045109355390638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR1,Natural cytotoxicity triggering receptor 1,22670,106,1.14 [0.73-1.77],0.5594651099247516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19704,87,1.49 [0.84-2.64],0.1676651134139262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,22917,109,2.47 [1.40-4.35],0.0017474111060008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDRG1,Protein NDRG1,22218,108,1.01 [0.77-1.31],0.9526408957653096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19698,87,0.84 [0.57-1.25],0.4012616944652247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19145,84,1.12 [0.62-2.03],0.7111794511006628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19704,87,0.83 [0.65-1.05],0.1150010647279039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22178,107,1.12 [0.93-1.36],0.2314763628097116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEB,Nebulin,19095,82,1.11 [0.67-1.86],0.6781071936462311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECAP2,Adaptin ear-binding coat-associated protein 2,19095,82,1.02 [0.74-1.40],0.897755598296498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN1,Nectin-1,19176,84,0.77 [0.39-1.51],0.4422884391787078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,22691,109,1.61 [0.96-2.70],0.0713738185268726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN4,Nectin-4,22780,108,1.48 [0.95-2.33],0.0863145045531888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19176,84,0.85 [0.56-1.30],0.4668296710993161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD9,Enhancer of filamentation 1,19176,84,0.72 [0.37-1.43],0.3473342406959906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,22152,108,1.81 [1.33-2.47],0.0001784286746496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEK7,Serine/threonine-protein kinase Nek7,19421,86,0.92 [0.68-1.25],0.5960950834344951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL1,Protein kinase C-binding protein NELL1,22780,108,0.78 [0.52-1.16],0.2153085305255785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL2,Protein kinase C-binding protein NELL2,22802,107,0.70 [0.39-1.28],0.2494190931518564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NENF,Neudesin,19698,87,0.96 [0.79-1.17],0.7149870756221952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEO1,Neogenin,19729,85,1.26 [0.53-2.98],0.606352521130005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEXN,Nexilin,19789,88,0.88 [0.65-1.20],0.4210287060840585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFASC,Neurofascin,22990,109,1.37 [0.78-2.40],0.2720857136254387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFAT5,Nuclear factor of activated T-cells 5,19176,84,0.72 [0.54-0.96],0.0278581025128993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22700,107,0.91 [0.76-1.08],0.2712036332295705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22323,107,1.05 [0.80-1.38],0.7282871160079825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFE2,Transcription factor NF-E2 45 kDa subunit,19224,81,0.78 [0.57-1.06],0.1095285500095848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFIC,Nuclear factor 1 C-type,19729,85,1.05 [0.67-1.64],0.8369090590521335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19095,82,0.82 [0.61-1.11],0.2046335927576925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19421,86,0.50 [0.26-0.96],0.0370900135266641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKBIE,NF-kappa-B inhibitor epsilon,22178,107,1.28 [0.92-1.78],0.1500984840711357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19704,87,0.96 [0.78-1.16],0.6492282225776878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFX1,Transcriptional repressor NF-X1,19095,82,0.83 [0.60-1.16],0.2813739361586556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFYA,Nuclear transcription factor Y subunit alpha,19095,82,0.80 [0.43-1.47],0.465986606102844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGF,Beta-nerve growth factor,22521,108,0.73 [0.18-3.00],0.6618184932823262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGFR,Tumor necrosis factor receptor superfamily member 16,19770,87,0.66 [0.31-1.42],0.2903529186804539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGRN,Neugrin,19716,86,0.90 [0.35-2.30],0.8232985780957344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NHLRC3,NHL repeat-containing protein 3,18872,83,1.18 [0.60-2.32],0.6218390658523243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID1,Nidogen-1,22762,108,0.98 [0.61-1.57],0.9443017654603468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID2,Nidogen-2,22727,108,0.96 [0.76-1.21],0.7163924161165371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NINJ1,Ninjurin-1,22178,107,0.63 [0.40-0.98],0.0385680547569621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT1,Deaminated glutathione amidase,19224,81,0.65 [0.42-1.01],0.0546224714225178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT2,Omega-amidase NIT2,19689,87,0.87 [0.65-1.16],0.3555629867470143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN1,Neuroligin-1,19237,83,0.92 [0.64-1.32],0.6458800667855246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN2,Neuroligin-2,19125,83,0.83 [0.49-1.40],0.479890647055801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME1,Nucleoside diphosphate kinase A,19176,84,0.73 [0.26-2.06],0.5574430906487631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME3,Nucleoside diphosphate kinase 3,22723,107,0.91 [0.43-1.95],0.8152591502574895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMI,N-myc-interactor,19620,87,1.00 [0.75-1.34],0.9964222351749964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22521,108,1.07 [0.87-1.31],0.532701714028196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMRK2,Nicotinamide riboside kinase 2,19082,85,0.86 [0.48-1.55],0.6199554442050101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19729,85,0.78 [0.54-1.12],0.1845153324090264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOMO1,Nodal modulator 1,22727,108,1.30 [0.62-2.71],0.4871727214418568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,19095,82,0.72 [0.54-0.96],0.022662383182025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",22218,108,1.29 [0.98-1.71],0.0704428712738577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS2,"Nitric oxide synthase, inducible",19095,82,1.09 [0.64-1.85],0.7567324808423637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS3,"Nitric oxide synthase, endothelial",22218,108,0.95 [0.68-1.33],0.7780965676234219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH1,Neurogenic locus notch homolog protein 1,23006,109,1.25 [0.44-3.56],0.6807655919002706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH2,Neurogenic locus notch homolog protein 2,19775,88,1.17 [0.49-2.78],0.7264396697777651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,23006,109,1.97 [1.22-3.19],0.0057559375624053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,19445,86,1.68 [1.03-2.73],0.0365300322909324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,22722,109,1.97 [1.32-2.94],0.0009237795802848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS1,Nephrin,19176,84,0.71 [0.37-1.35],0.2892927648400588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS2,Podocin,19176,84,1.01 [0.83-1.24],0.8948776136678805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPL,N-acetylneuraminate lyase,19770,87,0.67 [0.43-1.04],0.074353993489494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,22307,105,1.31 [1.16-1.48],1.028884603508216e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPC,C-type natriuretic peptide,22700,107,1.10 [0.81-1.50],0.543771946263699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPR1,Atrial natriuretic peptide receptor 1,19095,82,1.17 [0.72-1.89],0.5251750965114985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTN,Neuroplastin,22178,107,1.02 [0.82-1.27],0.8681207896077903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX1,Neuronal pentraxin-1,22727,108,0.95 [0.63-1.43],0.7998100229473843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX2,Neuronal pentraxin-2,19775,88,0.80 [0.44-1.47],0.4765614826881343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTXR,Neuronal pentraxin receptor,22722,109,0.87 [0.53-1.44],0.5893525805006186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPY,Pro-neuropeptide Y,22917,109,0.96 [0.74-1.24],0.752506003252687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRCAM,Neuronal cell adhesion molecule,22722,109,1.11 [0.62-2.00],0.7183832895082078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRGN,Neurogranin,19789,88,0.95 [0.76-1.19],0.6651113850604384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRN1,Neuritin,19729,85,0.70 [0.35-1.41],0.3136224730571663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,22870,108,1.84 [1.00-3.38],0.0508854306726703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP2,Neuropilin-2,22727,108,1.52 [0.87-2.64],0.1386122962663632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRTN,Neurturin,22323,107,0.97 [0.68-1.37],0.849740713782349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRXN3,Neurexin-3,19237,83,1.09 [0.61-1.93],0.7778339080584671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NSFL1C,NSFL1 cofactor p47,22930,109,0.91 [0.70-1.19],0.4818707439093037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19770,87,0.94 [0.71-1.25],0.6788416066471094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,19716,86,2.02 [1.41-2.88],0.000122332737183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C3A,Cytosolic 5'-nucleotidase 3A,22661,107,0.99 [0.81-1.21],0.93068954013809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,22780,108,1.14 [0.83-1.55],0.413033954115069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF3,Neurotrophin-3,22700,107,1.24 [0.77-1.99],0.374543284035427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF4,Neurotrophin-4,22178,107,1.07 [0.69-1.65],0.7636853324814379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK2,BDNF/NT-3 growth factors receptor,22722,109,1.01 [0.52-1.98],0.979151168305237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK3,NT-3 growth factor receptor,22930,109,1.31 [0.60-2.87],0.4980949614374075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22722,109,1.32 [1.17-1.50],8.630596721506304e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUB1,NEDD8 ultimate buster 1,22700,107,0.90 [0.73-1.11],0.3300797875926369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19698,87,0.88 [0.70-1.10],0.2716393121350767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUCB2,Nucleobindin-2,22883,109,1.29 [0.83-2.02],0.2578313451292906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDC,Nuclear migration protein nudC,22990,109,0.94 [0.72-1.23],0.6578109263485578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19224,81,0.80 [0.31-2.08],0.6519754356569838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19095,82,1.12 [0.77-1.62],0.556250702617346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT16,U8 snoRNA-decapping enzyme,19675,86,0.97 [0.77-1.23],0.8118451407623207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22609,108,1.01 [0.74-1.36],0.968789053278885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT5,ADP-sugar pyrophosphatase,22727,108,1.07 [0.76-1.51],0.6966909711888086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUMB,Protein numb homolog,19176,84,0.88 [0.68-1.13],0.3247838770771335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUP50,Nuclear pore complex protein Nup50,19095,82,1.10 [0.59-2.07],0.7590849986602767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPE4,NXPE family member 4,19095,82,1.36 [0.78-2.36],0.2846057039581588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH1,Neurexophilin-1,22218,108,0.86 [0.55-1.36],0.5278150187855806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH3,Neurexophilin-3,19176,84,0.77 [0.39-1.54],0.4630061304668051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OBP2B,Odorant-binding protein 2b,22443,108,0.84 [0.64-1.12],0.2439541089841035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,19729,85,1.38 [0.88-2.15],0.158000523255258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ODAM,Odontogenic ameloblast-associated protein,22180,108,0.97 [0.71-1.33],0.8498356168734165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OFD1,Oral-facial-digital syndrome 1 protein,19421,86,1.18 [0.90-1.55],0.2439811393406959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGA,Protein O-GlcNAcase,19704,87,0.83 [0.61-1.11],0.2101348019624514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGFR,Opioid growth factor receptor,22609,108,0.77 [0.45-1.33],0.3537881987416913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,22727,108,1.61 [1.11-2.32],0.0113244481840145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19421,86,0.94 [0.67-1.34],0.7451151009536225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLFM4,Olfactomedin-4,18605,83,0.97 [0.81-1.15],0.7034507994982324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,22507,107,1.43 [1.14-1.80],0.0021919466717294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMD,Osteomodulin,22802,107,1.06 [0.70-1.61],0.7819343518973123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,22609,108,0.72 [0.56-0.92],0.008300928802094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMP,Olfactory marker protein,19125,83,0.61 [0.35-1.05],0.077115475227603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPHN1,Oligophrenin-1,19716,86,0.90 [0.75-1.10],0.3050604114926688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPLAH,5-oxoprolinase,19224,81,0.78 [0.56-1.09],0.1458993119394471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPTC,Opticin,22609,108,1.07 [0.76-1.53],0.6921838142570731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,19711,88,2.28 [0.85-6.11],0.0997141946739343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSBPL2,Oxysterol-binding protein-related protein 2,19716,86,0.73 [0.37-1.43],0.356890160699609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22723,107,1.59 [0.97-2.59],0.0636899826070057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,22591,107,1.45 [1.14-1.83],0.0021877617353096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSMR,Oncostatin-M-specific receptor subunit beta,22870,108,1.97 [0.85-4.54],0.1136292842420528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSTN,Osteocrin,19237,83,0.80 [0.44-1.43],0.4429422665720679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTOA,Otoancorin,19125,83,0.86 [0.55-1.35],0.5173309926367671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD6B,Deubiquitinase OTUD6B,19704,87,0.76 [0.53-1.10],0.1462305409988679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD7B,OTU domain-containing protein 7B,19729,85,0.92 [0.66-1.29],0.6286032861244217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19224,81,1.09 [0.81-1.47],0.5534300924551696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXT,Oxytocin-neurophysin 1,22930,109,1.01 [0.90-1.13],0.8902803292655137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,P4HB,Protein disulfide-isomerase,22605,106,0.81 [0.51-1.27],0.3584315533701184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PACS2,Phosphofurin acidic cluster sorting protein 2,19095,82,0.81 [0.56-1.16],0.2476125956008152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI2,Protein-arginine deiminase type-2,22323,107,1.12 [0.87-1.44],0.3859650522605808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI4,Protein-arginine deiminase type-4,22180,108,1.01 [0.81-1.25],0.935480347388378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAEP,Glycodelin,22521,108,1.01 [0.86-1.18],0.945983643260876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19729,85,0.90 [0.73-1.11],0.3367350086458249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19421,86,0.78 [0.50-1.20],0.2575498062567858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22307,105,1.07 [0.79-1.45],0.6458961934141103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAGR1,PAXIP1-associated glutamate-rich protein 1,19224,81,0.72 [0.41-1.26],0.2502567597339499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19050,85,0.55 [0.34-0.87],0.010570158626601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAK4,Serine/threonine-protein kinase PAK 4,22218,108,0.91 [0.68-1.22],0.5208964866362913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALLD,Palladin,19176,84,0.78 [0.42-1.44],0.43134175632346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM,Paralemmin-1,19590,87,0.96 [0.50-1.85],0.8997056582687125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,19716,86,2.25 [1.47-3.45],0.0001976062422131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM3,Paralemmin-3,19095,82,0.69 [0.45-1.06],0.0937276361081429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22909,109,1.48 [0.79-2.75],0.2191057248906057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAMR1,Inactive serine protease PAMR1,22727,108,0.88 [0.47-1.67],0.7031518658382419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAPPA,Pappalysin-1,22323,107,1.21 [0.84-1.74],0.307177695245321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,19421,86,0.69 [0.49-0.97],0.0303592925630593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARK7,Parkinson disease protein 7,22727,108,1.04 [0.75-1.46],0.8019989951183654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARP1,Poly [ADP-ribose] polymerase 1,22700,107,0.98 [0.73-1.32],0.9094298847351654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAXX,Protein PAXX,19321,84,0.68 [0.41-1.11],0.1217355993620629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19082,85,1.24 [0.64-2.41],0.5289751558944092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBLD,Phenazine biosynthesis-like domain-containing protein,22218,108,0.91 [0.65-1.27],0.5869392615764494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19704,87,0.97 [0.48-1.94],0.9243739874856076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCARE,Photoreceptor cilium actin regulator,19125,83,1.05 [0.83-1.34],0.6668953820933501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19286,84,1.07 [0.69-1.65],0.7601736787207825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBP2,Poly(rC)-binding protein 2,19729,85,0.93 [0.70-1.24],0.6307178540538169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH1,Protocadherin-1,22914,108,1.37 [0.63-2.95],0.4284544515569303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH12,Protocadherin-12,19729,85,1.02 [0.45-2.32],0.9673392724994038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH17,Protocadherin-17,22722,109,0.87 [0.55-1.38],0.5589447400998823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH7,Protocadherin-7,19704,87,1.12 [0.65-1.93],0.6906707655747752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,19704,87,0.59 [0.36-0.98],0.0395088086727023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDHB15,Protocadherin beta-15,19698,87,0.86 [0.51-1.45],0.5789875941109781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCNA,Proliferating cell nuclear antigen,19082,85,0.97 [0.69-1.36],0.8504823526128681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK7,Proprotein convertase subtilisin/kexin type 7,19698,87,1.10 [0.72-1.67],0.6729656154589703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK9,Proprotein convertase subtilisin/kexin type 9,23006,109,1.04 [0.69-1.58],0.8488636515131447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19704,87,0.89 [0.68-1.17],0.4140423027560338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19770,87,0.95 [0.77-1.18],0.6512785671685977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1,Programmed cell death protein 1,22877,108,1.11 [0.75-1.66],0.6044549973093133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1LG2,Programmed cell death 1 ligand 2,22609,108,1.28 [0.76-2.16],0.3503311204132528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD5,Programmed cell death protein 5,22930,109,0.97 [0.72-1.30],0.8319585552120096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,22722,109,1.17 [0.89-1.54],0.264825319253429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCL2,Phosducin-like protein 2,19082,85,0.91 [0.60-1.38],0.6583241072325147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19082,85,1.21 [0.88-1.66],0.2401225371335884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19095,82,1.14 [0.84-1.56],0.3985998016634999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19321,84,0.86 [0.71-1.04],0.1281974321758408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFA,Platelet-derived growth factor subunit A,23006,109,0.88 [0.70-1.11],0.2994910156837366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFB,Platelet-derived growth factor subunit B,22802,107,0.90 [0.74-1.09],0.2702360176004843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFC,Platelet-derived growth factor C,22178,107,1.16 [0.63-2.16],0.6292355257788165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,22722,109,1.82 [1.02-3.22],0.0410393946709533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRB,Platelet-derived growth factor receptor beta,23006,109,1.08 [0.67-1.76],0.749887188121727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA2,Protein disulfide-isomerase A2,19082,85,1.00 [0.59-1.68],0.9928227817606016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,19321,84,1.14 [0.50-2.63],0.7539584381639086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA4,Protein disulfide-isomerase A4,19775,88,0.97 [0.69-1.36],0.8667820679348888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA5,Protein disulfide-isomerase A5,19082,85,1.00 [0.71-1.41],0.9941485465786428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM5,PDZ and LIM domain protein 5,19729,85,0.91 [0.77-1.08],0.2790530249674555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM7,PDZ and LIM domain protein 7,22802,107,0.99 [0.86-1.14],0.9127363590619194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22178,107,0.81 [0.55-1.20],0.299919468999953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDRG1,p53 and DNA damage-regulated protein 1,19237,83,0.83 [0.52-1.31],0.4214500297101956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19082,85,0.95 [0.64-1.42],0.8091579007583423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZD2,PDZ domain-containing protein 2,19095,82,0.82 [0.55-1.22],0.3298193162967343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19176,84,1.27 [0.83-1.95],0.2624266020046343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEAR1,Platelet endothelial aggregation receptor 1,23006,109,1.17 [0.55-2.48],0.6892561496698746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEBP1,Phosphatidylethanolamine-binding protein 1,22727,108,1.07 [0.79-1.44],0.6752855026176856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECAM1,Platelet endothelial cell adhesion molecule,22727,108,0.76 [0.43-1.36],0.3599450243368171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19224,81,0.83 [0.37-1.86],0.6476350406067157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PENK,Proenkephalin-A,19321,84,1.27 [0.66-2.43],0.4747809376160099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,19789,88,0.34 [0.16-0.72],0.0050897518461992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PER3,Period circadian protein homolog 3,19176,84,0.98 [0.82-1.16],0.8197374819106606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PF4,Platelet factor 4,19637,88,1.16 [0.95-1.43],0.1490782863742408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN2,Prefoldin subunit 2,22218,108,1.01 [0.73-1.38],0.9642869247375988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN4,Prefoldin subunit 4,19082,85,1.07 [0.73-1.56],0.7362995127487274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN6,Prefoldin subunit 6,19237,83,0.92 [0.65-1.32],0.6559767445388183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22575,108,0.96 [0.77-1.20],0.71756629359442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGA4,Pepsin A-4,19789,88,1.09 [0.84-1.42],0.4999338971573246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19770,87,0.95 [0.64-1.41],0.7989290571667602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,22990,109,1.94 [1.11-3.40],0.0202904108145808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,22895,109,1.51 [1.07-2.15],0.0204474578988248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19546,86,1.08 [0.53-2.21],0.8286256370851006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP4,Peptidoglycan recognition protein 4,19095,82,1.21 [0.89-1.64],0.2251563971786077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGM2,Phosphoglucomutase-2,19237,83,0.91 [0.62-1.35],0.6373556406845923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGR,Progesterone receptor,19176,84,0.79 [0.59-1.06],0.1230402304813788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHACTR2,Phosphatase and actin regulator 2,19729,85,0.90 [0.75-1.08],0.2480885836932099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB1,Pleckstrin homology-like domain family B member 1,19704,87,0.95 [0.64-1.42],0.8023457649420709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB2,Pleckstrin homology-like domain family B member 2,19082,85,1.07 [0.86-1.32],0.5576852986815869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22521,108,2.25 [1.30-3.88],0.0035400560509921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19321,84,0.78 [0.48-1.28],0.3295329278614042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI16,Peptidase inhibitor 16,19789,88,1.25 [0.54-2.89],0.6001378052112143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,22432,107,1.64 [1.29-2.09],5.857894204605445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19729,85,0.86 [0.65-1.14],0.2906934060941056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,22431,107,2.13 [1.39-3.26],0.0004856652371215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22700,107,0.90 [0.68-1.19],0.4727446214622864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22727,108,1.95 [1.17-3.24],0.0102437685254248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19176,84,0.63 [0.40-1.01],0.053832907566459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22727,108,1.48 [0.99-2.22],0.0551119745529202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,22722,109,1.23 [0.91-1.67],0.1847727170069739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19321,84,0.88 [0.66-1.17],0.3765045471021637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PITHD1,PITH domain-containing protein 1,19050,85,1.15 [0.91-1.46],0.2431125532298643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD1,Polycystin-1,19770,87,2.30 [1.07-4.94],0.0326089694419736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,19095,82,1.16 [0.82-1.64],0.3908114522382589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKLR,Pyruvate kinase PKLR,22724,107,1.06 [0.82-1.37],0.6543102622321257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKN3,Serine/threonine-protein kinase N3,19421,86,0.83 [0.62-1.12],0.217690980990138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G10,Group 10 secretory phospholipase A2,22521,108,1.01 [0.75-1.35],0.9733869520744434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,22780,108,1.72 [0.95-3.12],0.0720029969837845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G1B,Phospholipase A2,22974,109,1.35 [0.94-1.95],0.1068939702699883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G2A,"Phospholipase A2, membrane associated",22702,108,1.35 [1.05-1.74],0.0188131459910152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G4A,Cytosolic phospholipase A2,22802,107,1.02 [0.84-1.24],0.8046286721413278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G7,Platelet-activating factor acetylhydrolase,22727,108,0.92 [0.56-1.52],0.7511103801969086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAT,Tissue-type plasminogen activator,22929,109,0.78 [0.56-1.08],0.1387901248487772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAU,Urokinase-type plasminogen activator,22727,108,0.95 [0.53-1.70],0.86352543868631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,22538,107,3.59 [2.18-5.90],4.784648290318291e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLB1,"Phospholipase B1, membrane-associated",19716,86,0.89 [0.63-1.25],0.5052706615842065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19176,84,0.70 [0.38-1.27],0.2388663633034045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19716,86,0.93 [0.76-1.15],0.5046776279159378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19716,86,0.86 [0.63-1.16],0.3210224177385339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,19300,86,2.15 [0.95-4.88],0.0662515697499271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,22218,108,1.39 [0.90-2.14],0.1338394039719417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN3,Perilipin-3,22722,109,1.14 [0.77-1.69],0.5204191948653629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLPBP,Pyridoxal phosphate homeostasis protein,22722,109,0.93 [0.72-1.20],0.553764402720609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLSCR3,Phospholipid scramblase 3,19672,86,0.90 [0.62-1.30],0.5713476407336666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLTP,Phospholipid transfer protein,22939,109,1.15 [0.73-1.80],0.5523380605844301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC1,Plexin domain-containing protein 1,22178,107,0.83 [0.47-1.46],0.5110104385590252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC2,Plexin domain-containing protein 2,19716,86,1.56 [0.81-3.02],0.1833744217989141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNA4,Plexin-A4,22700,107,0.89 [0.72-1.10],0.2856419551890473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,22890,109,1.35 [0.69-2.63],0.3849656359480037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB3,Plexin-B3,22644,108,0.86 [0.60-1.24],0.422287817531104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22619,109,1.01 [0.93-1.11],0.7761251849572045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMCH,Pro-MCH,19095,82,1.22 [1.01-1.47],0.0441812208541906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMM2,Phosphomannomutase 2,19095,82,0.88 [0.61-1.27],0.4974410029406292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMS1,PMS1 protein homolog 1,19237,83,1.11 [0.75-1.65],0.5873034820392857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMVK,Phosphomevalonate kinase,22185,108,1.07 [0.91-1.25],0.4344798183464213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIP,Pancreatic triacylglycerol lipase,19789,88,1.20 [0.90-1.62],0.2167762638318105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19716,86,1.14 [0.89-1.46],0.2952865607333951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP2,Pancreatic lipase-related protein 2,22689,107,0.99 [0.94-1.05],0.7055818363162635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA1,Paraneoplastic antigen Ma1,19224,81,0.88 [0.59-1.30],0.5110841660724841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA2,Paraneoplastic antigen Ma2,19125,83,1.30 [0.86-1.94],0.2115591271519167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22323,107,0.97 [0.83-1.14],0.7202376085923237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL,Podocalyxin,22609,108,0.33 [0.11-0.99],0.0484378419905797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL2,Podocalyxin-like protein 2,22780,108,1.49 [0.83-2.68],0.1810205364723307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POF1B,Protein POF1B,19176,84,0.95 [0.59-1.55],0.8438119024636517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19176,84,0.99 [0.48-2.04],0.9729389056417604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22609,108,1.29 [0.86-1.92],0.2136660764518369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POMC,Pro-opiomelanocortin,19224,81,1.20 [0.90-1.59],0.2216583805339164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,19789,88,0.43 [0.24-0.77],0.0048692954982023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON2,Serum paraoxonase/arylesterase 2,22307,105,1.16 [0.72-1.87],0.5551478027554089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON3,Serum paraoxonase/lactonase 3,22802,107,0.96 [0.57-1.63],0.8888864747367196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POSTN,Periostin,19775,88,1.34 [0.79-2.27],0.2726026844279102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPBP,Platelet basic protein,19636,88,0.99 [0.78-1.26],0.9319490672551364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPCDC,Phosphopantothenoylcysteine decarboxylase,22930,109,0.87 [0.60-1.26],0.4542027230082198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIB,Peptidyl-prolyl cis-trans isomerase B,22744,109,0.99 [0.83-1.19],0.9548876342579592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIE,Peptidyl-prolyl cis-trans isomerase E,19421,86,1.14 [0.85-1.52],0.3692244972716469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19775,88,0.95 [0.69-1.31],0.7522117722189838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPL,Periplakin,19176,84,0.92 [0.47-1.79],0.8131867236502676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1A,Protein phosphatase 1A,22178,107,1.24 [0.78-1.96],0.3645271668453355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1B,Protein phosphatase 1B,19176,84,0.56 [0.33-0.96],0.0335321322702285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1F,Protein phosphatase 1F,19770,87,0.86 [0.58-1.28],0.4651866497294817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPME1,Protein phosphatase methylesterase 1,22609,108,0.91 [0.68-1.21],0.5026538890990269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19698,87,0.89 [0.69-1.15],0.3670287827458215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22780,108,0.91 [0.76-1.09],0.3069069603556493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19421,86,0.87 [0.63-1.21],0.4138744728804004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19729,85,0.87 [0.66-1.14],0.3116752721252142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19729,85,1.51 [0.97-2.33],0.0658052414110077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R2,Protein phosphatase inhibitor 2,22722,109,0.98 [0.79-1.22],0.8757826842082174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R9B,Neurabin-2,22990,109,0.93 [0.77-1.11],0.4064661615801479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19704,87,0.95 [0.80-1.13],0.5883419291034192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP3R1,Calcineurin subunit B type 1,22521,108,0.96 [0.63-1.47],0.8478890526132632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPT1,Palmitoyl-protein thioesterase 1,19237,83,1.07 [0.83-1.38],0.5907608271365064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPY,Pancreatic prohormone,22652,107,1.16 [0.99-1.36],0.0749252452798095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PQBP1,Polyglutamine-binding protein 1,22178,107,0.94 [0.69-1.29],0.7089910275587634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAME,Melanoma antigen preferentially expressed in tumors,19082,85,1.74 [0.90-3.36],0.0983014391256693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAP1,Proline-rich acidic protein 1,19775,88,1.39 [0.81-2.38],0.2322059112722433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRC1,Protein regulator of cytokinesis 1,19698,87,1.21 [0.84-1.75],0.2974837447714927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRCP,Lysosomal Pro-X carboxypeptidase,22864,108,0.65 [0.38-1.11],0.1135761183694946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX1,Peroxiredoxin-1,22044,107,1.00 [0.82-1.21],0.9707268440950064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,19454,88,0.69 [0.49-0.98],0.0379189697869951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22323,107,0.99 [0.77-1.25],0.906518228102472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX5,"Peroxiredoxin-5, mitochondrial",22990,109,1.00 [0.78-1.29],0.9854526594896664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX6,Peroxiredoxin-6,22917,109,0.94 [0.71-1.24],0.6433371938559889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,22323,107,1.77 [1.22-2.55],0.0023658115127102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,22689,107,2.21 [1.06-4.63],0.0354639117808253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,19775,88,1.46 [1.01-2.13],0.0459429144251602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG3,Proteoglycan 3,19775,88,1.16 [0.78-1.74],0.4573754284522385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22323,107,0.94 [0.68-1.31],0.7298177532329546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19237,83,0.43 [0.20-0.95],0.0363021851060582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22722,109,0.97 [0.79-1.18],0.7347546896076237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19673,86,0.83 [0.63-1.08],0.1657666999532295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKCQ,Protein kinase C theta type,22323,107,1.08 [0.73-1.59],0.6964662915749289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKD2,Serine/threonine-protein kinase D2,19095,82,0.71 [0.38-1.32],0.2762964912745562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKG1,cGMP-dependent protein kinase 1,19321,84,0.88 [0.75-1.04],0.1410743676191783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22178,107,0.97 [0.75-1.25],0.7983180193881909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRL,Prolactin,22930,109,0.98 [0.77-1.24],0.8553790313819628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRND,Prion-like protein doppel,19716,86,0.99 [0.64-1.51],0.9457798050913312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROC,Vitamin K-dependent protein C,22798,108,0.65 [0.34-1.24],0.1912331173660673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROCR,Endothelial protein C receptor,19095,82,1.16 [0.65-2.06],0.6186482416603816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,22700,107,1.24 [0.90-1.71],0.1928094218564705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROS1,Vitamin K-dependent protein S,19786,88,1.34 [0.60-2.97],0.4724520970960831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR4,Proline-rich protein 4,19171,84,0.94 [0.70-1.27],0.6941767212647725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,19176,84,1.20 [0.79-1.81],0.3974385519188891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRRT3,Proline-rich transmembrane protein 3,19224,81,1.07 [0.62-1.86],0.7968427809972733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS2,Trypsin-2,22832,108,1.21 [0.92-1.60],0.1710656776731718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,19176,84,1.29 [0.79-2.12],0.311198578527681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS27,Serine protease 27,22646,109,0.93 [0.61-1.42],0.7446551819701621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS53,Serine protease 53,19716,86,0.64 [0.38-1.06],0.0854077553669673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS8,Prostasin,22614,107,1.45 [0.98-2.15],0.0661665735262744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22218,108,1.03 [0.88-1.20],0.7126106896554959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,22917,109,1.95 [1.02-3.76],0.0447081004931202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTN3,Myeloblastin,22185,105,1.19 [0.86-1.64],0.2965660839689048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRUNE2,Protein prune homolog 2,19421,86,0.76 [0.35-1.64],0.480792749992159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,19594,88,1.55 [0.85-2.83],0.1535155993110262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAPL1,Proactivator polypeptide-like 1,19704,87,0.89 [0.59-1.33],0.5584162427463263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSCA,Prostate stem cell antigen,19704,87,1.03 [0.95-1.11],0.5345872213410072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22521,108,0.96 [0.83-1.12],0.6355687627829565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSIP1,PC4 and SFRS1-interacting protein,22700,107,1.00 [0.77-1.29],0.9899838186911148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMA1,Proteasome subunit alpha type-1,22178,107,0.64 [0.42-0.98],0.0408643121654904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,19082,85,0.48 [0.24-0.99],0.0468628814264628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19729,85,0.81 [0.52-1.27],0.3627360932316056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19237,83,0.74 [0.46-1.21],0.2328261108268794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22609,108,0.92 [0.67-1.25],0.5835618105291966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME1,Proteasome activator complex subunit 1,22480,108,0.94 [0.59-1.51],0.8114177395346024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME2,Proteasome activator complex subunit 2,22417,108,1.02 [0.64-1.65],0.9216872484894992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG3,Proteasome assembly chaperone 3,22700,107,1.05 [0.75-1.46],0.7700890796738403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG4,Proteasome assembly chaperone 4,19176,84,0.75 [0.50-1.12],0.1596270272375853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSPN,Persephin,22700,107,0.90 [0.75-1.09],0.2970680010295743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSRC1,Proline/serine-rich coiled-coil protein 1,22178,107,0.88 [0.65-1.20],0.4279606716462371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18648,77,0.94 [0.77-1.15],0.5382779231343713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22218,108,0.93 [0.53-1.65],0.8025891839096255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGDS,Prostaglandin-H2 D-isomerase,22573,107,1.54 [0.95-2.49],0.0800986170467587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGES2,Prostaglandin E synthase 2,19040,83,1.06 [0.72-1.55],0.7768668978114748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGR1,Prostaglandin reductase 1,19770,87,0.95 [0.75-1.21],0.6603333574841564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH,Parathyroid hormone,19237,83,1.13 [0.88-1.45],0.3455170635883287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22700,107,1.44 [1.04-1.98],0.0281607732549534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTK7,Inactive tyrosine-protein kinase 7,22218,108,1.25 [0.79-1.98],0.3314824271443817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,22307,105,1.19 [0.84-1.69],0.3190602003329317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTP4A3,Protein tyrosine phosphatase type IVA 3,19176,84,0.92 [0.60-1.42],0.7060526290790161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22521,108,0.99 [0.79-1.23],0.8997457211402181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22768,107,1.06 [0.87-1.28],0.56682111584468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19144,84,0.55 [0.29-1.05],0.071787554365555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19770,87,1.28 [0.65-2.53],0.4758609834515237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRC,Receptor-type tyrosine-protein phosphatase C,19775,88,0.95 [0.39-2.28],0.904842918501103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRF,Receptor-type tyrosine-protein phosphatase F,23006,109,0.84 [0.47-1.51],0.5688589159139712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRH,Receptor-type tyrosine-protein phosphatase H,19704,87,1.07 [0.70-1.63],0.746510880167774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19704,87,0.65 [0.23-1.81],0.4064855588265814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22663,107,0.87 [0.43-1.76],0.7060283750305211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22447,108,0.88 [0.52-1.48],0.6264370773535758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRR,Receptor-type tyrosine-protein phosphatase R,19716,86,0.77 [0.44-1.35],0.3619996555903153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRS,Receptor-type tyrosine-protein phosphatase S,23006,109,1.31 [0.68-2.53],0.4182278451398151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19770,87,1.59 [0.83-3.03],0.1637158866181993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19321,84,0.72 [0.50-1.03],0.0718688144426962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTS,6-pyruvoyl tetrahydrobiopterin synthase,22109,108,0.97 [0.71-1.33],0.8574183294205201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTTG1,Securin,19421,86,0.78 [0.46-1.34],0.3723767019372752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,22700,107,1.72 [1.15-2.58],0.0085656246166164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVALB,Parvalbumin alpha,22822,109,1.11 [0.95-1.30],0.1979623065982148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,22930,109,1.59 [1.05-2.41],0.0286741138465983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXDNL,Peroxidasin-like protein,19698,87,0.97 [0.67-1.40],0.8531235297891437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXN,Paxillin,22218,108,0.93 [0.67-1.31],0.6889482409531885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYDC1,Pyrin domain-containing protein 1,19224,81,0.89 [0.52-1.55],0.6871685737871147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,19095,82,1.31 [1.09-1.58],0.0049225985504293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PZP,Pregnancy zone protein,19786,88,1.33 [0.77-2.30],0.3135889174923222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QDPR,Dihydropteridine reductase,22604,108,0.95 [0.63-1.43],0.7896632953666535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,22741,107,2.30 [1.25-4.23],0.0072018699456567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,19398,88,1.63 [1.29-2.06],3.744022201221275e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB10,Ras-related protein Rab-10,19770,87,0.78 [0.52-1.17],0.2297018293681724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB11FIP3,Rab11 family-interacting protein 3,19770,87,0.85 [0.70-1.03],0.0901143671493635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB27B,Ras-related protein Rab-27B,19770,87,0.80 [0.63-1.01],0.0606386244122323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB2B,Ras-related protein Rab-2B,19698,87,0.95 [0.67-1.33],0.7482722766078995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB33A,Ras-related protein Rab-33A,19095,82,0.90 [0.64-1.25],0.5316413694655338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB37,Ras-related protein Rab-37,22323,107,0.84 [0.66-1.07],0.166481457933582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB39B,Ras-related protein Rab-39B,19095,82,0.86 [0.65-1.15],0.3198178663212562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19125,83,0.86 [0.57-1.30],0.482606091492619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB44,Ras-related protein Rab-44,19698,87,1.14 [0.77-1.67],0.5124299776183299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6A,Ras-related protein Rab-6A,22700,107,0.81 [0.55-1.19],0.2869341393653349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6B,Ras-related protein Rab-6B,22218,108,1.07 [0.76-1.51],0.7015507058358081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,19321,84,0.68 [0.51-0.91],0.0094961347778152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEPK,Rab9 effector protein with kelch motifs,22178,107,1.06 [0.79-1.41],0.690758752052953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABGAP1L,Rab GTPase-activating protein 1-like,22323,107,0.94 [0.71-1.26],0.7012185285879187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAC3,Ras-related C3 botulinum toxin substrate 3,19237,83,1.00 [0.73-1.37],0.9978195354364168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD23B,UV excision repair protein RAD23 homolog B,22178,107,0.97 [0.67-1.42],0.8929155507292833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD51,DNA repair protein RAD51 homolog 1,19421,86,0.59 [0.35-1.00],0.0490563188963881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALB,Ras-related protein Ral-B,19176,84,1.16 [0.57-2.35],0.6798003389818215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALY,RNA-binding protein Raly,19698,87,1.12 [0.76-1.65],0.5632089153049803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP1,Ran-specific GTPase-activating protein,19224,81,0.87 [0.57-1.31],0.4993108809250633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP2,E3 SUMO-protein ligase RanBP2,19125,83,0.98 [0.51-1.89],0.9537922814578516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,22178,107,0.89 [0.60-1.31],0.5428961106214102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,19176,84,1.07 [0.81-1.42],0.6273057842809295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAPGEF2,Rap guanine nucleotide exchange factor 2,19421,86,0.62 [0.40-0.97],0.0375213932425547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES1,Retinoic acid receptor responder protein 1,22178,107,1.53 [1.06-2.21],0.0216856100215449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,22870,108,1.20 [0.87-1.65],0.2781315160807508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASA1,Ras GTPase-activating protein 1,22218,108,1.36 [0.84-2.19],0.2103553495830163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19082,85,0.86 [0.52-1.41],0.5474881676414051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,22178,107,1.13 [0.87-1.45],0.3644210477037818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,19729,85,1.86 [1.29-2.67],0.000818114617387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBKS,Ribokinase,22196,108,1.06 [0.75-1.49],0.7404160925635279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM17,Splicing factor 45,19729,85,0.94 [0.71-1.24],0.6619991450388132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM19,Probable RNA-binding protein 19,19095,82,0.79 [0.46-1.36],0.3982668557045177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM25,RNA-binding protein 25,19082,85,1.02 [0.65-1.62],0.9175644116593736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP1,Retinol-binding protein 1,19237,83,1.12 [0.86-1.47],0.3971948015933603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP2,Retinol-binding protein 2,22609,108,1.06 [0.85-1.31],0.6196612073594476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP5,Retinol-binding protein 5,22609,108,1.32 [0.98-1.76],0.0641192557707973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP7,Retinoid-binding protein 7,19704,87,1.25 [0.93-1.67],0.1389046458409509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS,RNA-binding protein with multiple splicing,19176,84,0.82 [0.55-1.21],0.3157571888811787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS2,RNA-binding protein with multiple splicing 2,19224,81,0.90 [0.72-1.11],0.323205805667188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCC1,Regulator of chromosome condensation,19698,87,1.19 [0.84-1.70],0.3286891741619948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCOR1,REST corepressor 1,22307,105,0.89 [0.56-1.41],0.6287465711523339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19224,81,1.65 [0.61-4.52],0.3256275867751397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REEP4,Receptor expression-enhancing protein 4,19729,85,0.83 [0.57-1.20],0.3185383661006084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,22605,106,1.55 [1.16-2.08],0.0031605014821052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,23006,109,1.43 [1.10-1.85],0.0070165800935195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,23006,109,1.44 [1.14-1.82],0.0022125079100783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3G,Regenerating islet-derived protein 3-gamma,19698,87,1.15 [0.71-1.87],0.5609609268261277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,22723,107,1.55 [1.15-2.08],0.0043299807860104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELB,Transcription factor RelB,19176,84,1.05 [0.68-1.62],0.8108254639030421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,22727,108,1.70 [1.01-2.87],0.0454049037869194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,22722,109,1.06 [0.87-1.28],0.5819812530826117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REPS1,RalBP1-associated Eps domain-containing protein 1,19176,84,1.05 [0.62-1.80],0.8493955873517889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REST,RE1-silencing transcription factor,19082,85,0.85 [0.45-1.59],0.6093680413524987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22609,108,0.53 [0.34-0.83],0.0050798458731394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,22684,107,1.74 [1.27-2.40],0.0006293836895954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REXO2,"Oligoribonuclease, mitochondrial",19095,82,0.83 [0.50-1.39],0.4835202305565793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RFC4,Replication factor C subunit 4,19698,87,0.76 [0.28-2.04],0.5872196561634067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGCC,Regulator of cell cycle RGCC,19729,85,0.88 [0.67-1.16],0.3771965911009528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19421,86,1.00 [0.73-1.39],0.9791380106159168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMA,Repulsive guidance molecule A,22930,109,1.09 [0.65-1.85],0.741721417121033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMB,RGM domain family member B,22930,109,1.12 [0.62-2.04],0.7013747018889951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS10,Regulator of G-protein signaling 10,19729,85,0.94 [0.66-1.34],0.7396804438860026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,22323,107,0.84 [0.62-1.14],0.2644507793005918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RHOC,Rho-related GTP-binding protein RhoC,22411,108,1.01 [0.87-1.17],0.9234108735327388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RICTOR,Rapamycin-insensitive companion of mTOR,19176,84,0.99 [0.63-1.55],0.9692438107334372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19321,84,0.94 [0.62-1.43],0.7702025473951862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILP,Rab-interacting lysosomal protein,22856,109,0.99 [0.74-1.31],0.929018444758742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILPL2,RILP-like protein 2,19770,87,0.96 [0.78-1.18],0.6753586067716564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19095,82,1.04 [0.76-1.43],0.8054823949091129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN1,Prorelaxin H1,19729,85,0.96 [0.58-1.60],0.8817885624896197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN2,Prorelaxin H2,19286,84,0.74 [0.48-1.14],0.1728737064355139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE1,Ribonuclease pancreatic,19789,88,1.95 [0.98-3.90],0.0587029462318663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE10,Inactive ribonuclease-like protein 10,19224,81,0.95 [0.60-1.49],0.8169859937978465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE3,Eosinophil cationic protein,22611,109,1.05 [0.91-1.21],0.47444874229404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE4,Ribonuclease 4,19153,87,1.54 [0.79-2.99],0.2032288882814389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,19663,88,1.56 [1.03-2.38],0.0377815928763594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASEH2A,Ribonuclease H2 subunit A,19729,85,0.55 [0.31-0.96],0.0339752514672554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,22901,108,2.28 [1.30-4.02],0.0042963328290574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF149,E3 ubiquitin-protein ligase RNF149,19224,81,1.42 [0.74-2.70],0.2895571561891437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF168,E3 ubiquitin-protein ligase RNF168,19176,84,0.67 [0.36-1.23],0.1935151797373932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF31,E3 ubiquitin-protein ligase RNF31,19176,84,0.70 [0.36-1.39],0.312566550593551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF4,E3 ubiquitin-protein ligase RNF4,19421,86,0.82 [0.57-1.17],0.2687262790038824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF41,E3 ubiquitin-protein ligase NRDP1,22178,107,0.90 [0.69-1.18],0.4494259929956722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF43,E3 ubiquitin-protein ligase RNF43,19421,86,0.73 [0.45-1.18],0.1987169158285563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF5,E3 ubiquitin-protein ligase RNF5,19224,81,0.82 [0.62-1.09],0.1824019144555901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO1,Roundabout homolog 1,22723,107,1.36 [0.68-2.73],0.3891206823180327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO2,Roundabout homolog 2,22930,109,1.23 [0.58-2.60],0.5851363932023574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO4,Roundabout homolog 4,19224,81,2.30 [0.70-7.62],0.1715788352868278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22722,109,1.86 [1.12-3.10],0.016780565710101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RP2,Protein XRP2,22609,108,1.11 [0.76-1.63],0.5797888525984797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPA2,Replication protein A 32 kDa subunit,19176,84,0.63 [0.30-1.36],0.2393150563686053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPE,Ribulose-phosphate 3-epimerase,19421,86,0.81 [0.59-1.11],0.1851059585866791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPGR,X-linked retinitis pigmentosa GTPase regulator,19237,83,1.33 [0.88-2.01],0.1702520570573801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPL14,60S ribosomal protein L14,19224,81,0.86 [0.48-1.53],0.6106446620213042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPS10,40S ribosomal protein S10,19095,82,1.32 [0.87-2.00],0.1881365904174143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRAS,Ras-related protein R-Ras,19237,83,0.90 [0.76-1.07],0.2202223584516546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22178,107,1.18 [0.86-1.60],0.3088769291880842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22178,107,0.99 [0.77-1.28],0.946919317638586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRP15,RRP15-like protein,19125,83,0.96 [0.76-1.21],0.7055658897227317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,22521,108,1.34 [0.82-2.19],0.2435160661983543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,22917,109,2.64 [1.58-4.40],0.0002002124272387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTBDN,Retbindin,22609,108,0.80 [0.45-1.43],0.4539809313331531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTKN2,Rhotekin-2,19095,82,1.24 [0.87-1.77],0.2333389388617215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19729,85,0.93 [0.74-1.16],0.501340408844005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,22917,109,1.54 [0.97-2.45],0.0670983388821005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RUVBL1,RuvB-like 1,22178,107,1.02 [0.86-1.21],0.8270252363565241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RWDD1,RWD domain-containing protein 1,22930,109,0.89 [0.67-1.17],0.3985881497401479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RYR1,Ryanodine receptor 1,19095,82,0.79 [0.39-1.57],0.4950040494773458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,22550,108,1.40 [1.06-1.84],0.0174144451779685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,22380,108,1.21 [0.97-1.51],0.098061075055468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,19176,84,1.79 [1.13-2.81],0.0122022534574211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A14,Protein S100-A14,19729,85,0.84 [0.55-1.29],0.4223716069935153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A16,Protein S100-A16,22180,108,0.76 [0.56-1.04],0.0829181215688009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A3,Protein S100-A3,19698,87,0.74 [0.40-1.36],0.3321634927588348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A4,Protein S100-A4,22780,108,0.79 [0.59-1.07],0.1343227787246371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100G,Protein S100-G,19729,85,1.21 [0.82-1.80],0.3329956846955552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100P,Protein S100-P,22307,105,1.15 [0.87-1.52],0.336973915535344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,19786,88,1.65 [1.21-2.25],0.0014612949658832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAFB2,Scaffold attachment factor B2,19729,85,0.85 [0.38-1.90],0.7005316305819778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAG,S-arrestin,19125,83,0.88 [0.57-1.36],0.5721048927736571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22700,107,0.98 [0.77-1.25],0.873721092192861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAP18,Histone deacetylase complex subunit SAP18,19421,86,0.99 [0.74-1.32],0.935568073562716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SARG,Specifically androgen-regulated gene protein,19700,87,0.96 [0.80-1.16],0.6955973598506996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19095,82,0.93 [0.52-1.68],0.820967100264524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT1,Diamine acetyltransferase 1,19095,82,1.19 [0.81-1.75],0.3844451304233877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT2,Thialysine N-epsilon-acetyltransferase,19421,86,1.02 [0.75-1.38],0.9193396078939092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SATB1,DNA-binding protein SATB1,19729,85,0.84 [0.39-1.81],0.6636416314093574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SBSN,Suprabasin,19741,88,0.98 [0.56-1.74],0.9506265952562112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCAMP3,Secretory carrier-associated membrane protein 3,22609,108,0.96 [0.78-1.19],0.7302303420446467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,22930,109,1.58 [0.92-2.71],0.0978805905807466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB1,Scavenger receptor class B member 1,22218,108,0.94 [0.67-1.30],0.6944724371006236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,22077,107,1.86 [1.19-2.93],0.006978601948261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF1,Scavenger receptor class F member 1,23006,109,1.04 [0.69-1.55],0.8568196927114046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,22930,109,2.37 [1.37-4.12],0.0021064143840007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,22822,109,1.83 [1.12-2.99],0.0153175431854589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG3,Secretogranin-3,22723,107,1.19 [0.72-1.98],0.5004816105887466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB1A1,Uteroglobin,22727,106,0.88 [0.65-1.19],0.4197336703756084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB2A2,Mammaglobin-A,19095,82,1.28 [0.68-2.39],0.4432670517864249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A1,Secretoglobin family 3A member 1,19321,84,0.68 [0.30-1.52],0.3455645671524929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A2,Secretoglobin family 3A member 2,22768,107,1.10 [0.90-1.34],0.3711631602195417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGN,Secretagogin,22323,107,1.19 [0.82-1.72],0.3502702229348837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCIN,Adseverin,19125,83,0.92 [0.68-1.24],0.5863732740342582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCLY,Selenocysteine lyase,22856,109,1.15 [0.81-1.64],0.4366846981097586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2A,Sodium channel protein type 2 subunit alpha,19125,83,1.26 [0.87-1.82],0.2242397848386479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2B,Sodium channel subunit beta-2,19237,83,1.14 [0.53-2.44],0.7324904424560362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3A,Sodium channel protein type 3 subunit alpha,19237,83,1.19 [0.69-2.05],0.5362357633489472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3B,Sodium channel subunit beta-3,19125,83,0.86 [0.53-1.40],0.5455948133201095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN4B,Sodium channel subunit beta-4,19224,81,0.86 [0.52-1.42],0.552250952940374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCP2,Non-specific lipid-transfer protein,22178,107,0.98 [0.77-1.24],0.8405175867172519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCPEP1,Retinoid-inducible serine carboxypeptidase,19161,81,0.89 [0.58-1.38],0.6106370064876948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRG1,Scrapie-responsive protein 1,19770,87,1.69 [0.94-3.04],0.0787600399459984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRIB,Protein scribble homolog,19224,81,0.73 [0.54-1.00],0.0486522837029458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRN1,Secernin-1,22700,107,1.01 [0.74-1.38],0.947782162144018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCT,Secretin,19237,83,1.30 [0.86-1.98],0.2159974136769734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC1,Syndecan-1,22722,109,1.17 [0.77-1.77],0.4636874752664984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC4,Syndecan-4,22722,109,0.70 [0.49-0.99],0.0432956590319479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDCCAG8,Serologically defined colon cancer antigen 8,19698,87,0.89 [0.74-1.06],0.1921461430832072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDHB,Succinate dehydrogenase,19704,87,0.90 [0.64-1.28],0.5583850548030533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDK2,Protein sidekick-2,19321,84,1.03 [0.60-1.76],0.9263719199381713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEC31A,Protein transport protein Sec31A,19224,81,0.93 [0.71-1.22],0.5973151148326843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEL1L,Protein sel-1 homolog 1,19224,81,1.11 [0.57-2.18],0.755124591697361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELE,E-selectin,23006,109,0.88 [0.63-1.22],0.4467788811308059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELENOP,Selenoprotein P,19786,88,1.29 [0.55-3.01],0.5607940206525905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELL,L-selectin,19786,88,1.27 [0.53-3.05],0.5864511484766719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELP,P-selectin,22832,108,0.71 [0.52-0.97],0.0317274818463518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELPLG,P-selectin glycoprotein ligand 1,22700,107,0.98 [0.56-1.74],0.9504338308821028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3F,Semaphorin-3F,22722,109,1.32 [0.70-2.49],0.3833532669124756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3G,Semaphorin-3G,19321,84,1.28 [0.82-1.99],0.2795986410751427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,22609,108,0.88 [0.47-1.66],0.6888867831596333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4D,Semaphorin-4D,22930,109,0.71 [0.41-1.23],0.2193094835761846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA6C,Semaphorin-6C,19176,84,1.39 [0.69-2.81],0.3577864709321211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA7A,Semaphorin-7A,22929,109,1.17 [0.66-2.06],0.5904901288397324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN3,Neuronal-specific septin-3,19729,85,1.05 [0.80-1.36],0.7338125133949066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN7,Septin-7,19421,86,1.08 [0.75-1.56],0.680660670954303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN8,Septin-8,19681,86,1.49 [0.82-2.70],0.1861347767292991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN9,Septin-9,22609,108,1.34 [0.78-2.30],0.2859459416648432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,19426,88,2.53 [0.29-22.17],0.400627996584473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,23006,109,1.80 [1.19-2.73],0.005149846297272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA12,Serpin A12,22072,105,1.03 [0.89-1.20],0.7112522219987569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA3,Alpha-1-antichymotrypsin,19727,88,1.52 [0.45-5.21],0.5020205569908691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA4,Kallistatin,19437,86,1.88 [0.79-4.46],0.1517933927548169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA5,Plasma serine protease inhibitor,19505,87,1.05 [0.54-2.04],0.8949978876741148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA6,Corticosteroid-binding globulin,19786,88,1.88 [0.51-6.89],0.3439214572855286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA7,Thyroxine-binding globulin,19786,88,0.61 [0.20-1.83],0.3779957137343296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA9,Serpin A9,22516,108,1.09 [0.87-1.37],0.4596700508731994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB1,Leukocyte elastase inhibitor,22651,108,1.04 [0.86-1.26],0.6589152348496861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB5,Serpin B5,22307,105,1.13 [0.78-1.63],0.5236836603251511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB6,Serpin B6,22851,109,0.90 [0.67-1.21],0.4705502602287578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,22990,109,1.09 [0.84-1.41],0.5078336631045695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB9,Serpin B9,22521,108,1.22 [0.72-2.06],0.4684691536643333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINC1,Antithrombin-III,19754,88,1.81 [0.46-7.21],0.398606772835909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPIND1,Heparin cofactor 2,19754,88,1.43 [0.71-2.92],0.3194913521604922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE1,Plasminogen activator inhibitor 1,23006,109,0.84 [0.66-1.08],0.1809776253900503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE2,Glia-derived nexin,19770,87,0.81 [0.59-1.12],0.1996448457218814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF1,Pigment epithelium-derived factor,19482,88,1.03 [0.47-2.24],0.9472075058052832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,19418,87,2.57 [0.57-11.60],0.21969735099892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,19754,88,1.69 [0.56-5.11],0.3492269827387086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINH1,Serpin H1,19421,86,1.00 [0.85-1.17],0.9929828155946752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI1,Neuroserpin,19290,84,0.85 [0.40-1.81],0.6812965401658582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI2,Serpin I2,19704,87,1.15 [0.81-1.62],0.4320646923379599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22218,108,0.90 [0.68-1.19],0.4457101957354605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SETMAR,Histone-lysine N-methyltransferase SETMAR,22439,108,0.84 [0.47-1.48],0.5360847485565932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6,Seizure protein 6 homolog,19237,83,1.18 [0.60-2.32],0.6299246237062535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L,Seizure 6-like protein,22780,108,1.21 [0.67-2.22],0.5274722420398708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L2,Seizure 6-like protein 2,22609,108,1.23 [0.61-2.51],0.5642478182304302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SF3B4,Splicing factor 3B subunit 4,22609,108,1.03 [0.82-1.30],0.8061570708645935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,22439,108,1.44 [1.01-2.05],0.0459359162072791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP4,Secreted frizzled-related protein 4,19321,84,0.83 [0.49-1.42],0.5001419560407532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA1,Pulmonary surfactant-associated protein A1,22178,107,1.12 [0.84-1.49],0.4507627366706639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,22178,107,1.49 [1.11-2.00],0.0087514536114334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPD,Pulmonary surfactant-associated protein D,22722,109,0.84 [0.66-1.08],0.1755984430011941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SGSH,N-sulphoglucosamine sulphohydrolase,19456,87,1.00 [0.69-1.44],0.9998762121873715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2B3,SH2B adapter protein 3,22178,107,0.94 [0.79-1.12],0.5104536818284919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2D1A,SH2 domain-containing protein 1A,22700,107,0.81 [0.59-1.12],0.2092869021688191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19125,83,1.09 [0.79-1.49],0.6044842539280124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BP1,SH3 domain-binding protein 1,19704,87,0.92 [0.60-1.41],0.7060763371073115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GL3,Endophilin-A3,19312,86,0.81 [0.65-1.01],0.059341281194624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GLB2,Endophilin-B2,19716,86,0.87 [0.64-1.18],0.3626633229942319
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHBG,Sex hormone-binding globulin,19789,88,1.26 [0.81-1.97],0.3067255108207564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHC1,SHC-transforming protein 1,19082,85,1.02 [0.85-1.22],0.8151041269027224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHD,SH2 domain-containing adapter protein D,19062,82,1.18 [0.98-1.42],0.0867822587649463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHH,Sonic hedgehog protein,19176,84,0.56 [0.33-0.95],0.0312986296957974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,19775,88,1.77 [1.08-2.90],0.0239512213625972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22768,107,0.93 [0.76-1.14],0.4902128286970013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHPK,Sedoheptulokinase,19421,86,0.93 [0.54-1.60],0.7860204685981097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIAE,Sialate O-acetylesterase,22740,107,0.93 [0.64-1.35],0.7107928578080791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,22802,107,1.48 [1.00-2.19],0.0479525074689636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22700,107,0.82 [0.50-1.35],0.4302114226609083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC15,Sialic acid-binding Ig-like lectin 15,22218,108,0.87 [0.67-1.13],0.2973550448284805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22727,108,1.15 [0.98-1.36],0.0939559033830169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22917,109,1.42 [0.87-2.32],0.15992950974706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22722,109,0.98 [0.53-1.80],0.94108775616568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19224,81,1.15 [0.73-1.82],0.5481966028043463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22883,109,1.11 [0.64-1.91],0.7207863661229021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIL1,Nucleotide exchange factor SIL1,19224,81,0.84 [0.39-1.82],0.6656451404799836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22780,109,1.26 [0.93-1.73],0.139704435029848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPB1,Signal-regulatory protein beta-1,22645,107,1.13 [0.79-1.61],0.4971286241816476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19176,84,0.81 [0.58-1.12],0.2009648252321607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22609,108,1.01 [0.83-1.23],0.9292982425677532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22218,108,1.14 [0.85-1.53],0.3888452694782984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIT1,Signaling threshold-regulating transmembrane adapter 1,22323,107,1.11 [0.82-1.51],0.4935767576689992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP1,Src kinase-associated phosphoprotein 1,22488,108,0.90 [0.71-1.14],0.3694716413239118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP2,Src kinase-associated phosphoprotein 2,22802,107,0.92 [0.78-1.09],0.324628099974005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKIV2L,Helicase SKI2W,19095,82,0.82 [0.45-1.49],0.50950475585219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLA2,Src-like-adapter 2,19729,85,0.98 [0.81-1.19],0.8413129013496453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,22323,107,1.36 [1.01-1.82],0.0398051625280648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF6,SLAM family member 6,22178,107,0.78 [0.49-1.25],0.3086825188361161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF7,SLAM family member 7,22700,107,1.10 [0.83-1.46],0.5189555047463832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,22178,107,1.17 [0.85-1.62],0.3363646085705978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC12A2,Solute carrier family 12 member 2,19095,82,1.49 [0.79-2.80],0.2187645361361463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC13A1,Solute carrier family 13 member 1,19698,87,0.74 [0.46-1.19],0.2118669465542621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC16A1,Monocarboxylate transporter 1,22218,108,1.11 [0.82-1.49],0.5021443235460933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC1A4,Neutral amino acid transporter A,19237,83,1.00 [0.65-1.53],0.9946901336522994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC27A4,Long-chain fatty acid transport protein 4,22218,108,1.00 [0.76-1.31],0.995251477231289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC28A1,Sodium/nucleoside cotransporter 1,19082,85,1.00 [0.69-1.43],0.9794469947450806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC34A3,Sodium-dependent phosphate transport protein 2C,19082,85,0.89 [0.54-1.44],0.627759048248459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A14,Zinc transporter ZIP14,22218,108,1.25 [0.78-1.99],0.3610266431928287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A5,Zinc transporter ZIP5,22700,107,1.20 [0.88-1.64],0.254793839609401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC44A4,Choline transporter-like protein 4,19237,83,1.18 [0.90-1.54],0.2348953518906433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC4A1,Band 3 anion transport protein,19775,88,0.96 [0.62-1.47],0.8393575451719337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC51B,Organic solute transporter subunit beta,19095,82,0.90 [0.66-1.24],0.524001729658037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19321,84,0.93 [0.72-1.19],0.5520126772909288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19704,87,1.18 [0.84-1.66],0.3442390827212213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19082,85,0.74 [0.48-1.15],0.1797014953909388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIT2,Slit homolog 2 protein,22218,108,0.99 [0.71-1.37],0.9314340588778304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK1,SLIT and NTRK-like protein 1,19176,84,0.54 [0.28-1.03],0.0618237271340237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK2,SLIT and NTRK-like protein 2,22917,109,0.88 [0.58-1.33],0.5374271098332015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK6,SLIT and NTRK-like protein 6,22307,105,1.05 [0.65-1.72],0.8301658078054577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLK,STE20-like serine/threonine-protein kinase,19421,86,0.75 [0.52-1.09],0.1311155661204544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLMAP,Sarcolemmal membrane-associated protein,19704,87,0.90 [0.69-1.16],0.3980813950025043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLURP1,Secreted Ly-6/uPAR-related protein 1,19640,87,1.14 [0.68-1.92],0.6070675386271872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD1,Mothers against decapentaplegic homolog 1,22178,107,0.91 [0.74-1.13],0.402004562869853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD2,Mothers against decapentaplegic homolog 2,19698,87,0.86 [0.63-1.17],0.3335331210393364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD3,Mothers against decapentaplegic homolog 3,19698,87,0.95 [0.63-1.42],0.7916081920450924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD5,Mothers against decapentaplegic homolog 5,22609,108,1.02 [0.42-2.47],0.9639347981190552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMARCA2,Probable global transcription activator SNF2L2,22218,108,0.85 [0.66-1.09],0.205325884085597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMC3,Structural maintenance of chromosomes protein 3,19082,85,0.77 [0.49-1.22],0.2667542826851951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMNDC1,Survival of motor neuron-related-splicing factor 30,19704,87,1.01 [0.74-1.39],0.9349567816022532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,22917,109,1.94 [1.21-3.12],0.0060620716417025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,22802,107,1.30 [0.84-2.01],0.2326147237928222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD1,Sphingomyelin phosphodiesterase,22817,109,0.97 [0.69-1.35],0.843053741577807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD3,Sphingomyelin phosphodiesterase 3,19176,84,0.79 [0.50-1.27],0.3353190444548284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22758,107,1.04 [0.80-1.34],0.7855674598887236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19698,87,0.99 [0.75-1.29],0.9199432658124748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMS,Spermine synthase,19125,83,0.86 [0.59-1.24],0.4237972308637302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMTN,Smoothelin,19676,86,0.92 [0.72-1.17],0.4796674512366474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP23,Synaptosomal-associated protein 23,22722,109,0.91 [0.75-1.09],0.3057017804451873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP25,Synaptosomal-associated protein 25,19125,83,1.11 [0.71-1.72],0.6471916709217191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP29,Synaptosomal-associated protein 29,22780,108,0.89 [0.74-1.07],0.2269225396054032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAPIN,SNARE-associated protein Snapin,19729,85,0.62 [0.43-0.92],0.0162197749381731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCA,Alpha-synuclein,19321,84,0.91 [0.76-1.09],0.2922425878623305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,22521,108,1.41 [1.08-1.83],0.0107967117001157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19224,81,1.25 [0.66-2.37],0.4852439970780708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNRPB2,U2 small nuclear ribonucleoprotein B'',19716,86,1.04 [0.69-1.59],0.8395654874483744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNU13,NHP2-like protein 1,19095,82,0.74 [0.48-1.15],0.1806977351693298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX15,Sorting nexin-15,19321,84,0.77 [0.52-1.14],0.1917911134712385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX18,Sorting nexin-18,19704,87,1.26 [0.84-1.89],0.2584563529132151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX2,Sorting nexin-2,19698,87,0.82 [0.63-1.06],0.1344222259905303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX5,Sorting nexin-5,19224,81,0.87 [0.41-1.86],0.7177795937651861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX9,Sorting nexin-9,22722,109,1.03 [0.80-1.33],0.8015716649976006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD1,Superoxide dismutase [Cu-Zn],22296,106,0.97 [0.67-1.39],0.8492066120741996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD2,"Superoxide dismutase [Mn], mitochondrial",22727,108,0.98 [0.63-1.53],0.9415797382157474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD3,Extracellular superoxide dismutase,19789,88,1.15 [0.88-1.51],0.3059308127937975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,19729,85,1.35 [0.90-2.02],0.1521088470632825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORCS2,VPS10 domain-containing receptor SorCS2,22178,107,1.41 [0.89-2.22],0.1410678926329715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORD,Sorbitol dehydrogenase,22818,109,0.92 [0.72-1.17],0.4818559715305475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORT1,Sortilin,22691,109,0.87 [0.56-1.37],0.5531391434095088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOST,Sclerostin,22691,109,0.79 [0.51-1.22],0.2842409354707337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19237,83,0.87 [0.54-1.41],0.5743436009951448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX2,Transcription factor SOX-2,19685,85,0.82 [0.33-1.99],0.6527862329757528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX9,Transcription factor SOX-9,19237,83,1.90 [0.85-4.22],0.1167248385879764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19729,85,1.41 [0.80-2.48],0.2311324585585964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPAG1,Sperm-associated antigen 1,19729,85,0.85 [0.57-1.25],0.4015623376987387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARC,SPARC,22780,108,0.93 [0.74-1.17],0.5414710899237162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARCL1,SPARC-like protein 1,22756,108,1.56 [0.94-2.56],0.0830165026241008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPART,Spartin,19321,84,0.73 [0.54-0.97],0.0299933610035692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPESP1,Sperm equatorial segment protein 1,19770,87,1.12 [0.62-2.01],0.7066903019543529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,22727,108,1.98 [1.42-2.77],6.616852478118775e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK2,Serine protease inhibitor Kazal-type 2,19321,84,1.25 [0.72-2.16],0.4278525411882415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,22700,107,1.41 [1.12-1.78],0.0032673037618264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK5,Serine protease inhibitor Kazal-type 5,22727,108,1.73 [1.10-2.72],0.0179789448636362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,22917,109,1.32 [0.95-1.83],0.0965570598200982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK8,Serine protease inhibitor Kazal-type 8,19095,82,0.76 [0.38-1.48],0.4153223727771623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,22643,108,1.84 [1.03-3.29],0.0402581915035544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT2,Kunitz-type protease inhibitor 2,22802,107,1.26 [0.82-1.95],0.2941586228401104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT3,Kunitz-type protease inhibitor 3,19704,87,0.95 [0.84-1.07],0.3652765561799226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPOCK1,Testican-1,22521,108,0.72 [0.38-1.37],0.3160545243084363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,22723,107,2.13 [1.43-3.17],0.000202776812292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,22610,108,1.52 [0.94-2.46],0.0901921856119683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,22972,109,1.58 [1.10-2.25],0.0128189889262865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19176,84,0.64 [0.36-1.13],0.1221616286636413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRING1,SREBP regulating gene protein,19082,85,0.87 [0.59-1.30],0.5065245363239494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR1B,Cornifin-B,19421,86,0.88 [0.66-1.17],0.3872535493828567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR3,Small proline-rich protein 3,19716,86,1.02 [0.73-1.42],0.896227872332665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRY2,Protein sprouty homolog 2,22323,107,0.95 [0.79-1.15],0.5960246047187368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19125,83,0.74 [0.35-1.55],0.425767098832553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTLC1,Serine palmitoyltransferase 1,19716,86,0.74 [0.39-1.39],0.3460429992078455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRC,Proto-oncogene tyrosine-protein kinase Src,22744,108,0.97 [0.84-1.12],0.6701895439220821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRP14,Signal recognition particle 14 kDa protein,22609,108,1.24 [0.96-1.61],0.104965460718609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPK2,SRSF protein kinase 2,22700,107,0.89 [0.72-1.11],0.3116959916217852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,19770,87,1.83 [1.06-3.16],0.0303747526389956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSB,Lupus La protein,22218,108,0.91 [0.66-1.25],0.5592622934388809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19176,84,0.87 [0.45-1.66],0.6702964364354953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22691,109,0.87 [0.75-1.00],0.042393783569818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22832,108,1.29 [0.87-1.91],0.2028728789010996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSH3,Protein phosphatase Slingshot homolog 3,19082,85,0.94 [0.45-1.97],0.8744557109903305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19704,87,0.95 [0.64-1.42],0.8116655751310247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST13,Hsc70-interacting protein,19321,84,0.65 [0.44-0.95],0.0273181902074728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22609,108,0.96 [0.64-1.44],0.8273903811638557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23006,109,0.87 [0.49-1.53],0.6189115998020334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19176,84,0.71 [0.40-1.25],0.2331056275591499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAB2,Stabilin-2,19775,88,1.28 [0.61-2.67],0.5178547723570343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAM,Signal transducing adapter molecule 1,19698,87,0.68 [0.36-1.30],0.2441417307785496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAMBP,STAM-binding protein,22488,108,0.90 [0.68-1.18],0.4359795581049731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT2,Signal transducer and activator of transcription 2,19176,84,0.87 [0.66-1.16],0.3436055821807185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT5B,Signal transducer and activator of transcription 5B,22609,108,0.98 [0.87-1.11],0.7692552388881598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19082,85,0.69 [0.46-1.03],0.0710085204678491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,22930,109,1.15 [0.81-1.65],0.4309703837113074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC2,Stanniocalcin-2,22696,108,2.06 [1.01-4.23],0.0477093366850554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STEAP4,Metalloreductase STEAP4,19125,83,0.83 [0.58-1.18],0.2871329600068125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STIP1,Stress-induced-phosphoprotein 1,22683,108,0.97 [0.75-1.27],0.8475820203872286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK11,Serine/threonine-protein kinase STK11,22307,105,1.00 [0.78-1.27],0.9869788907849182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK24,Serine/threonine-protein kinase 24,22218,108,0.93 [0.70-1.24],0.6256344627633124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK4,Serine/threonine-protein kinase 4,22722,109,0.97 [0.80-1.18],0.7685523482578513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STOML2,"Stomatin-like protein 2, mitochondrial",19082,85,1.10 [0.89-1.35],0.3751320756850499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX16,Syntaxin-16,22178,107,0.81 [0.57-1.14],0.233022396357257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX1B,Syntaxin-1B,19237,83,1.10 [0.69-1.76],0.6948738709993756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX3,Syntaxin-3,19716,86,0.61 [0.30-1.23],0.1666998571328685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX4,Syntaxin-4,22609,108,0.92 [0.67-1.26],0.5904896562255576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX5,Syntaxin-5,19176,84,0.78 [0.43-1.42],0.4195198302231154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX6,Syntaxin-6,22178,107,0.71 [0.51-0.98],0.0401347389755351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX7,Syntaxin-7,19176,84,0.69 [0.44-1.07],0.0970887445228176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX8,Syntaxin-8,22700,107,0.95 [0.65-1.37],0.766000525669553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP1,Syntaxin-binding protein 1,19729,85,0.94 [0.72-1.23],0.6544602115966678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP3,Syntaxin-binding protein 3,22178,107,1.06 [0.71-1.57],0.7752579529801921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGP1,SURP and G-patch domain-containing protein 1,19704,87,0.46 [0.25-0.83],0.0105648611282887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGT1,Protein SGT1 homolog,22178,107,1.04 [0.83-1.29],0.7398541837771592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT1A1,Sulfotransferase 1A1,22930,109,1.02 [0.90-1.17],0.7222508137156377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,22700,107,1.23 [0.95-1.60],0.115501780618222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF1,Formylglycine-generating enzyme,19176,84,1.06 [0.78-1.45],0.7051892854750997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22930,109,0.91 [0.66-1.25],0.5578419357735267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUOX,"Sulfite oxidase, mitochondrial",19729,85,0.90 [0.64-1.28],0.5674798524269965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD1,Sushi domain-containing protein 1,22307,105,0.98 [0.69-1.40],0.930418165727822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD2,Sushi domain-containing protein 2,22727,108,1.56 [0.89-2.73],0.1205756765723419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD4,Sushi domain-containing protein 4,19698,87,1.17 [0.71-1.92],0.5387195264200006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD5,Sushi domain-containing protein 5,19225,84,1.22 [0.66-2.25],0.5166665687475729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SV2A,Synaptic vesicle glycoprotein 2A,19237,83,0.80 [0.55-1.16],0.2339123489631177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SWAP70,Switch-associated protein 70,19704,87,0.97 [0.54-1.73],0.9162771745252176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYAP1,Synapse-associated protein 1,19321,84,0.69 [0.47-1.03],0.0720036837268326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19125,83,0.80 [0.52-1.23],0.3057164917676804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYT1,Synaptotagmin-1,19716,86,0.91 [0.52-1.58],0.7370039942522639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYTL4,Synaptotagmin-like protein 4,19770,87,0.82 [0.61-1.11],0.2051583243801128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19421,86,0.81 [0.66-0.99],0.0391249160686614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACC3,Transforming acidic coiled-coil-containing protein 3,22609,108,1.00 [0.87-1.16],0.9549606859849388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,20120,93,2.17 [1.19-3.97],0.011552203213051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TADA3,Transcriptional adapter 3,19698,87,1.15 [0.69-1.90],0.5992709569729626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,22609,108,1.47 [0.96-2.27],0.0786567861703534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAGLN3,Transgelin-3,19082,85,1.16 [0.83-1.61],0.3886472210124898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TALDO1,Transaldolase,19710,88,0.72 [0.44-1.17],0.1803612534869551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TANK,TRAF family member-associated NF-kappa-B activator,22323,107,0.91 [0.71-1.17],0.4566850664482584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAP1,Antigen peptide transporter 1,19421,86,0.90 [0.60-1.35],0.6134253630204124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARBP2,RISC-loading complex subunit TARBP2,22218,108,0.94 [0.76-1.18],0.6149525060259634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19237,83,0.89 [0.65-1.21],0.456775468304111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19698,87,0.96 [0.55-1.68],0.8834489794970981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAX1BP1,Tax1-binding protein 1,19716,86,0.71 [0.49-1.04],0.0802708419835621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D17,TBC1 domain family member 17,22218,108,0.89 [0.59-1.33],0.5605496215806074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D23,TBC1 domain family member 23,22609,108,0.89 [0.73-1.08],0.2267102403084926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D5,TBC1 domain family member 5,22700,107,0.91 [0.73-1.15],0.4469893716931462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCA,Tubulin-specific chaperone A,19321,84,0.84 [0.65-1.08],0.1752693703895541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCB,Tubulin-folding cofactor B,22521,108,1.03 [0.87-1.23],0.6995822488027548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCC,Tubulin-specific chaperone C,22521,108,0.99 [0.80-1.23],0.9592363556518668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22178,107,0.97 [0.79-1.18],0.736990104932651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBR1,T-box brain protein 1,19237,83,0.95 [0.60-1.49],0.8125570956509263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,22492,108,0.78 [0.66-0.92],0.0026267529772879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1B,T-cell leukemia/lymphoma protein 1B,22307,105,0.97 [0.77-1.23],0.8267972780430712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN1,Transcobalamin-1,19410,88,1.27 [0.82-1.99],0.2865143623195831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,22972,109,1.35 [0.80-2.28],0.2569202328499336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCOF1,Treacle protein,19770,87,0.86 [0.44-1.68],0.65112154631123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCP11,T-complex protein 11 homolog,19421,86,1.16 [0.86-1.58],0.3306740601789352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCTN3,Tectonic-3,19770,87,0.87 [0.44-1.69],0.6742898501952787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDGF1,Teratocarcinoma-derived growth factor 1,22218,108,0.94 [0.84-1.06],0.334232918714045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDO2,"Tryptophan 2,3-dioxygenase",19237,83,0.82 [0.45-1.50],0.5180776998758028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDP1,Tyrosyl-DNA phosphodiesterase 1,19698,87,0.89 [0.65-1.22],0.4638503371177843
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDRKH,Tudor and KH domain-containing protein,22218,108,0.99 [0.81-1.23],0.9616653477087006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEF,Thyrotroph embryonic factor,19095,82,1.02 [0.63-1.68],0.922448260106409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEK,Angiopoietin-1 receptor,22780,108,1.82 [0.85-3.86],0.1205209566052076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TERF1,Telomeric repeat-binding factor 1,19176,84,1.01 [0.48-2.12],0.9826013113581517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TET2,Methylcytosine dioxygenase TET2,19388,86,1.15 [0.97-1.35],0.1048034681560788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,19237,83,0.69 [0.49-0.98],0.0401082346857652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX33,Testis-expressed protein 33,19421,86,0.79 [0.42-1.49],0.4649136733027853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TF,Serotransferrin,19786,88,0.71 [0.28-1.82],0.4769388958523494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFAP2A,Transcription factor AP-2-alpha,19125,83,1.02 [0.72-1.44],0.9150713125944832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,22619,108,1.27 [1.05-1.53],0.0116835987508773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,22768,107,1.55 [1.19-2.01],0.0009839409882055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,22723,108,1.63 [1.25-2.13],0.0003146491329346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI,Tissue factor pathway inhibitor,22686,108,0.81 [0.46-1.42],0.4588416127305362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI2,Tissue factor pathway inhibitor 2,22718,108,1.16 [0.81-1.67],0.4129033905290007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFRC,Transferrin receptor protein 1,22830,107,1.07 [0.69-1.66],0.7612500749779374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TG,Thyroglobulin,19698,87,1.04 [0.86-1.26],0.6535507354340397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,22700,107,1.52 [1.09-2.12],0.0134603655053234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB1,Transforming growth factor beta-1 proprotein,22952,108,0.98 [0.63-1.51],0.9152443361692896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB2,Transforming growth factor beta-2 proprotein,19698,87,0.89 [0.59-1.33],0.5594389547648468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22610,107,0.58 [0.30-1.09],0.0885493749904187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR1,TGF-beta receptor type-1,19176,84,1.36 [0.58-3.19],0.4843604792961218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,22780,108,1.72 [1.14-2.60],0.0094493220373406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR3,Transforming growth factor beta receptor type 3,23006,109,1.93 [1.12-3.31],0.0179024611365779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22681,109,0.98 [0.78-1.23],0.8768752070064613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGOLN2,Trans-Golgi network integral membrane protein 2,19789,88,1.97 [0.95-4.12],0.0695856340344053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THAP12,52 kDa repressor of the inhibitor of the protein kinase,19050,85,0.94 [0.72-1.23],0.6357839293179023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBD,Thrombomodulin,22722,109,1.12 [0.64-1.99],0.6876431486230745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,22727,108,1.75 [1.21-2.55],0.0033178176120819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,22762,108,1.63 [1.13-2.34],0.0086068864530984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THOP1,Thimet oligopeptidase,22612,108,0.74 [0.42-1.29],0.2836612366210692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THPO,Thrombopoietin,22307,105,0.96 [0.61-1.49],0.8417768051629352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THRAP3,Thyroid hormone receptor-associated protein 3,19095,82,1.15 [0.98-1.36],0.0929709164846687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THSD1,Thrombospondin type-1 domain-containing protein 1,19034,83,0.74 [0.39-1.43],0.372725226558225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THTPA,Thiamine-triphosphatase,19653,87,0.88 [0.70-1.12],0.3086053699371751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THY1,Thy-1 membrane glycoprotein,22930,109,1.26 [0.71-2.24],0.4357850736208905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIA1,Nucleolysin TIA-1 isoform p40,22063,104,1.03 [0.89-1.19],0.6887872479097769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIE1,Tyrosine-protein kinase receptor Tie-1,23006,109,1.05 [0.70-1.58],0.8251192838350919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22185,108,1.27 [0.90-1.78],0.1695137129968035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19421,86,0.60 [0.32-1.12],0.1078831832475302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22832,108,1.73 [1.19-2.50],0.0040295498698871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19770,87,0.81 [0.48-1.39],0.4530981865560987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19716,86,0.91 [0.71-1.16],0.4424102128359427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,22511,107,1.34 [0.76-2.37],0.3127249808167918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP2,Metalloproteinase inhibitor 2,19770,87,1.43 [0.89-2.27],0.1358738650669292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP3,Metalloproteinase inhibitor 3,22802,107,0.97 [0.85-1.10],0.6276165829798939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,22727,108,1.72 [1.18-2.52],0.0050798812047964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TINAGL1,Tubulointerstitial nephritis antigen-like,22656,109,1.00 [0.46-2.18],0.99199584226356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJAP1,Tight junction-associated protein 1,22780,108,0.85 [0.68-1.05],0.1228790952699587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJP3,Tight junction protein ZO-3,19125,83,0.96 [0.58-1.60],0.8812333919375747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TK1,"Thymidine kinase, cytosolic",19421,86,0.86 [0.53-1.42],0.5616070964669464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR1,Toll-like receptor 1,19176,84,1.10 [0.50-2.43],0.8131395796019866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR2,Toll-like receptor 2,19421,86,1.16 [0.48-2.79],0.7484519359520941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR3,Toll-like receptor 3,22990,109,0.95 [0.72-1.25],0.7229662110683966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR4,Toll-like receptor 4,19176,84,0.87 [0.41-1.87],0.7302766494569461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19237,83,1.30 [0.94-1.81],0.1172566685330574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED1,Transmembrane emp24 domain-containing protein 1,19421,86,0.68 [0.44-1.06],0.0914394241964466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED10,Transmembrane emp24 domain-containing protein 10,19095,82,1.13 [0.79-1.63],0.5036645213089694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED4,Transmembrane emp24 domain-containing protein 4,19095,82,1.12 [0.81-1.56],0.4872302064176222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED8,Protein TMED8,19704,87,0.94 [0.77-1.15],0.5534516855276554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM106A,Transmembrane protein 106A,19698,87,0.82 [0.61-1.11],0.207548756361106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM132A,Transmembrane protein 132A,19224,81,0.94 [0.66-1.33],0.7130936171488068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM25,Transmembrane protein 25,19729,85,1.10 [0.73-1.66],0.6447740536301219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMOD4,Tropomodulin-4,19082,85,0.76 [0.44-1.32],0.3292563236821894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11B,Transmembrane protease serine 11B,19125,83,1.07 [0.82-1.39],0.6282428327002033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11D,Transmembrane protease serine 11D,19681,86,1.34 [0.83-2.17],0.2360830532699679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS15,Enteropeptidase,22609,108,0.88 [0.72-1.07],0.197431669907952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS5,Transmembrane protease serine 5,22413,108,0.86 [0.55-1.33],0.4887476113693427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,22727,108,1.18 [0.94-1.47],0.162441923245765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,22832,108,1.54 [1.10-2.16],0.0116660031831097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNF,Tumor necrosis factor,22276,105,1.10 [0.69-1.73],0.6972497915743264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19704,87,0.91 [0.59-1.40],0.6722899345590418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22323,107,0.94 [0.59-1.49],0.7901466168822333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19321,84,0.75 [0.52-1.07],0.1085687824003287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22521,108,1.58 [1.06-2.37],0.0261519795417503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22521,108,1.30 [1.05-1.63],0.0179755755598108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22794,109,0.99 [0.70-1.40],0.9492244152431656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22990,109,1.52 [1.03-2.26],0.0347379191589738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22689,107,2.24 [1.33-3.79],0.0025558188952886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22780,108,1.43 [0.91-2.24],0.1169530749166175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22723,107,1.62 [1.13-2.31],0.0082271180321298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22323,107,0.81 [0.54-1.22],0.307930716508251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22723,107,1.44 [0.86-2.42],0.167798733153658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19321,84,0.96 [0.58-1.60],0.8823118078869576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22917,109,1.62 [1.04-2.54],0.0339121067775914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22727,108,2.12 [1.33-3.39],0.0016146380249208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22727,108,1.52 [1.08-2.14],0.0161013538608929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22930,109,1.77 [1.00-3.14],0.0494858046306501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22952,108,1.42 [0.93-2.16],0.1022956577623216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22521,108,1.38 [1.06-1.78],0.0156671875760116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22930,109,1.10 [0.76-1.61],0.6051537159300906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22521,108,1.33 [0.94-1.88],0.109808354294278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22990,109,0.45 [0.23-0.87],0.0167497871162125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22700,107,0.79 [0.59-1.04],0.0937324012362011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22990,109,0.73 [0.40-1.34],0.3068525819708108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22802,107,1.54 [0.84-2.83],0.1627092135747763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22970,109,1.77 [1.02-3.06],0.0427473473545578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22521,108,1.11 [0.83-1.48],0.4848397067575566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19775,88,1.10 [0.63-1.90],0.7423806803104269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNIP1,TNFAIP3-interacting protein 1,19716,86,0.84 [0.65-1.07],0.1493249352974631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNN,Tenascin-N,19775,88,1.00 [0.62-1.61],0.9928431068077314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNNI3,"Troponin I, cardiac muscle",22307,105,1.25 [1.01-1.54],0.0424204609088479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNPO1,Transportin-1,19421,86,0.76 [0.42-1.38],0.3658140491446153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,22521,108,0.88 [0.58-1.32],0.5320779262571069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNXB,Tenascin-X,22727,108,1.14 [0.59-2.18],0.6979014532036183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19770,87,0.83 [0.63-1.11],0.2067801079196352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1,DNA topoisomerase 1,19704,87,0.93 [0.79-1.10],0.3829367180241924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1MT,"DNA topoisomerase I, mitochondrial",19082,85,1.34 [0.94-1.92],0.1054961211513412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP2B,DNA topoisomerase 2-beta,19176,84,0.94 [0.72-1.23],0.6548848045595823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOR1AIP1,Torsin-1A-interacting protein 1,19224,81,0.97 [0.64-1.46],0.8711129431780384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53,Cellular tumor antigen p53,22178,107,1.01 [0.68-1.50],0.9504243600933876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53BP1,TP53-binding protein 1,19176,84,0.95 [0.73-1.22],0.6704533730411937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53I3,Quinone oxidoreductase PIG3,18907,83,0.73 [0.48-1.10],0.1355159456549457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22307,105,1.30 [0.80-2.09],0.2911075518304559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP73,Tumor protein p73,19237,83,1.50 [0.81-2.78],0.1932359504730889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPBGL,Trophoblast glycoprotein-like,19237,83,0.87 [0.50-1.49],0.6016691380494874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPD52L2,Tumor protein D54,19321,84,0.94 [0.78-1.14],0.5449520338222564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPK1,Thiamin pyrophosphokinase 1,19770,87,0.59 [0.28-1.23],0.1564112004487291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPM3,Tropomyosin alpha-3 chain,19095,82,1.14 [0.74-1.76],0.5595048132372253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPMT,Thiopurine S-methyltransferase,22178,107,0.98 [0.76-1.25],0.8617365336108253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPP1,Tripeptidyl-peptidase 1,22540,106,0.96 [0.66-1.40],0.838627018966295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP2,Tubulin polymerization-promoting protein family member 2,19421,86,0.80 [0.58-1.10],0.1659715134694955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP3,Tubulin polymerization-promoting protein family member 3,22218,108,0.82 [0.50-1.34],0.4252732953614159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPR,Nucleoprotein TPR,19095,82,0.81 [0.49-1.35],0.4235041483605622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPRKB,EKC/KEOPS complex subunit TPRKB,19082,85,1.15 [0.88-1.50],0.3110275729377691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,22952,109,1.07 [0.77-1.49],0.6732246393387699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSD1,Tryptase delta,19729,85,0.98 [0.56-1.72],0.9515277279532406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSG1,Tryptase gamma,19176,84,0.77 [0.34-1.76],0.5425593405968757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPT1,Translationally-controlled tumor protein,22323,107,1.08 [0.84-1.37],0.5579713351331026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF2,TNF receptor-associated factor 2,22700,107,0.79 [0.61-1.02],0.0653406851909074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19176,84,0.62 [0.32-1.19],0.1503239457664009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19095,82,0.91 [0.56-1.46],0.6831131932055345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19421,86,0.89 [0.68-1.15],0.3540507074300523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREH,Trehalase,19775,88,1.11 [0.84-1.46],0.4627866738170736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREM2,Triggering receptor expressed on myeloid cells 2,22689,107,0.95 [0.70-1.31],0.7638360698354284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML1,Trem-like transcript 1 protein,19789,88,0.73 [0.49-1.09],0.1274524675633903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML2,Trem-like transcript 2 protein,22727,108,1.09 [0.67-1.76],0.7370302354133375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22917,109,1.15 [0.87-1.51],0.3227089255472466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM21,E3 ubiquitin-protein ligase TRIM21,22700,107,0.86 [0.69-1.09],0.2095289910003739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM24,Transcription intermediary factor 1-alpha,19388,86,0.95 [0.68-1.32],0.7397018470096757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19704,87,0.83 [0.68-1.01],0.0564814131380426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM26,Tripartite motif-containing protein 26,19082,85,0.88 [0.59-1.32],0.5363395241360103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM40,E3 ubiquitin ligase TRIM40,19237,83,0.98 [0.73-1.32],0.9073838035159624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM5,Tripartite motif-containing protein 5,22700,107,0.99 [0.81-1.21],0.8986740348884006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM58,E3 ubiquitin-protein ligase TRIM58,19698,87,0.83 [0.65-1.06],0.1298648442176031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRPV3,Transient receptor potential cation channel subfamily V member 3,19095,82,1.26 [0.90-1.78],0.1792164228074773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC1,Hamartin,19176,84,0.66 [0.43-1.00],0.0498245635017208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC22D1,TSC22 domain family protein 1,19729,85,0.91 [0.66-1.27],0.5821124550097798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSHB,Thyrotropin subunit beta,22722,109,0.82 [0.64-1.05],0.109462131693024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSLP,Thymic stromal lymphopoietin,22307,105,0.76 [0.54-1.07],0.1186296845842245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSNAX,Translin-associated protein X,19095,82,0.72 [0.41-1.26],0.248584861389553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN1,Tetraspanin-1,22307,105,0.95 [0.78-1.17],0.6552789926122458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN15,Tetraspanin-15,19095,82,1.18 [0.84-1.66],0.3374942524277698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN7,Tetraspanin-7,19125,83,0.98 [0.78-1.23],0.8640720308134276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN8,Tetraspanin-8,19704,87,1.06 [0.85-1.32],0.5935382129872957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPYL1,Testis-specific Y-encoded-like protein 1,19176,84,1.13 [0.67-1.90],0.6557860083014362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TST,Thiosulfate sulfurtransferase,22182,108,0.94 [0.74-1.18],0.5803214031978439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTF2,Transcription termination factor 2,19237,83,0.57 [0.35-0.91],0.0176759908006908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTN,Titin,19095,82,1.03 [0.75-1.41],0.865901417724311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTR,Transthyretin,19580,86,0.66 [0.29-1.47],0.3081160509708687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TUBB3,Tubulin beta-3 chain,19125,83,1.30 [0.64-2.63],0.4635897199420065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TWF2,Twinfilin-2,19775,88,0.94 [0.73-1.19],0.5996749114885851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXK,Tyrosine-protein kinase TXK,19421,86,0.92 [0.68-1.25],0.6043827713157173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXLNA,Alpha-taxilin,22521,108,0.93 [0.76-1.13],0.4624341141760149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXN,Thioredoxin,19483,87,0.91 [0.56-1.50],0.7191601592120012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC15,Thioredoxin domain-containing protein 15,22780,108,1.50 [0.81-2.75],0.1947431635660705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC5,Thioredoxin domain-containing protein 5,22930,109,1.04 [0.82-1.34],0.7298110659616586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC9,Thioredoxin domain-containing protein 9,19716,86,0.95 [0.63-1.41],0.7837615420893775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNL1,Thioredoxin-like protein 1,19091,83,0.81 [0.61-1.06],0.1215462502358573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22727,108,0.92 [0.63-1.34],0.6622501411608631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYMP,Thymidine phosphorylase,22580,107,1.02 [0.78-1.33],0.8846639299878557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRO3,Tyrosine-protein kinase receptor TYRO3,22722,109,1.21 [0.66-2.21],0.5297020948767768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19176,84,1.19 [0.85-1.67],0.313661651503397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBAC1,Ubiquitin-associated domain-containing protein 1,22609,108,0.88 [0.53-1.45],0.6096558733349917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2B,Ubiquitin-conjugating enzyme E2 B,19698,87,0.79 [0.37-1.66],0.5307635938652995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19770,87,0.93 [0.66-1.32],0.6976751541010621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19176,84,0.87 [0.59-1.28],0.4792413906896839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,19095,82,1.48 [1.16-1.88],0.0015100320851528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBXN1,UBX domain-containing protein 1,19321,84,0.85 [0.62-1.18],0.3344533267414369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19704,87,0.95 [0.82-1.10],0.459964556466909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UGDH,UDP-glucose 6-dehydrogenase,19095,82,0.94 [0.74-1.19],0.6126159994910956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UHRF2,E3 ubiquitin-protein ligase UHRF2,19095,82,1.00 [0.53-1.88],0.9907597258373452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ULBP2,UL16-binding protein 2,22521,108,1.13 [0.74-1.73],0.5770727648989753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UMOD,Uromodulin,22928,109,0.70 [0.53-0.94],0.0162010053379677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC5D,Netrin receptor UNC5D,19176,84,0.71 [0.31-1.63],0.4181927338988778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC79,Protein unc-79 homolog,19082,85,0.83 [0.55-1.25],0.3790973755632358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNG,Uracil-DNA glycosylase,19698,87,0.85 [0.46-1.57],0.6056410071838236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPB1,Beta-ureidopropionase,19770,87,1.11 [0.89-1.38],0.340802186676406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3A,Uroplakin-3a,19125,83,1.13 [0.74-1.72],0.5795891542103152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3BL1,Uroplakin-3b-like protein 1,19377,86,0.81 [0.50-1.31],0.3964522825245895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROD,Uroporphyrinogen decarboxylase,19321,84,0.81 [0.59-1.11],0.1876129962157349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROS,Uroporphyrinogen-III synthase,19237,83,0.71 [0.49-1.01],0.0589995100775402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USO1,General vesicular transport factor p115,22609,108,1.01 [0.84-1.23],0.8811083844662465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19698,87,0.87 [0.65-1.17],0.3573257317128776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19716,86,1.22 [0.74-2.03],0.4365311102844826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19095,82,0.97 [0.75-1.25],0.813979869002858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22307,105,0.97 [0.81-1.18],0.7803114643323965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UXS1,UDP-glucuronic acid decarboxylase 1,22178,107,1.00 [0.71-1.40],0.9976228434902492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP5,Vesicle-associated membrane protein 5,22307,105,1.11 [0.81-1.51],0.5264760709023064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP8,Vesicle-associated membrane protein 8,19176,84,0.89 [0.69-1.14],0.3496093355489029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22700,107,1.04 [0.85-1.28],0.7050643716207696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASN,Vasorin,22384,104,1.14 [0.61-2.13],0.68470746029473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASP,Vasodilator-stimulated phosphoprotein,19789,88,0.90 [0.68-1.20],0.4900328953959295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22609,108,0.67 [0.28-1.62],0.3728692273100482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAV3,Guanine nucleotide exchange factor VAV3,19125,83,0.94 [0.76-1.17],0.6047818624685679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,22798,108,1.91 [1.08-3.38],0.0268556593422868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAN,Versican core protein,22930,109,1.72 [1.00-2.95],0.0501089136862576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCPKMT,Protein-lysine methyltransferase METTL21D,19082,85,1.00 [0.78-1.28],0.9818461536889947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFA,Vascular endothelial growth factor A,22918,108,0.86 [0.63-1.17],0.3314267145150976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFB,Vascular endothelial growth factor B,19176,84,0.77 [0.38-1.59],0.4847145703488337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFC,Vascular endothelial growth factor C,22780,108,0.87 [0.65-1.18],0.3708996995759984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,22958,108,1.34 [0.86-2.10],0.1975863377526147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VGF,Neurosecretory protein VGF,19729,85,0.54 [0.27-1.08],0.0810907315146517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIM,Vimentin,22307,105,1.00 [0.86-1.16],0.989211780709818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIPR1,Vasoactive intestinal polypeptide receptor 1,19224,81,1.25 [0.53-2.93],0.606163516128569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIT,Vitrin,19770,87,1.54 [0.91-2.61],0.1064411599444451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VMO1,Vitelline membrane outer layer protein 1 homolog,22609,108,0.98 [0.76-1.25],0.8441132862227807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN1,Pantetheinase,19789,88,0.93 [0.71-1.23],0.6159020847255413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,22609,108,1.32 [0.91-1.93],0.1465656928137495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19421,86,0.85 [0.61-1.19],0.3393958590921636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS37A,Vacuolar protein sorting-associated protein 37A,22609,108,0.91 [0.73-1.13],0.38326986132173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS4B,Vacuolar protein sorting-associated protein 4B,19698,87,0.93 [0.75-1.16],0.5035681612543919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22609,108,0.92 [0.73-1.15],0.445067816940682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10,V-set and immunoglobulin domain-containing protein 10,19698,87,0.84 [0.45-1.58],0.5927476922286457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19095,82,0.86 [0.44-1.67],0.6480613070236891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,19698,87,1.27 [0.95-1.70],0.1076264504257882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,22696,108,1.76 [1.21-2.56],0.0030538997821722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22687,109,0.95 [0.72-1.26],0.717806565704701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSNL1,Visinin-like protein 1,19716,86,0.92 [0.53-1.58],0.7612742622365946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM1,V-set and transmembrane domain-containing protein 1,22218,108,1.04 [0.75-1.46],0.7986118583632619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2B,V-set and transmembrane domain-containing protein 2B,19421,86,0.80 [0.45-1.43],0.4531904188826455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22307,105,0.87 [0.64-1.20],0.4035071229389227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22930,109,0.95 [0.75-1.21],0.7011053230563182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22178,107,1.54 [0.94-2.54],0.0878385380653223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19321,84,0.68 [0.45-1.03],0.0700940433339703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA1,von Willebrand factor A domain-containing protein 1,22890,109,1.09 [0.73-1.64],0.6663062416700527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA5A,von Willebrand factor A domain-containing protein 5A,19082,85,0.84 [0.60-1.16],0.2867672274856844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2,Brorin,22447,108,1.23 [0.81-1.85],0.3326587570766067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2L,von Willebrand factor C domain-containing protein 2-like,19729,85,0.71 [0.40-1.28],0.2535959101608621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWF,von Willebrand factor,23006,109,1.02 [0.81-1.28],0.8495395689105457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22727,108,1.13 [0.72-1.77],0.588878484199804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WAS,Wiskott-Aldrich syndrome protein,22323,107,0.90 [0.68-1.18],0.4395731937767404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF1,Wiskott-Aldrich syndrome protein family member 1,22307,105,0.93 [0.77-1.12],0.4378778755946605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF3,Wiskott-Aldrich syndrome protein family member 3,22218,108,0.98 [0.80-1.20],0.8219316456574978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASHC3,WASH complex subunit 3,19716,86,0.79 [0.59-1.07],0.1334350018497037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASL,Neural Wiskott-Aldrich syndrome protein,19176,84,0.79 [0.52-1.19],0.2577385123953974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WDR46,WD repeat-containing protein 46,19698,87,1.01 [0.58-1.75],0.9741051621349164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC1,WAP four-disulfide core domain protein 1,19301,85,1.00 [0.68-1.46],0.9851453578067136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC12,WAP four-disulfide core domain protein 12,22869,109,1.13 [0.87-1.46],0.370981497010772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,21588,101,1.95 [1.38-2.75],0.000158410326992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22439,108,0.66 [0.44-1.01],0.0568469566279666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22723,107,1.19 [0.71-2.00],0.4997305550057207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,22917,109,1.92 [1.19-3.11],0.0079171646431265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,22323,107,1.73 [1.02-2.95],0.0434770414957386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22521,108,0.73 [0.52-1.02],0.0663700626940285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,22917,109,1.22 [0.92-1.62],0.1703638923187411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,22902,109,1.65 [1.03-2.63],0.0365233550350169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XIAP,E3 ubiquitin-protein ligase XIAP,19176,84,0.73 [0.50-1.09],0.1262189229174282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,22780,108,0.89 [0.77-1.03],0.1304186971994408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XRCC4,DNA repair protein XRCC4,22218,108,0.67 [0.40-1.10],0.1110293180833399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,19716,86,3.28 [1.78-6.04],0.0001339940082609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19704,87,0.99 [0.86-1.14],0.8676837799880117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YES1,Tyrosine-protein kinase Yes,22609,108,0.95 [0.82-1.11],0.5353226922949016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YJU2,Splicing factor YJU2,19698,87,1.09 [0.59-2.04],0.7748504820342436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,19095,82,0.70 [0.49-0.99],0.0441400758999687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YTHDF3,YTH domain-containing family protein 3,22323,107,0.93 [0.76-1.14],0.4825366217848861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YWHAQ,14-3-3 protein theta,19321,84,0.81 [0.60-1.09],0.1559237167299353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YY1,Transcriptional repressor protein YY1,19176,84,0.54 [0.25-1.20],0.1310158150666614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBP1,Z-DNA-binding protein 1,19176,84,0.76 [0.41-1.39],0.3683722361559831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB16,Zinc finger and BTB domain-containing protein 16,22178,107,0.91 [0.71-1.17],0.4726284327012443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB17,Zinc finger and BTB domain-containing protein 17,22307,105,0.90 [0.59-1.39],0.6465987325572599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19095,82,0.80 [0.53-1.20],0.2788288665321304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZFYVE19,Abscission/NoCut checkpoint regulator,19704,87,0.97 [0.77-1.22],0.8069323291404736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZHX2,Zinc fingers and homeoboxes protein 2,19716,86,0.88 [0.46-1.70],0.7029403545303945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF174,Zinc finger protein 174,19176,84,0.93 [0.51-1.69],0.8046306125918504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF75D,Zinc finger protein 75D,19421,86,0.97 [0.69-1.38],0.8858820254708457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,19698,87,1.31 [1.07-1.61],0.0098766032151971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRD2,Protein ZNRD2,19704,87,0.96 [0.71-1.30],0.8002597467760127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19698,87,1.05 [0.72-1.53],0.8179476529353045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP3,Zona pellucida sperm-binding protein 3,19224,81,1.00 [0.92-1.08],0.9990644008866968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP4,Zona pellucida sperm-binding protein 4,19082,85,0.66 [0.30-1.48],0.3173093108669975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZPR1,Zinc finger protein ZPR1,19125,83,0.93 [0.73-1.19],0.5857250142000494
